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ABSTRACT 
Connexins are gap junction proteins which allow selective permeability of small 
metabolites and ions between cells. Three main cardiac isoforms (Cx40, Cx43 and 
Cx45) which have been extensively studied are unequally distributed throughout the 
heart, suggesting specific functional roles. Connexins 40, 43 and 45 null mice have 
been shown to develop cardiac abnormalities, including conduction disturbances 
similar to those of known human diseases. Interestingly, features of human myotonic 
dystrophy (DM) include cardiac conduction disturbances; the DM-causative gene 
encodes a protein kinase (DMPK) that is a ligand of the COOH-terminus of Cx43. 
This has lead to the suggestion that other unidentified Cx ligands may be involved in 
cardiac conduction, and, if defective, may cause conduction disease. It is proposed 
that such ligands may be involved in the pathophysiology of the conduction disease 
PFHB II. To date, most studies have focused on Cx43; hence the main aim of this 
study was to assess functional specificity of cardiac Cx45 to further understand its 
role in cardiac function and possibly in the development of cardiac conduction 
diseases. Yeast-2-hybrid technology was applied to identify putative Cx45 ligands; 
by constructing a bait clone encoding the Cx45 COOH-terminus domain and using it 
to screen a cardiac cDNA library in S. cerivisiae. Successive selection stages 
reduced the number of putative ligands from 371 to 25. Selected ligands were 
identified by sequence homology searches in Genbank databases and prioritised for 
further study based on likely biological relevance and subcellular localisation. The 
authenticity of putative protein interactions was further assessed by mammalian 2 
hybrid analysis. The priortised ligands included three mitochondrial proteins (NADH 
dehydrogenase subunit IV, thioredoxin 2, and cytochrome C oxidase subunit I), and 
four cytoplasmic proteins (obscurin, myomegalin, CD63-antigen and SCF-apoptosis 
response protein 1) which bore biological relevance to cardiac function. In contrast, 
in another study (R. Keyser, 2007, MSc Thesis – University of Stellenbosch) most 
Cx40 ligands were cytoplasmic proteins.  
 
In addition to Y2H and M2H, whole exome sequencing (WES) was conducted to 
identify PFHBII-causing mutations. Numerous filtering and variant prioritization tools 
were used to identify plausible PFHBII-causing variants in the PFHBII patients based 
on in silico predictions of their potential to cause disease and the function of these 
genes its situated in. These included two variants associated with obscurin, a Cx 45 
ligand. This variant was was also identified in three of the patients which could be 
predicted to cause disease. Based on chromosome mapping, the Cx 45 ligands 
identified in the current study could be excluded from involvement in PFHB II. 
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Obsurin, in spite its chromosomal location, is an exception due to its clinical 
association with dilated cardiomyopathy, a clinical symptom of PFHBII. The link 
between obscurin and dilated cardiomyopathy in PFHBII patients needs to be 
investigated further. 
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OPSOMMING 
Connexins (Cx) is gaping verbindings proteïene wat die selektiewe deurlaatbaarheid 
van klein metaboliete en ione tussen selle toelaat. Drie goed-bestudeerde hart iso-
forme (Cxs40, 43 en 45) is oneweredig deur die hart versprei, wat dui op hul 
spesifieke funksionele rolle. Daar is aangetoon dat Cx uit-klop muise hartkwale 
ontwikkel, onder meer geleidingsongeruimdhede soortgelyk aan sekere bekende 
menssiektes.  Dit is interessant om op te merk dat menslike miotoniese distrofie 
(DM) kenmerke soos hartgeleidingsongeruimdhede insluit; die DM-veroorsakende 
geen kodeer vir ‘n proteïen-kinase (DMPK) wat ‘n ligand van die karboksielterminus 
van Cx43 is.  Hierdie observasie het gelei tot die voorstel dat ander, 
ongeïdentifiseerde Cx ligande betrokke kan wees by hartgeleiding en, indien 
defektief, geleidingsiekte mag veroorsaak.  Daar is voorgestel dat sulke ligande 
betrokke kan wees by die patofisiologie van die geleidingssiekte PFHBII.  Tot op 
hede het meeste studies gefokus op Cx43; derhalwe was die hoofdoel van hierdie 
studie om die funksionele spesifisiteit van hart Cx45 te bepaal om sodoende ‘n beter 
begrip van Cx45 se rol in hartfunksie, of moontlik in die ontwikkeling van 
hartgeleidings siektes, te vorm.  Gis-2-hibried-tegnologie is aangewend om 
moontlike Cx45 ligande te identifiseer; ‘n aas-kloon wat kodeer vir die COOH-
terminale domein van Cx45 is gekonstrueer en is gebruik om ‘n hart kDNS-biblioteek 
te fynkam in S. cerevisiae.  Opeenvolgende selekteerstadiums het die hoeveelheid 
moontlike ligande verminder van 371 na 25. Geselekteerde ligande is geïdentifiseer 
deur sekwensie-homologie soektogte in Genbank databasisse en is geprioritiseer vir 
verdere studie op grond van hul waarskynlike biologiese relevansie en subsellulêre 
lokalisering.  Die egtheid van moontlike proteïen-interaksies is verder bepaal deur 
soogdier 2-hibried analise.  Die geprioritiseerde ligande sluit in drie mitokondriale 
proteïene (NADH dehidrogenase sub-eenheid IV, tioredoksien 2 en  sitokroom C 
oksidase sub-eenheid I) en vier sitoplasmiese proteïene (obskurien, miomegalien, 
CD63-antigeen en SCF-apoptosis respons proteïen 1) wat biologies relevant is tot 
hartfunksie.  Hierteenoor het ‘n studie (R. Keyser, 2007, MSc Thesis – University of 
Stellenbosch),) bevind dat meeste Cx40 ligande sitoplasmiese proteïene is.     
 
Behalwe vir Y2H en M2H, is wieele exome sequencing (WES) uitgevoer om PFHBII-
veroorsakende mutasies te identifiseer. Verskeie filter- en 
variantprioriteringsinstrumente is gebruik om waarskynlike PFHBII-veroorsakende 
variante in die PFHBII-pasiënte te identifiseer gebaseer op siliko voorspellings van 
hul potensiaal om siekte te veroorsaak en die funksie van hierdie gene is geleë in. 
Dit sluit twee variante in wat verband hou met obscurine, 'n Cx 45 ligand. Hierdie 
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variant was ook geïdentifiseer in drie van die pasiënte wat voorspel kan word om 
siekte te veroorsaak. Gebaseer op chromosoom kartering, kan die Cx 45 ligande wat 
in die huidige studie geïdentifiseer is, uitgesluit word van betrokkenheid by PFHB II. 
Obsurien, ten spyte van sy chromosomale ligging, is 'n uitsondering as gevolg van sy 
kliniese assosiasie met verwydde kardiomyopatie, 'n kliniese simptoom van PFHBII. 
Die verband tussen obskurine en verwydde kardiomyopatie in PFHBII pasiënte moet 
verder ondersoek word. 
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THESIS STRUCTURE 
The thesis is structured as four chapters. In Chapter 1 (Sections 1.1.2 to 1.1.7) the 
literature for the connexin structure in gap junction architecture and formation, their 
role in cell-cell communication, protein-protein interaction, cardiovascular function 
and diseases associated with connexin mutations is presented.  Further literature for 
connexin deficient animal models, selected inhetited cardiac conduction disorders, 
methods to study protein-protein interactions as well as whole exome sequencing is 
presented (sections 1.1.8 to 1.1.11). Section 1.1.12 presents the research focus and 
study objectives.   
 
Chapter 2 is organized into 2 parts, where part I one focuses on the methodology 
followed for the identification of Cx 45 ligands while part II entails the approach 
adopted for whole exome sequencing and analysis of bioinformatics data.  
 
Chapter 3 presents the results obtained from the experiments conducted while 
Chapter 4 discusses the study outcomes and concludes the thesis.  
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1.1  INTRODUCTION 
The cells of multicellular organisms need to communicate with each other for the 
successful exchange of nutrients and signals. In order to achieve this goal, 
multicellular organisms have evolved multiple strategies. These include long-range 
interactions mediated by neural or endocrine mechanisms or short-range interactions 
mediated by direct physical contact. This is accomplished in a number of ways, 
mostly by the formation of a series of pores, or communicating channels, which 
facilitate cell–cell communication. In animal cell systems, gap junctions between the 
cells form one such communication system (Dbouk et. al., 2009; Hussain, 2014; 
Vinken, 2016; Aasen et. al., 2018). 
 
For the heart, a multicellular organ, to beat efficiently, both physical and electrical 
factors come into play, which facilitate the synchronised manner in which 
cardiomyocytes operate. This synchrony is a result of three types of cell junctions 
known as the fascia adherens and desmosomes, which both serve as anchors of 
the desmin cytoskeleton facilitating structural connectivity, and gap junction 
proteins, which facilitate the passage of ions from one cell to another (Severs, 2000; 
Dbouk et. al., 2009; Vinken, 2016; Aasen et. al., 2018). So, because of their role in 
cell-cell communication and in cardiac impulse propagation, gap junctions will be the 
focal point of this review.  
  
Gap junction channel communication is one of the most widespread communication 
mechanisms in animal cells. It was first demonstrated in 1959, by Hama, who 
ultimately published the first electron micrographs of gap junctions in earthworm 
giant axons (Hama, 1959). In the same year, studies were performed in nerve cells 
of crayfish where it was noted that, by inserting an electrode in each of the 
interacting cells and applying some voltage, a large amount of current flowed 
between them (Furshpan et al, 1959). Subsequent studies also showed that small 
fluorescent dye molecules injected into a cell could pass to a second cell without 
leaking into the extracellular space (Simpson et al, 1977, Brink and Dewey, 1980). 
These findings were collectively significant in shedding light on the cell-cell 
communication phenomenon, making gap junctions the pillar of cell-cell 
communication studies. 
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Gap junction channels are mainly constituted of a conglomerate of proteins known 
as connexins (Cxs) which gives the channels the ability to selectively allow the 
passage of ions and small particles, from one cell to another. Six of these Cx units 
make up half a channel, which is also known as a connexon (Bruzzone, 2001, Evans 
and Martin, 2002, Dbouk et al, 2009; Hussain, 2014, Vinken, 2016; Aasen et. al., 
2018).  
 
To date, 21 Cx isoforms have been identified in humans, some of which have been 
linked to known human diseases. They extend from isoforms of 21 to those of 70 kilo 
daltons (kDa) in size (Martin and Evans, 2004, Hussain, 2014; Vinken, 2016; Aasen 
et. al., 2018). This variation in molecular weight is useful in distinguishing the various 
isoforms, for instance, a 45kDa Cx is referred to as Cx45. In another system, 
different Cxs are abbr eviated with GJ, for gap junction, and serially numbered 
according to the order of their discovery. Additionally, the three α, β and γ Cx gene 
homology groupings are considered. These groupings are determined by comparing 
DNA sequences and length of the cytoplasmic domains, particularly that cytoplasmic 
loop and the carboxyl (COOH)-terminal domain by ClustalW alignments (Sohl and 
Willecke, 2003). Connexin 43, for instance, was the first of the α-group to be 
discovered, and was designated GJA1. Connexin 45, although now known to be in 
the γ-group, is still known as GJA7, because it was initially perceived to be an α–
group member (Sohl and Willecke, 2003). So, due to discrepancies such as these, 
the former system, based on molecular weight, is the most favoured in distinguishing 
the various Cxs.   
 
Work by Fernandez et al., 2005 identified the PFBH II causative gene locus to be in 
the 2.85 Mb regions in Chromosome 1q13.2 – q13.3. Subsequent to this, no studies 
have been conducted to explore the causative genes of this condition using next-
generation sequencing (NGS). Recent advances in next generation sequencing have 
evolved our understanding of many cardiovascular diseases which provides insights 
to other types of heart diseases and the management of these disorders.   
 
Whole-exome sequencing (WES) is application of the next-generation technology to 
determine the variations of all coding regions, or exons, of known genes. WES 
provides coverage of more than 95% of the exons, which contains 85% of disease-
causing mutations in Mendelian disorders and many disease-predisposing SNPs 
throughout the genome. For this reason, sequencing of the complete coding regions 
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(exome) has the potential to uncover the causes of large number of rare, mostly 
monogenic, genetic disorders as well as predisposing variants in a number of 
diseases(Rabbani et al., 2014) including PFBH II under study.  
 
1.2  CONNEXIN STRUCTURE IN GAP JUNCTION ARCHITECTURE 
All Cx isoforms present a common topology, composed of four transmembrane 
segments; three (TM1, TM2 and TM4) of which are hydrophobic, while the third 
segment (TM3) is amphipathic; three loops - one intracellular (IL) and two 
extracellular (EL1 and EL2) - and a cytoplasmic amino (NH2-) terminus and a 
carboxyl (COOH-) terminus (Bruzzone, 2001; Pfenniger et. al., 2011; Solan and 
Lampe, 2017) (Figure 1.1). The four transmembrane domains possess α-helical 
conformations and, as shown in Figure 1.1, the two extracellular loops, which 
facilitate docking by recognising compatible Cxs, are held together by di-sulphide 
bonds through three cystein residues (Martin and Evans, 2004). The amino acid 
sequences of EL1 and EL2 and the NH2-terminus are highly conserved (van Veen et 
al., 2001) among the various isoforms, while major differences are observed in the 
amino acid sequence and length of the COOH-terminus (Goodenough et al., 1996; 
Evans and Martin, 2002) and the IL (Saez et al., 2003). In the present study, it was 
based on these differences and on its involvement in protein-protein interactions that 
the COOH-terminal domain of Cx45 was used as bait in the yeast-2-hybrid (Y2H) 
“fishing expedition”. The rationale was that the COOH-terminal domain would allow 
selection of the specific Cx45 ligands, which would ultimately give an indication of 
specific and possibly overlapping functions of various isoforms. 
  
Cxs present a common topology, and they have also been shown to generally 
present a common and simple gene structure, which constitutes two exons, one of 
which contains part of the 5’ untranslated region (5’UTR), separated by an intron of 
variable length, while the other exon constitutes the remaining 5’UTR segment, a full 
coding region and the 3’ untranslated region (3’UTR) (Figure 1.2) (Sohl and Willecke, 
2004). The Cx43 gene, one of the major cardiac isoforms, presents this gene 
structure (Figure 1.2).  
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Figure 1.1 Generic connexin topology and arrangement on cell membrane.  
Connexins span the membrane four times with two highly conserved extracellular 
loops (EL1 and EL2). The amino (NH2) terminus, intracellular loop (IL) and carboxyl 
terminus (COOH) lie within the cytoplasm (Martin and Evans, 2004). 
 
 
 
Figure 1.2 Common gene structure of a connexin with splicing of 5’UTR.  
The part in orange represents the coding region (adapted from Sohl and Willecke, 
2004). 
 
Connexin genes 40 and 45, on the other hand, present a rather more complex 
structure which is thought to be due to the usage of alternate promoters, with 
multiple transcription factors (to be discussed in section 1.1.4.3), and alternative 
3’ 5’ 
Exon 1 Exon 2 
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splicing which then produce different 5’ UTRs of the Cx mRNA (Oyamada et al., 
2005, 2013). The Cx40 gene in humans has only two exons, similar to the structure 
presented in figure 1.2, while in mice it consists of three exons as shown in Figure 
1.3 A. On the other hand, Cx45 in humans consists of three exons (exons 1 and 2 
containing the 5’ UTR and exon 3, part of the 5’UTR, the full coding region as well as 
the 3’UTR) (Figure 1.3C) while in mice, it has five exons (exon 1A, exon 1B, exon 
1C, exon 2 containing the 5’UTR and exon 3, which contains the rest of the 5’UTR, 
the coding region, as well as the 3’UTR) (Sohl and Willecke, 2003; Teunissen and 
Bierhuizen, 2004; Anderson et al., 2005). As can be seen in Cx40 and Cx45, Cxs 
may also present varying transcripts between species as well as among different 
tissues of a species. In Cx40 for instance, the transcript containing exon AS (Figure 
1.3A) is scarce in hearts of mice embryos but abundant in the oesophogus 
(Oyamada et al., 2005, 2013).  
 
 
Figure 1.3 Gene structures presented by the most prominent cardiac Cxs, 
Cx40, Cx43 and Cx45, in human, mice and rats.  
A=Mouse Cx40, B=Human Cx40, C=Mouse Cx45, D= Human Cx45;  
D
, 
1A 1B AS 2 
1A 1B 2A 
1A 1B 1C 2 
1 2 3 
5’ 
5’ 
5’ 
5’ 
3’ 
3’ 
3’ 
3’ 
C 3 
A 
B 
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Parts in orange represent coding regions; the transcript containing exon AS mCx40 
is sometimes absent in mice embryos (adapted from Teunissen and Bierhuizen, 
2004, Oyamada et al., 2005). 
 
1.3  CONNEXINS IN GAP JUNCTION FORMATION 
Connexins, like all eukaryotic transmembrane proteins, are synthesised by 
ribosomes that are bound to the endoplasmic reticulum (ER) membrane. Thereafter, 
they are either assembled into connexons and trafficked from the endoplasmic 
reticulum (ER) to the plasma membrane or are directly inserted in the plasma 
membrane where they dock head-to-head to form fully functional gap junction 
channels as shown in Figure 1.4 (Martin and Evans, 2004, Aasen et. al., 2018).   
 
Figure 1.4 Gap junction formation.  
After translation, connexins are inserted in the membrane of the endoplasmic 
reticulum (ER) and oligomerised to connexons in the Golgi apparatus. Thereafter, 
they are delivered to the plasma membrane where they dock head-to-head to form a 
functional gap junction channel. N= Nucleus; (A) some Cx proteins are directly 
inserted in the plasma membrane while others are packaged in the ER transported 
to the plasma membrane (B) (Evan and Martin, 2002, Aassen et. al., 2018).   
Gap junctions exist in various configurations of Cx units, which can oligomerise to 
form homomeric and heteromeric connexons, as well as homotypic and heterotypic 
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channels as shown in Figure 1.5. Homomeric connexons and homotypic channels 
form when identical Cxs assemble, while heterotypic channels form when different 
homomeric connexons dock head-to-head. Biheteromeric channels, on the other 
hand, form when heteromeric connexons assemble (Moreno, 2004).  
 
Figure 1.5 Combinations of cardiac Cxs 43 and 45 forming gap junction 
channels (Moreno, 2004). 
These highly variable combinations in connexon oligomerisation may greatly affect 
permeability of gap junction channels (Elenes et al., 1999; Moreno, 2004) where 
under conditions of mechanical, or ischemic stress, allowing the flux of small 
molecules like Ca2+, ATP, glutamate, or NAD+ across the plasmamembrane, 
thereby eliciting signaling cascades and diverse physiological responses (Evans et 
al., 2006; Retamal et al., 2015). 
 
1.4  GAP JUNCTIONS AND THEIR ROLE IN CELL-CELL COMMUNICATION 
Intercellular communication in multicellular organisms is the basis for all 
physiological processes. It is mediated by gap junctions, previously perceived as a 
group of cell junctions which control the direct exchange of cellular metabolites 
between cells. To date, intercellular communication is known to influence a wide 
range of cellular and physiological processes (Vinken et al., 2006, Aasen, 2015 and 
Aasen et. al., 2016). For instance in cardiac function, gap junctions facilitate the flow 
of the action potential from one cardiomyocyte to another, providing rhythmic 
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contraction of the heart (Veenstra et al., 1990). At some synapses in the brain, they 
allow the arrival of an action potential at the synaptic terminals to be transmitted 
across the postsynaptic cell, needed for the release of a neurotransmitter 
(Kelmanson et al., 2002). Additionally, before childbirth, gap junctions between the 
smooth muscle cells of the uterus enable coordinated, powerful contractions to begin 
(Ciray et al., 1994). Essentially, they selectively allow ions and other metabolites to 
move between cells (Evan and Martins, 2002, Nielsen et. al., 2012), electrically 
connecting and transforming them from individual cells to a highly synchronised 
organ (Evans and Martins, 2002; Vinken, 2016).  
 
Gap junction channel communication involves the passage of small and hydrophilic 
molecules, less than 1kDa in size, such as metabolites (eg., adenosine triphosphate 
or [ATP]), nutrients (eg., glucose), and second messengers (eg., potassium ions 
(K+), sodium ions (Na+) and calcium ions [Ca2+]) (Alexander and Goldberg, 2003). It 
is regulated at several levels ranging from Cx gene transcription to gap junction 
degradation (Vinken et al., 2006; Hussain, 2014; Vinken, 2016). Gap junction 
channel communication is regulated via three communication networks, namely, (i) 
intracellular communication: Cx proteins affect gene expression of a number of 
regulatory proteins, (ii) intercellular communication: gap junctions mediate passage 
of signalling molecules between cells and (iii) extracellular communication: 
hemichannels control paracrine release of cellular metabolites (Vinken et al., 2006; 
Vinken et. al., 2015; Vinken, 2017). As these communication networks work 
together, for the purpose of this review, the focus will be on intercellular 
communication because of the role of gap junctions in cardiac impulse propagation. 
 
Gap junction channel intercellular communication is regulated by two broad factors; 
namely gating, also described as fast-control, and Cx gene expression, or long-term 
control (Holder et al, 1993). Gating, which can be subdivided into voltage or 
chemical, is said to be triggered by a number of factors including transmembrane 
voltage (Vm) and transjunctional voltage (Vj) (voltage gating) and hydrogen ions (H
+) 
and Ca2+ (chemical gating). Phosphorylation of the COOH-terminal of Cx has also 
been implicated in chemical gating of gap junction channels (Seaz, 2003; 
Epifantseva and Shaw, 2018). Conversely, long-term regulation involves regulation 
of Cx gene expression by various steps in the pathway from DNA to RNA to protein; 
steps such as transcription control which is mediated by factors such as T-box 
transcription factors (Tbx5, Tbx2 and Tbx3), Sp1/Sp3, activator protein 1 (AP-1), 
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cyclic AMP, Nkx2-5 and epigenetic factors such as DNA methylation (Oyamada et 
al., 2005; Vinken et al, 2006; Vinken, 2017). The following sub-sections will thus give 
an overview of selectivity, as well as fast-control and long-term control, in the 
regulation of gap junction cell-cell communication.  
 
1.4.1  Selectivity and permeability 
Selectivity and permeability of gap junction channels is the pinnacle of gap junction 
channel intercellular communication and is governed by a number of both physical 
and electrical factors. It depends primarily on channel physical properties, including 
pore structure, surface charge and, in some instances, the interaction between the 
pore and the permeant. Differences in selectivity represent the diversity of 
mechanisms of conduction in specific combinations of Cxs, which is also influenced 
by conductance of the specific Cx isoforms (Elenes, 2000; Moreno, 2004, Vinken, 
2016). For instance, each homotypic Cx45 gap junction channel has a conductance 
of approximately 40pS* and a selectivity cation:anion ratio of 10:1, while Cx40 (+/- 
200pS*) and Cx43 (+/- 100pS*) have a 2:1 and 4:1 ratio, respectively, which means 
that each channel allows passage of a certain number of cations per anion (Moreno 
et al., 1995; Veenstra, 1996; Valiunas, 2002 and Valiunas et al., 2002). From these 
findings, it can therefore be deduced that channels of low conductance more freely 
allow passage of cations than channels of higher conductance.  
 
* Unitary conductance results from the amount of current that passes through a 
single channel and is usually measured in Ohmic Sum (pS) (Frangie, 1997)  
 
1.4.2  Fast-regulation 
Voltage-gating 
Voltage-gating in gap junctions implies the closing and opening of the channels as a 
result of voltage differences across the connexons of abutting cells. These 
differences may also arise as a result of variability in the degree of sensitivity among 
the constituent Cx isoforms (Spray, 1994). The voltage-sensitivity and potential 
difference exhibited by gap junctions also have the ability to metabolically uncouple 
communicating cells (Bukauskas and Verselis, 2004). For instance, when each of 
the two abutting cells has an equal voltage, no transjunctonal voltage is produced as 
the voltage amounts in each cell cancel the other out, which results in free passage 
of particularly large molecules such as cAMP. However, when transjunctional voltage 
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is produced between the two adjoining cells, the cells are electrically coupled but 
metabolically uncoupled. All in all, transjunctional voltage electrically couples the 
cells, but limits the passage of larger molecules (Bukauskas and Verselis, 2004).    
 
Chemical-gating 
Chemical-gating in gap junctions is governed by a myriad of factors which, directly or 
indirectly, affect the interaction of channels with their surrounding membranes. 
These factors include pH, Ca2+ concentration and phosphorylation. 
 
i. pH  
Intracellular pH has always been thought to play a major role in gap junction channel 
gating and has been tested in various cell types expressing different Cx isoforms. 
When Delmar compared the pH sensitivity in oocyte pairs expressing a range of Cxs, 
a spectrum of sensitivity that spread from Cx50 to Cx32, as shown in decreasing 
order -Cx50 >Cx46 >Cx45 >Cx26 > Cx37 >Cx43 >Cx40 >Cx32 (Delmar, 2002) – 
was observed. It was evident that indeed intracellular pH affected various isoforms in 
varying degrees. Among the three isoforms predominantly expressed in the heart, 
Cx45 seemed to be the most sensitive to pH.  In other words, Cx45 gap junction 
channels, closed readily at low pH. This has also been suggested to serve as a 
mechanism to limit the spread of injury from damaged to normal tissue. In fact, 
Bukauskas and Peracchia (1997) showed in HeLa cells and in fibroblasts from 
sciatic nerves transfected with Cx43 and Cx45 that low pH produces full uncoupling 
of Cx43 and Cx45 gap junction channels, by inducing slow gating transitions 
between open and closed states (Bukauskas and Peracchia, 1997). They also 
deduced that gating activity of individual Cxs could be fast, but may not always be 
synchronous, which gives the false impression that transitions between open and 
closed states are slow, or consist of a series of resolvable transient sub-transitions. 
 
The most studied mechanism of Cx acidification is the one that occurs by 
cytoplasmic acidification. The H+ binding that initiates the gating effect of pH has 
been shown to be on the cytoplasmic side of the hemichannels, possibly near the 
entrance of the pore. In fact, several studies performed in Xenopus oocytes 
suggested that the cytoplasmic loop and COOH-terminal domain residues are 
important in pH gating (Ahmed et al., 2001). The COOH-terminal domain has also 
been suggested to behave like a gating particle that binds to a receptor domain 
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which leads to channel closure (Girsch and Peracchia, 1991). Furthermore, 
experiments by Wang and Peracchia in Xenopus oocytes demonstrated that 
replacing the cytoplasmic loop of Cx32 with that of Cx38 increased pH-gating 
sensitivity to that of Cx38 channels, further supporting the proposal that the 
cytoplasmic loop is important in pH-sensitive gating (Wang and Peracchia., 1998). It 
is in fact the first 11 residues of the COOH-terminal domain that significantly 
modulate pH-gating sensitivity of the Cx channels. These observations were 
collectively made by groups of Torok and Saez, where they showed that deletion of 
272 of up 283 amino acid residues, of the COOH-terminal domain of Cx32 did not 
affect the kinetics of uncoupling (Saez et al., 1990; Torok et al., 1997). Additionally, 
Girsch and Peracchia showed that replacing five positively charged arginines (R215, 
R219, R220, R223 and R224) of the 11, either with polar residues asparagine, 
histidine or glutamic acid, increased the sensitivity of Cx32 channels to intracellular 
acidification induced by application of CO2. Interestingly, the initial segment of the 
COOH-terminal domain was identified as a calmodulin (CaM)-binding domain 
(Girsch and Peracchia, 1991) and its basic residues would be expected to be 
relevant for interaction with CaM, which may plug the channel mouth (Peracchia et 
al., 1996).  
 
ii. Phosphorylation 
Protein phosphorylation is a reversible process in which protein functions are 
regulated by kinase-mediated addition of a phosphate group, principally to serine 
(S), threonine (T) or tyrosine residues (Y) (Ciesla et al., 2011; Davis, 2011). Many 
critical events involved in cellular responses are mediated by phosphorylation and 
dephosphorylation. These include regulation of enzymatic activity, protein 
conformational change, protein–protein interaction and cellular localisation (Huttlin et 
al., 2010; Davis, 2011; Nishi et al., 2011). Abnormal phosphorylation has been 
implicated in many diseases such as cancer (Grek et al.,, 2016; Banerjee et al., 
2016; Kitini et al., 2015; Boucher et al., 2017; Philips et al.,, 2017, Stoletov et al., 
2013), brain disorders (Nakase et al., 2004; Giaume et al., 2013; Cotrina et al., 
2012), obesity (Ganesan et al., 2015), diabetes (Wright et al., 2012) and 
immunological disorders influencing inflammatory responses (Wong et al., 2017), 
activation of T lymphocytes (Oviedo-Orta et al., 2010; Kuczma et al., 2011 and Ni et 
al., 2017) and haematopoietic stem cell maintenance  (Ishikawa et al., 2012; Genet 
et al., 2018;Saez et al., 2003; Colomer and Means, 2007). Connexins 26, 31, 32, 36, 
37, 40, 43, 45, 46, 50 and 56 have been shown to be be regulated by 
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phosphorylation (Saez et al., 1998; Lampe and Lau, 2000; Lampe et al., 2000; Locke 
et al., 2009).  
A number of Cx-phosphorylation studies focussed on serine (S), threonine (T) and 
tyrosine (Y) amino acids via protein kinase B (PKB/Akt) (Dunn et al., 2011), c- and v-
src, mitogen-activated protein kinase (MAPK), protein kinase C (PKC), p34cdc2, 
casein kinase 1 (CK1), protein kinase A (PKA) or calmodulin-dependent protein 
kinase pathways (Saez et al., 1998; Lampe et al., 2000; Lampe and Lau, 2004; 
Solan and Lampe, 2005, 2009). Basic amino acid phosphorylation for Cxs has not 
been reported.  
 
In Cxs, phosphorylation of cytoplasmic residues mainly occurs in the C-terminal 
domain (Cooper et al., 2000; Rikova et al., 2007; Wisniewski et al., 2010), and 
occasionally in the N-terminal domain (Wisniewski et al., 2010; Chen et al., 2012) or 
cytoplasmic loop domain (Berthoud et al., 1997; Alev et al., 2008; Rigbolt et al., 
2011). 
In multiple tissues, Cxs are regulated by multi-site phosphorylation resulting in 
altered Cx-protein synthesis and turnover, trafficking, membrane insertion and 
aggregation. Hence, Cx phosphorylation is involved in the efficient delivery of 
hemichannels to the gap junction plaque (Palatinus et al., 2011a; Johnson et al., 
2012), gap junction channel assembly, function and turnover under both normal and 
disease conditions (Saez et al., 1998; Lampe and Lau, 2000, Saez et al., 2003; 
2004; Laird, 2005; Solan and Lampe, 2005, 2007, 2009; Marquez-Rosado et al., 
2011). However, it is suggested that phosphorylation is neither required for Cx 
insertion to the membrane (Musil et al., 1990; Solan and Lampe, 2005) nor for the 
formation of functional channels (Martinez et al., 2003; Johnstone et al., 2009).  
 
Studies of truncation constructs of Cx43 showed that truncated at aa 236 was not 
trafficked to the to the membrane, whereas Cx43 truncated at aa 239 remained able 
to traffic to the membrane and form functional gap junction channels, but not 
functional hemichannels (De Vuyst et al., 2007; Wayakanon et al., 2012). Thus, only 
a portion of the Cx43 C-terminal domain is shown to be required for its trafficking. 
 
To date, the effects of phosphorylation on Cx43 structure and function have been 
extensively reviewed (Solan and Lampe, 2009; Jeyaraman et al., 2011; Marquez-
Rosado et al., 2011; Johnstone et al., 2012; Yeganeh, 2012; Slavi, 2018). There is a 
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paucity of studies investigating the phosphorylation of other Cx isoforms. Cx45 
phosphorylation in the C-terminal domain differentially regulates electrical 
intercellular conductance via Cx45 gap junctions. Yet, regulation does not alter the 
single channel conductance, but most likely modulates the open probability of Cx45 
gap junction channels (van Veen et al., 2000). Phosphorylation of Cx45 occurs at 
S381, S382, S384 and S385. Mutating these serine residues into phosphodead 
mutants, in order to disable Cx45 phosphorylation, increased the turnover rate of 
Cx45 (Hertlein et al., 1998). 
 
iii. Calcium ion concentration  
In 1877, Engelmann reported that cardiac cells in direct contact with each other 
during life became independent as they died (Engelmann, 1877), a phenomenon 
believed to result from the formation of ionic barriers between injured and uninjured 
cells (reviewed by Peracchia et al., 2004). Approximately a century later, Délèze 
(1970) reported that cut heart fibres from rats do not heal in the absence of 
extracellular calcium (Ca2+), but do so rapidly when Ca2+ is supplied as a result of 
Ca-induced cellular uncoupling which limits the spread of injury to other parts of the 
tissue. This observation, suggested for the first time the role of Ca in the regulation 
of gap junctional communication. Later, the role of Ca2+ in cell uncoupling was 
confirmed through a study correlating loss of electrical and dye coupling among cells 
exposed to treatments known to increase intracellular Ca2+ concentration (Paracchia, 
1980). Additional evidence of the importance of Ca2+ was provided by studies of 
Rose and Lowenstein, where they showed that in insect gland cells, monitored by 
the Ca2+ indicator aequorin (a photoprotein isolated from luminescent jellyfish, 
Aequorea species), electrical uncoupling coincides with an increase in 
Ca2+concentration (Rose and Loewenstein, 1975, 1980).  
In various cells, Ca is said to self-limit its cell–cell diffusion. Initially, it was reported in 
pancreatic acinar cells (Yule et al., 1996) then another report by Leite et al., (2002) 
confirmed this observation in human hepatoma (SK-Hep1) cultured cells. The latter 
authors, showed Ca2+, uncaged by photolysis in one SK-Hep1 cell expressing either 
Cx32 or Cx43, to be restricted to one cell and never to spread to its neighbouring 
cells. These findings further suggested that an increase in intracellular Ca2+ 
concentration closes gap junction channels and completely uncouples the abutting 
cells (Peracchia et al., 2004).  
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Additionally, Ca2+ has also been shown to indirectly interact with the constituent Cxs 
via an intermediate component. Girsch and Peracchia (1991) and Lurtz and Louis 
(2003) collectively made the following observations when studying the mode of 
interaction between Cxs and Ca2+. Since Cxs typically contain only one acidic 
residue facing the cytosol, Ca2+ could not directly interact with Cxs. Furthermore, this 
residue was a glutamate situated in between the TM4 and the COOH-terminal 
domains (residue 208 in Cx32) and was believed to be incapable of binding Ca2+ with 
sufficiently high affinity to affect gating. This residue was unable to distinguish 
between Ca2+and magnesium ions (Mg2+), and was not near the pore. Thus, they 
postulated that the Ca2+ effect on gating was mediated by an intermediate 
component, possibly CaM (reviewed by Peracchia et al., 2004). 
1.4.3  Long-term regulation 
As previously indicated, long-term regulation of gap junction channel communication 
is one of the two routes believed to contribute to gap junction channel gating. As the 
term suggests, it is based on the length of time required to effect regulatory changes 
in function, ranging from a few minutes to hours, and mainly involves Cx gene 
expression (Vinken et al., 2006, 2015).  
 
The general Cx gene structure contains different promoter sites for specific 
transcription factors (section 1.1.2), which ultimately control gap junction channel 
activity. These factors include TATA box binding-protein, Sp/Sp3, AP-1, Nkz2-5, 
GATAA4 and Tbx5 (Oyamadu et al., 2005), to name but a few. These factors may 
suppress or enhance Cx gene expression. For instance, cardiac specific Nkx2-5, a 
transcription factor critical for cardiac development (Bruneau, 2002), also associated 
with the development of cardiac conduction defects such as atrial septal defects 
(ASD) (Shiojima et al., 1995) and heart block, down-regulates the expression of 
Cx43 (Jay et al., 2004). Tbx5, also implicated in the development of Holt-Oram 
syndrome (HOS) (to be discussed later in section 1.1.9), up-regulates Cx40 gene 
expression (Bruneau et al., 2001).  
 
Apart from cis/trans regulation, Cx gene expression is also controlled by epigenetic 
factors such as DNA methylation of the Cx gene promoters. DNA methylation of 
Cx32 and Cx43 promoter regions has been shown to result in Cx gene silencing 
(Piechocki et al., 1999; Tan et al., 2002; D’hondt et al., 2013). Apparently, promoter 
methylation interferes with the binding of some activators resulting in lack of Cx gene 
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expression. Although no clear correlation has been made between promoter 
methylation and Cx gene expression, down-regulation of Cx26 in breast cancer cells 
(Singal et al., 2000), of Cx32 in human renal carcinoma cells (Yano et al., 2004) and 
Cx32 in human renal carcinoma cells (Yano et al., 2004) has been observed.   
 
In short, evidence suggests that regulation of Cx gene expression by both 
transcription and epigenetic factors plays a vital role in cell-cell communication. It 
can be speculated that, for instance, if gene expression of certain Cxs is down-
regulated or suppressed, this would ultimately disrupt Cx oligomerisation, which in 
turn may result in the development of disease. 
 
Summary of section 1.4 
In summary, from gating factors discussed from section 1.1.4.1 to section 1.1.4.3, it 
can be deduced that gap junction channel communication has layers of complexity. 
In most cases, it is simultaneously regulated by many of the factors discussed, by 
varying mechanisms, which makes it challenging to tease out individual components, 
in order to understand gap junction intercellular communication. However, findings 
from studies such as those mentioned above have, to a certain extent, shed some 
light in this phenomenon, making Cx proteins plausible platforms for gaining an 
understanding of the role of ion channels in cell-cell communication.   
 
1.5  CONNEXINS AND PROTEIN-PROTEIN INTERACTIONS 
Connexins have been shown to interact with a diverse array of proteins to form multi-
protein complexes (Duffy et al., 2002; Herve et al., 2004; Epifantseva and Shaw, 
2018). Such interactions are likely to regulate Cx function at several levels, including 
gating. Studies have also shown the possible involvement of these interactions in the 
modulation of Cx function in response to physiological stimulation and pathological 
conditions, to be introduced below (Thomas et al., 2002; Fu et al, 2004; Aasen et al., 
2018).  
 
1.5.1  Adherens Junction-Associated Protein interactions 
Gap junctions have been shown to form a close association with cadherin-based 
adherens junctions. Cadherins comprise a major family of transmembrane 
glycoproteins known to play an important role in the regulation of cell adhesion and 
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cell motility (Juliano, 2002; Wheelock and Johnson, 2003). Cadherins have the ability 
to disrupt cell-cell coupling and have been shown to play a vital role in gap junction 
formation. In fact, inhibition of cadherin function by anti-cadherin antibodies disrupts 
cell-cell coupling (Frenzel and Johnson 1996; Hertig et al., 1996; Kostin et al., 1999; 
Meyer et al., 1992; Zuppinger et al., 2000). Cadherin-mediated cell adhesion is also 
regulated by signaling through the Rho-Guanosine triphosphatases (Rho-GTP)-ases 
and receptor tyrosine kinases (Wheelock and Johnson, 2003), as well as through a 
variety of extracellular signals that include signals passed through gap junctions 
(Paul et al., 1995). The cytoplasmic domains of cadherins bind α/β-catenins and 
other F-actin binding proteins, including α-actinin, vinculin, and zonula occludens-1 
(ZO-1) and thus provides linkage to the actin cytoskeleton (Nagafuchi, 2001). In rat 
cardiac myocytes, β-catenin interacts with Cx43 (Ai et al., 2000), and the formation 
of the Cx43/ZO-1/β-catenin complex is required for targeting of Cx43 to the plasma 
membrane (Wu et al., 2003).  
 
Another study also suggests that α-catenin is important for Cx43 trafficking and 
assembly (Govindarajan et al., 2002). Given that N-cadherin and catenins are co-
assembled in the ER/Golgi compartments (Wahl et al., 2003), this raises the 
possibility that Cx43 is assembled as part of a multi-protein complex that may 
regulate both adherens and gap junction assembly. It should also be borne in mind 
that most Cxs follow this route of assembly (section 1.1.4), which suggests that Cx45 
and other Cxs may play a role in gap junction assembly, as part of the multi-protein 
complex. 
 
It is also interesting to note that another adherens junction protein interacts with one 
of the major cardiac Cx isoforms. Mussini et al., (1999) provided evidence for 
colocalisation of Cx43 and myotonic dystrophy protein kinase (DMPK), the product of 
the mytonic dystrophy gene (DMPK), in rat cardiac muscle. Mytonic dystrophy 
protein kinase is found to localise in specialised structures in both heart and skeletal 
muscle, particularly in intercalated disks (van der Ven et al., 1993, Whitney et al., 
1995, Salvatori et al., 1997). The manner in which Cx43 and DMPK interact is 
unclear, however, Mussini et al. (1999) showed, with the use of polyclonal 
antibodies, the interaction to be on the cytoplasmic face of the gap junction. From 
the data presented by this study, they further suggested the participation of this 
interaction is a regulatory mechanism of connexon activity (Mussini et al, 1999). 
These findings have in fact formed part of the rationale for our current study, which 
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was to identify ligands of cardiac Cx45 in order to gain further understanding of the 
functional specificity cardiac Cxs – and to investigate their possible role in cardiac 
conduction disturbances, details of which will be discussed in section 1.1.11. 
 
1.5.2  Cytoskeletal Protein Interactions 
A number of investigations indicate that gap junctions constituted exclusively of 
Cx43, in vitro, may be closely associated with cytoskeletal proteins. One study, in 
Morris hepatoma H5123 cells, showed that formation of functional Cx43 gap 
junctions required elevated cAMP and intact microfilaments, which suggests the 
possibility that clustering of Cx43 gap junctions may involve protein kinase A (PKA) 
and actin filaments (Wang and Rose, 1995). The association of Cx43 with actin 
filament, and perhaps other actin-binding proteins, was also implicated in studies 
with cultured astrocytes, where microinjection of anti-actin antibody impaired Cx43 
membrane trafficking and inhibited gap junctional communication (Theiss and Meller, 
2002). Direct interaction of Cx43 with microtubules also has been demonstrated in 
lysates from rat liver epithelial T51B cells, human fibroblasts, and HEK293 cells 
(Giepmans et al., 2001, Guo et al., 2003). Although the nature of this interaction is 
still unclear, it is possible that Cx43 acts as an anchor to stabilise microtubules, or it 
may serve to regulate Cx43 expression and distribution via the integrin-mediated cell 
signaling pathway (Giepmans et al., 2001; Guo et al., 2003; Dunn and Lampe 2014). 
 
1.5.3  Tight junction Associated Proteins 
As mentioned in subsection 1.1.5.1, Laing et al., (2001) showed that the COOH-
terminal domain of Cx43 binds ZO-1 in osteoblastic cells. Connexin 43 has also 
been shown to bind to ZO-1 in several cells, such as KEK 293 and COS7 cells, and 
this interaction is regulated by phosphorylation of Cx43 by Src tyrosine kinases 
(Giepmans et al., 2001; Toyofuku et al., 1998). Zonula occludens-1 is a peripheral 
membrane scaffolding protein that is specifically enriched at the tight junctions of 
epithelial and endothelial cells (Stevenson et al., 1986). It functions to tether 
transmembrane proteins to the actin cytoskeleton (Denker and Nigam, 1998) and is 
also part of adherens junctions (Itoh et al., 1993). Although the role of ZO-1 in the 
functioning of both Cx43 and Cx45 is not clear, it is possible that ZO-1 serves as a 
scaffold to recruit signaling molecules and/or actin filaments to members of the Cx 
family, which may help in regulating gap junction formation, with the conversion of 
the actin cytoskeleton or with intracellular signaling (Wei et al., 2004).  
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1.5.4  Caveolin and Membrane Microdomain 
Connexin 43 has also been shown to interact with caveolin-1 (CAV-1), a structural 
protein that resides in a specialised lipid raft domain known as a caveolae (Schubert 
et al., 2002). Lipid rafts are membrane microdomains enriched in cholesterol and 
glycosphingolipids, which serve as a platform for a number of diverse cellular 
processes such as signal transduction, endocytosis, and cholesterol trafficking (Pike, 
2004). The functional significance of Cx43’s interaction with CAV-1 is still unclear, 
while Cx45 has not yet been shown to have a role in cholesterol trafficking or any of 
the above-mentioned processes. Extrapolating from the polarity of Cxs in general, 
and structural similarities between Cx43 and Cx45, it is possible that Cx45 is also 
involved in regulating cholesterol trafficking through a non-specific association.  
 
In summary, it can be deduced from the findings discussed in subsections 1.1.5.1 – 
1.1.5.4, that Cxs interact with a variety of proteins and molecules to facilitate efficient 
functioning of physiological processes. It is also evident that most of these findings 
are derived from studies with Cx 43 and it is therefore important to delineate ligands 
of other predominant Cx isoforms, such as Cx 45, the subject of the present study. 
This would aid in elucidating the role of gap junction mediated cell-cell 
communication. 
 
1.5.5  A speculative model of protein-protein interactions 
The characterisation of protein-protein interactions of Cxs and their functional 
importance has been extensively studies. As a result, studies such as those 
described above have contributed to the construction of a speculative model based 
on Cx43 (Wei et al, 2004), in order to further elucidate the protein-protein interaction 
phenomenon in Cxs. Thus, to date, it is known that gap junction channels are 
associated with a variety of molecules to achieve their physiological functions. In 
addition to coupling to supporting subunits that regulate biophysical properties of the 
pore-forming subunit, the channels have also been shown to interact with scaffolding 
proteins and the cytoskeleton and such interactions are essential for the channel 
regulation and targeting (Giepmans et al., 2001, Sorgen et al., 2018).  
 
Taking all the information discussed from section 1.1.5.1 to 1.1.5.4 into account, Wei 
et al. (2004) proposed that Cx43 interacts with a diverse array of protein-binding 
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partners which may include signaling proteins (α/β-catenin, p120ctn), structural 
proteins (ZO-1, caveolin-1), membrane proteins (cadherins), and proteins that 
interact with, or are part of, the cell cytoskeleton (α-actinin, microtubule). This 
network of proteins may cross talk with cell signaling pathways that regulate cell 
adhesion, cell motility, and the actin cytoskeleton (Figure 1.6). Additionally, several 
protein kinases, including Src tyrosine kinase, PKC, and MAPK can phosphorylate 
the COOH-terminal of Cx43, potentially altering not only gating of the channel but 
also protein interactions that may be important in cell signaling. Transcriptional 
effects may also be elicited via the p120ctn/Kaiso receptors, resulting in additional 
long-term effects through gene expression changes (Wei, Xu and Lo, 2004).  
 
 
Figure 1.6 Model proposing protein-protein interactions in connexins.  
Connexin 43 gap junction interacts with other several members of the signaling 
complex that include β-catenin (β-cat), p120ctn, N-cadherin (N-cad), T-cell 
factor/lymphocyte enhancer binding factor (TCF/LEF), and a host of other proteins, 
Gap junctions  
Gap junctions 
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and together, they facilitate cross talk to affect the coordinate regulation of cell-cell 
communication (Wei, Xu and Lo, 2004).  
 
Subsequent to the model proposed by We et al., 2004; numerous studies have been 
conducted to show the role played by the Cx43 carboxyl terminal (Cx43CT) domain 
in the trafficking, localization, and turnover of gap junction channels via numerous 
post-translational modifications and protein–protein interactions (Nielsen et al., 2012; 
Laird, 2010; Herve et al., 2007; Thevenin et al., 2013). Close to 50 proteins have 
been identified to date to interact with Cx 43 (Sorgen et al., 2018) 
 
1.6  CONNEXINS IN CARDIOVASCULAR FUNCTION 
Connexins have been shown to play a role in numerous physiological systems, such 
as the, digestive, reproductive, immune and cardiovascular systems (Saez et al., 
2003; Srinivas et al., 2018). A range of studies has been conducted in order to 
assess the various roles played by Cxs in these systems. However, since the main 
objective of the current study is to gain further understanding of the functional 
specificities of cardiac Cxs and their possible involvement in the development of 
cardiac conduction disorders, only Cx40, Cx43 and Cx45 will be discussed, focusing 
on their distribution patterns and their speculative roles in cardiac function.   
 
1.6.1  Cardiac conduction system and gap junctions 
Cardiac contraction is initiated by an electrical impulse originating from the 
pacemaker cells of the sinoatrial node (SAN), which is located at the junction of the 
superior vena cava and the right atrium (Figure. 1.7). The impulse rapidly spreads 
from the SAN through both atria but its transmission to the ventricular myocardium is 
prevented by a nonconducting band, the annulus fibrosus. The atrioventricular node 
(AVN) is located at the junction of the atria and ventricles and is the only conducting 
route towards the ventricles. The impulse is then transmitted from the AVN to the 
bundle of His, which is located at the top of the interventricular septum and which 
divides on either side of the septum into a highly ramified network of Purkinje fibres 
that activate both ventricular chambers simultaneously. The SAN and AVN node are 
pace-making and slow-conducting, whereas the bundle of His and Purkinje fibres are 
fast-conducting pathways (Gaussin, 2004). 
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Immunohistochemistry and confocal microscopy studies conducted by Yamada and 
co-workers (2004), on Cx43 and Cx45 gap junctions, have shown that cardiac 
tissues that differ in their conduction properties show remarkable differences in their 
relative abundance of gap junctions. They, in fact, showed Cx43 expression in mice 
hearts to be significantly greater in the endocardial and midmyocardial, compared to 
the epicardial, layers of the mouse heart, while Cx45 was evenly expressed 
throughout the ventricles. 
 
Figure 1.7 Cardiac conduction system (Gaussin, 2004).  
Cardiac contraction is initiated by an electrical impulse originating from the 
pacemaker cells of the sinoatrial node (SAN) then through both atria, the bundle of 
His and ultimately to Purkinje fibres that activate both ventricular chambers 
simultaneously.  
 
These findings support the notion that differences in expression patterns of Cxs 
could contribute to differences in cardiac conduction abilities of different areas of the 
heart’s conduction system (Yao et al., 2003). 
 
1.6.2  Connexin distribution in the heart 
Connexin 40, Cx43 and Cx45 are the major Cx isoforms expressed in the heart, 
which have been shown to exhibit different distribution patterns in specialised 
cardiac tissues. The absolute amounts of different Cxs in cardiac myocytes have not 
been determined; rather, their relative distribution has been derived from the 
intensity of immunostaining (Severs et al., 2001). Connexin 43 appears to be the 
major Cx in the working myocardium of the ventricle (Becker and Davies, 1995), 
Sinoatrial node (SAN) 
Atrioventricular node (AVN) 
 Bundle of His 
Annulus fibrosus 
Pukinje Fibres 
(Left 
atrium) 
 
 
 
 
(Right 
atrium) 
(Left 
ventricle) 
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ventricle) 
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whereas in atrial myocytes Cx43 is coexpressed with Cx40 (Severs et al, 2001). 
Studies of cardiac tissues from several different species (human, dog, cow, rabbit) 
have shown that Cx43 is rare or absent in cells of the specialised conducting regions 
of the SAN and AVN (Figure 1.8A and 1.8B) (Teunissen and Bierhuizen, 2004). 
However, some studies have found Cx43-expressing cells that might form 
specialised pathways for electrical conduction out of nodal zones (Severs et al., 
2004). Although it varies from animal to animal and stage of developments, 
expression of Cx40 in the heart is more restricted than that of Cx43. It is abundant in 
atrial myocytes and cells of the His-Purkinje system and is also found in cells of the 
SA and AV nodes (Bukauskas et al, 1995). Connexin 45 expression is detectable in 
cells of the atria, ventricle, SAN and AVN, and His bundle (Coppen et al., 1999).  
   A          B  
Figure 1.8 Distribution of major cardiac connexins    
(A) during heart development, (B) in the adult heart. A=atrium, V=ventricle, 
AVC=Atrioventricular canal, OT=Outflow Tract, RA and LA=Right and left atria, RV 
and LV=Right and left ventricles, Cx 45=green, Cx 40=yellow, Cx 43= red (Gaussin, 
2004). 
 
Generally, all types of blood vessel wall cells express Cx43, in vivo and in vitro. In 
vivo, Cx40 mRNA or protein has been demonstrated in large and small vessel 
endothelium and in smooth muscle from several species (Bastide et al., 1993 and 
Gros et al., 1994). Cx40 is a major gap junction protein of endothelial cells of the 
adult vasculature in most organs (van Veen, 2004; Hucker et al., 2008 and Greener 
et al., 2011). While arterial smooth muscle cells abundantly express Cx43, they may 
also express Cx40 (Severs et al., 2001; Chandler et al., 2009 and Kreuzberg et al., 
2009) and Cx45 (Coppen et al., 1999; Kreuzberg et al., 2009 and Greener et al., 
2011).  
Stellenbosch University  https://scholar.sun.ac.za
  
24 
 
1.7  DISEASES ASSOCIATED WITH CONNEXIN MUTATIONS 
The importance of connexin-based signalling in human physiology has been 
highlighted by the discovery of numerous mutations in connexin genes causing 
severe disorders in a wide range of tissues and systems (Pfenniger et al, 2011). 
These disorders can be broadly grouped into six classifications, namely hearing loss, 
myelin-related disorders, oculodentodigital and craniometaphyseal dysplasias, 
cataracts, skin disorders and cardiovascular disorders (Kelly et al., 2015).  These 
diseases can either present themselves in a non-sydromic (only one phenotype 
associated with the disease) or syndromic (more than one phenotype) manner. 
These diseases can be caused by a by a range of missense, nonsense, insertion, 
deletion and frame-shift mutations and can be inherited in an autosomal dominant, 
recessive or X-linked fashion (Kelly et al., 2015; Srinivas et al., 2017). 
 
To date, twenty eight (Table 1) distinct human disorders have been linked to 
mutations in ten connexin genes (Srinivas et al., 2017). Eight of these disorders 
result from mutations in Cx26, and an additional six disorders are caused by 
mutations in Cx43. The highest number of distinct mutations has been identified in 
Cx32. Chromosome-X-linked Charcot-Marie-Tooth disease was the first disease to 
be linked to a Cx, when it was shown that point mutations in Cx32 gave rise to 
abnormal Cx32 trafficking, which ultimately led to distorted gap junction channel 
assembly and abnormal gating properties (Latour et al., 1997, Sun et. al., 2016). 
However, because of the broad range of phenotypes across which these diseases 
extend, only cardiovascular diseases will be discussed, as they are pertinent to the 
scope of this study.  
 
Table 1.1: Genetic disorders caused by human connexin mutations (Adapted 
from Srinivas et al. 2018) 
Protein Chromosome Disorder OMIM 
Cx 43 6q22.31 Craniometaphyseal 
dysplasia, 
218400 
autosomal recessive 
Erythrokeratodermia 
variabilis et 
progressiva 
133200 
Oculodentodigital dysplasia 164200 
Oculodentodigital dysplasia, 257850 
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Protein Chromosome Disorder OMIM 
autosomal recessive 
Palmoplantar keratoderma 
with 
congenital alopecia 
104100 
Cx 46 13q12.11 Cataract 601885 
Cx 37 1p34.3   
Cx 40 1q21.2 Atrial fibrillation, familial, 11 614049 
Atrial standstill, digenic 
(GJA5/SCN5A) 
108770 
Cx 50 1q21.2 Cataract 116200 
Cx 59 1p34.3   
Cx 62 6q15   
Cx 32 Xq13.1 Charcot-Marie-Tooth 
neuropathy, 
X-linked 1 
302800 
Cx 26 13q12.11 Bart-Pumphrey syndrome 149200 
Deafness, autosomal 
dominant 3A 
601544 
Deafness, autosomal 
recessive 1A 
220290 
Hystrix-like ichthyosis with 
deafness 
602540 
Keratitis-ichthyosis-
deafness syndrome 
148210 
Keratoderma, palmoplantar, 
with 
deafness 
148350 
Vohwinkel syndrome 124500 
Porokeratotic eccrine ostial 
and dermal 
duct nevus 
 
Cx 31 1p34.3 Deafness, autosomal 
dominant 2B 
612644 
Deafness, digenic, 
(GJB2/GJB3) 
220290 
Erythrokeratodermia 
variabilis et 
progressiva 
133200 
Cx30.3 1p34.3 Erythrokeratodermia 
variabilis et 
133200 
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Protein Chromosome Disorder OMIM 
progressiva 
Cx31.1 1p34.3   
Cx 30 13q12.11 Deafness, autosomal 
dominant 3B 
612643 
Deafness, autosomal 
recessive 1B 
612645 
Deafness, digenic 
(GJB2/GJB6) 
220290 
Ectodermal dysplasia 2, 
Clouston type 
129500 
Cx 25 6q14.3-q15   
Cx 45 17q21.31   
Cx 47 1q42.13 Leukodystrophy, 
hypomyelinating, 2 
608804 
Spastic paraplegia 44, 
autosomal 
recessive 
613206 
Lymphedema, hereditary, 
IC 
613480 
Cx30.2 7q22.1   
Cx 36 15q14   
Cx 31.9 17q21.2   
Cx 40.1 10p11.21   
Cx 23 6q24.1   
 
Connexin 40 gene mutations have been found to be associated with atrial fibrillation, 
whereas Cx43 gene mutations have been linked to both atrial fibrillation and sudden 
infant death syndrome (SIDS) (Van Norstrand et al. 2012). Connexin 40 has been 
argued to be the dominant connexin required for impulse conduction in the atria and, 
thus, both somatic and germ-line mutations in this connexin have been shown to 
predispose patients to atrial fibrillation (Christophersen et al. 2013; Gollob et al. 
2006). Atrial fibrillation is characterised by uncoordinated electrical activity in the 
atria of the heart, causing the heartbeat to become fast and irregular, in addition to 
increasing the risk of stroke and sudden death (Molica et al., 2014). These 
observations have also been summarised in a mouse model of atrial fibrillation that 
expresses the human Cx40-A96S mutation and in which the mouse heart exhibits 
significantly reduced atrial conduction velocities and prolonged episodes of atrial 
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fibrillation (Lubkemeier et al. 2013). To date, three somatic mutations and six 
autosomal dominant germline mutations in Cx40 (and one somatic mutation in Cx43) 
have been identified in 23 lone atrial fibrillation patients (Bai 2014).  
 
Sudden infant death syndrome (SIDS) is a poorly understood disease that leads to 
the death of as many as 2000 children per year under the age of one in the USA 
(Kochanek et al. 2011). Mutations in the E42K and S272P regions of Cx43 have 
been found to be associated with SIDS (Van Norstrand et al. 2012). Although both 
mutations are found in highly conserved regions, the E42K mutation clearly disrupts 
normal Cx43 properties, whereas the S272P mutant has been found to traffic and 
function normally. Therefore, Van Norstrand et al. (2012) suggested that the S272P 
mutation cannot be considered as a sudden-death predisposing mutation, whereas 
Cx43-E42K, although rare, is the first connexin mutation to be implicated in the 
pathogenesis of SIDS. 
 
1.8  CONNEXIN-DEFICIENT ANIMAL MODELS 
A variety of experimental approaches have been used to identify molecules and 
regulatory factors involved in cardiac development and function. Some of these 
approaches include transgenic mouse models which have proven useful, particularly 
in determining the roles played by various Cx isoforms in the heart. A range of 
alterations in their number and distribution has been observed in Cx-deficient 
animals and this has been correlated to cardiac abnormalities similar to those 
reported in known cardiac Cx-associated human diseases, as detailed below 
(Gutstein et al., 2001, Reame et al., 1995, Oyamadu et al., 2005; 2013). 
 
Cx43 knock-out mice 
Reaume and colleagues used knock-out mice to determine the function of Cx43 in 
cardiogenesis and cardiac function (Reaume et al., 1995). These mice survived until 
birth and presented a relatively normal heart structure and contractile function. 
However, at birth they appeared cyanotic and died shortly thereafter, apparently due 
to a lack of blood flow to their lungs caused by swelling and obstruction of the right 
ventricular outflow tract (Reaume et al., 1995). Gutstein and co-workers further 
verified these observations by generating heart specific knock-outs of Cx43 (Gutstein 
et al., 2001). The Gutstein study also showed the down-regulation of other isoforms, 
such as Cx45 (Gutsein et al., 2001), suggesting co-expression of these two Cx 
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isoforms. Furthermore, a series of transgenic experiments (using wild-type or mutant 
Cx43) by Lo and colleagues (1999) have emphasised the role of Cx43 expressed by 
cardiac neural crest cells for the proper development of the heart (Lo et al., 1999). 
Heart looping defects have also been described in Cx43-null mice, although these 
abnormalities disappeared by embryonic day (E) 12 (E12) (Ya et al., 1998). These 
observations, therefore, suggested that the presence of Cx43, although important, is 
not an absolute requirement for the heart to beat, or for the anatomic development of 
the heart. It thus can be speculated that Cxs do replace one another in certain 
processes. 
 
Cx40 knock-out mice 
Cx40-null mice, on the other hand, were shown to present prolonged atrioventricular 
conduction (as shown by widened QRS complexes on electrocardiograms), right 
bundle branch block and were prone to develop arrhythmias (Kirchhoff et al., 1998, 
Simon et al., 1998). These animals developed to adulthood and reproduced 
normally, which indicated that Cx40 may not be necessary for cardiac development, 
since the cardiac structure and chambers appeared normal (Simon et al., 2004). 
These mice also retained gap junctional communication between aortic endothelial 
cells, despite altered characteristics with respect to wild-type mice. Additionally, 
Cx37 and Cx43 were upregulated and redistributed (Simon et al., 2004), suggesting 
a compensatory mechanism, to be discussed below.  
 
Cx45-knock out mice 
Among the three predominant cardiac Cxs, Cx45 is the only isoform expressed in 
earliest cardiomyocytes (Alcolea et al., 1999) and its knock-out experiments have 
been useful in gaining understanding of the physiology of early cardiomyocytes. 
Independent studies by Kruger et al., (2000) and Kumai et al., (2000) showed Cx45-
null mice to die during embryogenesis, due to abnormalities of vascular development 
and cardiogenesis (Kruger et al., 2000). Endothelial cell development and positioning 
appeared normal, but further formation of vascular trees was impaired and the 
smooth muscle layer of major arteries failed to develop. The hearts of these animals 
were dilated, and apoptosis was observed in almost all tissues by E9.5, which 
contributed to their death by E10.5. Their hearts also showed a looping defect, 
reduced trabeculation, and disrupted formation of the endocardial cushions and a 
conduction block (Kumai et al., 2000; Kruger et al., 2000; Nishii et al., 2003). 
Significantly, expression of the calcium-dependent transcription factor, NF-ATc1, 
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was inactivated in the endocardium. NF-ATc1-deficient mice were also seen to 
present defects associated with formation of endocardially-derived valve tissues (de 
la Pompa et al., 1998; Kruger et al., 2000; Kumai et al., 2000; Ranger et al., 1998), 
suggesting the possibility that Cx45 has a role in modulating calcineurin signaling 
required for NF-ATc activation.  
 
Functional equivalence of connexins 
As discussed throughout section 1.1.8, all Cx isoforms present unique molecular 
structures, implying that they possess unique functions. However, mice knock-out 
studies have shown some Cxs to have overlapping functions. For instance, Cx40 
knock-out/Cx45 knock-in mice (Cx40KO/Cx45KI) presented normal impulse 
propagation in the RA, AV note and the left His bundle branch, suggesting that Cx45 
is sufficient to partially compensate for lack of Cx40 (Alcolea et al., 2004). 
Furthermore, as previously discussed, Cx45 knock-out mice die at E10 and, as Cx45 
is widespread during heart development, it was surprising when Kumai et al., (2000) 
detected heart contractions at E8.5, implying that other Cx isoforms were functional 
in the heart tube. In addition, Verheula et al., (1999) found Cx43 knock-out mice to 
survive early stages of heart development due to Cx40 and Cx45 expression, they, 
however, die due to the migration of neural crest cells to the pulmonary outflow tract.  
 
Summary of section 1.1.8 
In summary, knock-out mice studies show the importance of gap-junction mediated 
communication in normal embryonic development and suggest both common and 
unique functions for various Cx isoforms during cardiac development. It is also 
evident that while some Cxs can partially replace other isoforms, morphological 
differences observed in knock out mice suggest that they are functionally 
inequivalent. These studies also may give an indication of possible cardiac disorders 
that may ensue as a result of mutations in any of the Cx isoforms and/or possibly 
their binding partners. 
 
1.9  SELECTED INHERITED CARDIAC CONDUCTION DISORDERS 
Almost every person’s heart will occasionally produce an extra beat or two, and the 
distressing symptoms that may accompany the extra beats such as dizziness and 
palpitations do not necessarily signal a serious health problem (McPherson et al., 
2003). However, more serious disorders may ensue as a result a malfunction in the 
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heart’s conduction system. Furthermore, the conduction system is crucial in the 
synchronised coordination of cardiomyoctes, allowing the passage of electrical 
impulsewhich ultimately cause the heart to beat.  
 
The pathophysiological mechanisms underlying these conditions are diverse 
(Michaelson et al., 1995). Previously, cardiac conduction disorders were viewed as a 
structural disease of the heart in which macro- or microscopical structural 
abnormalities in the conduction system underlay disruption of normal impulse 
propagation. Conduction disturbances were later observed to be present in the 
absence of anatomical abnormalities. To date, it is believed that functional, rather 
than structural, alterations underlie most conduction disturbances (Wilde and 
Bezzina, 2005; Jansen, 2010; Mezzano, 2014; Nademanee, 2015). The molecular 
causes of most of these disorders have been identified inherited forms of which are 
believed to be from abnormalities in cardiac conductive pathways which are 
governed by electromechanical factors. The following sub-sections, will therefore 
give an overview of two inherited syndromic diseases associated with cardiac 
conduction abnormalities, among other features; namely: Myotonic Dystrophy (DM) 
(Gatchel and Zoghbi, 2005), Holt-Oram Syndrome (HOS) (Bruneau et al., 2001), and 
Progressive Familial Heart Block type II (PFHBII), identified in South Africa, whose 
primary clinical features include cardiac conduction disturbances as well as heart 
block (Brink and Torrington, 1977).  
 
A. Myotonic dystrophy (DM) 
Myotonic dystrophy, or Steinert's disease, an inherited condition showing an 
autosomal dominant mode of inheritance, is the most prevalent form of muscular 
dystrophy with a frequency of 1 in 8000 individuals worldwide. Affected individuals 
express highly heterogeneous, multisystemic symptoms including myotonia, 
progressive muscle weakness and wasting, cataract development, testicular atrophy, 
and cardiac conduction defects (Gatchel and Zoghbi, 2005). The molecular 
mechanism of this disorder was determined from its linkage to chromosome 19q13.3 
and subsequent identification of an expanded CTG repeat in the 3′ UTR of the 
myotonic dystrophy protein kinase gene DMPK in patients with DM (Brook et al., 
1992). Furthermore, studies revealed that disease severity generally correlates with 
repeat length. Notably, non-mutant carriers have 5–38 CTG repeats at this locus, 
whereas DM-affected individuals have repeats in the hundreds to thousands.  
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This condition was later divided into two forms, DM1 and DM2, for after the genetic 
cause of DM1 was revealed, a group of DM patients who did not have CTG 
expansions at the known DM locus were identified (Liquori et al., 2001). Despite 
common clinical features, such as myopathy, myotonia, cataracts, and cardiac 
disturbances and a common mode of inheritance, these patients also presented 
proximal muscle weakness, often involving hip flexors and extensors. Hence, 
proximal myotonic myopathy (PROMM) was the initial term used in diagnosis for 
those who did not have DM1 (Thornton et al., 1997, Ricker et al., 1995, Day et al., 
2003). Almost a decade after the discovery of unstable CTG repeats in 3′ UTR of 
DMPK, in 2001 Liquori and colleagues revealed that a CCTG expansion in intron 1 
of the zinc finger protein 9 gene ZNF9, on chromosome 3q21, is associated with 
individuals who were diagnosed with having PROMM/DM2 (Liquori et al., 2001). This 
new locus associated with the myotonic dystrophy disorder PROMM was then 
designated DM2.  
Both the DM1- and DM2-causing genes share repeat expansions in noncoding 
regions of genes (DMPK and ZNF9, respectively) that are expressed in tissues 
affected by this disease. The fact that both genes were associated with repeat 
expansions in transcribed but untranslated regions suggested that the mutant RNA 
might have a significant role in the disease process (Harper, 2004). However, 
another recognised difference between DM1 and DM2 is that only the DM1 locus 
presents a congenital form of this disorder (reviewed by Cho and Tapscott, 2006). 
 
B. Holt-Oram syndrome (HOS) 
Holt-Oram syndrome was first clearly described by Holt and Oram (1960), who 
observed cardiac atrial septal defect in four generations of a family whose affected 
members also presented with a congenital anomaly of the thumbs which lay in the 
same plane as the fingers, and inwardly curved terminal phalanges (reviewed by 
Davies, 1992). McKusick and co-workers (1961) reported a mother and daughter 
with atrial septal defect and absent or triphalangeal, fingerlike thumbs (McKusick et 
al., 1961). In 1966, the daughter gave birth to a male infant with flipper-like hands 
and ventricular septal defect. The involvement of the arm was more extensive and 
the cardiovascular involvement more varied in the families described by Lewis et al. 
(1965) and Harris and Osborne (1966) than in the family of Holt and Oram (1960). 
These studies clarified the autosomal dominant pattern in which HOS is inherited, as 
well as the clinical manifestation of the disease.  
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Basson and co-worked (1994) validated previous clinical findings described in the 
60s in patients with HOS. These authors found the affected individual to have upper 
limb malformations and a high incidence of congenital heart disease, accompanied 
by abnormal cardiac electrophysiology, including AV block (Basson et al., 1994). The 
HOS causative gene, TBX5 gene, a T-box transcription factor, has been linked to the 
development of the heart and upper limbs before birth. This gene’s product was also 
suggested to be important particularly for cardiac septation and possibly the 
development of bones in the arms and hands (Basson et al., 1997; Li et al., 1997). 
These findings were further validated in heterozygous knock-out mice, which 
exhibited the morphological defects of the HOS, as well as conduction defects 
(Bruneau et al., 2001). Additionally, the TBX domain has been proposed to act as a 
DNA-binding domain (Basson et al., 1999). In another study, Hiroi et al., (2001) 
found that TBX5 associated with NKX2-5 and synergistically promotes 
cardiomyocyte differentiation. TBX5-binding has also been found in a number of 
cardiac expressed genes, such as α-actin, α-cardiac myosin heavy chain (MYH) and 
β-cardiac myosin heavy chain MYH genes, which suggests a role by TBX5 in their 
regulation (Ghosh et al., 2001). 
 
C. Progressive familial heart block I and II (PFHBI and PFHBII) 
Progressive familial heart block type I (PFHBI) is an autosomal dominantly inherited 
disease of the cardiac bundle branch, first described by Brink and Torrington in 
1977. It segregates in a large South African pedigree of Portuguese descent and two 
smaller pedigree (Figure 1.9). Clinically it is characterised by right bundle branch 
block, left anterior or posterior hemiblock, or complete heart block detected on ECG 
by the presence of broad QRS complexes (Brink and Torrington, 1977; Van der 
Merwe et al., 1986; Van der Merwe et al., 1988).  
 
Initial linkage studies mapped the PFHBI causative-gene to a 10cM region between 
genetic markers D19S412 at the centromeric limit, and D19S866 at the telomeric 
limit of chromosome 19q13.3 (Brink et al. 1995). Concomitantly, another conduction 
disorder known as isolated cardiac conduction disease (ICCD) was mapped in a 
Lebanese family to the same region as PFHBI (Stephan et al., 1995). However, 
since these two conditions shared common clinical symptoms and genetic loci, they 
later were regarded as the same disease (Brink – personal communication, reported 
by Arieff, 2004). Fine-mapping strategies later reduced the PFHBI locus to about 
7cM (De Jager - personal communication, reported by Arieff, 2004), and further fine-
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mapped it to the 4cM (2.42Mb) region of chromosome 19q13.3 which ultimately set 
the centromeric limit to D19S606 (Figure 1.10) (Arieff, 2004). The genetic cause for 
PFHBI was found to be caused by the mutation c.19G-->A in the transient receptor 
potential cation channel, subfamily M, member 4 gene (TRPM4) at chromosomal 
locus 19q13.3 (Kruse et al., 2009). 
 
 
Figure 1.9 Pedigrees (1, 2 and 5) in which PFHBI segregates.  
A. Pedigree 2 is a nine generation pedigree traced back to a single male of 
Portuguese descent (I.01) and his wife (I.02), who married in 1735. B. Pedigrees 1 
and 5, are smaller pedigrees of individuals who presented the same phenotype as 
PFHBI-affected individuals and share the same haplotype, although no genealogical 
links have been established with pedigree 2 (Brink et al, 1995).  
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Figure 1.10 The PFHBI locus  
Flanked by the D19S606 and D19S866 markers is harboured in the 4cM region in 
chromosome 19q13.3 (Arieff, 2004 – PhD thesis). 
Progressive familial heart block type II (PFHBII) segregates in a South African 
Afrikaner family of Dutch descent (Figure 1.12). Like PFHBI, it is inherited in an 
autosomal dominant manner (Brink and Torrington, 1977). However, its clinical 
features include sinus bradycardia and left posterior hemiblock which later 
progresses to complete heart block, detected as narrow QRS complexes on ECG 
(Brink and Torrington, 1977). Progressive familial heart block type II is associated 
with syncopal episodes, Stoke-Adam seizures (light-headedness) (van der Merwe, 
1986) and dilated cardiomyopathy (Fernandez et al., 2004). The genetic cause for 
PFHBII is still illusive ; however, it was found to be located within a 2.85Mb region on 
p- arm 
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chromosome 1 between q32.2 and q32.3, a region flanked by the D1S70 and 
D1S505 markers (Fernandez et al., 2005). 
 
 
 
Figure 1.11 The PFHBII locus, flanked by the D1S70 and D1S505 markers is 
harboured in the 2.85Mb region in chromosome 1q32.2 – q32.3 (Fernandez et 
al., 2005). 
 
D1S70 
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PFHBII locus 
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Figure 1.12: A four-generation pedigree in which PFHBII was identified and 
described (Brink and Torrington, 1977).  
Twenty four members of the family were clinically evaluated in the original study and 
10 of them were affected. 
 
1.9.1  Exclusion of connexins as FHBII causative genes 
 A number of cardiac ions channels which control the flow of ions, such as Na+, Ca2+, 
K+ and Cl- ions, are present in membranes of cardiomyocytes. These channels 
facilitate the passage of electrical potential which ultimately causes the heart to beat. 
However, when conduction pathways are dysfunctional and the electrical flow is 
disrupted, cardiac conduction disorders, such as PFHBII, may ensue. It therefore 
seemed plausible to deduce that genes encoding proteins of channels physically and 
electrically joining cardiac myocytes such as the Cxs would be good candidates for 
PFHBII. Hence, Cxs were included in a list of putative candidate genes for PFHBII. 
However, independent bioinformatic and genetic mapping analyses conducted by 
Fernandez (2004) excluded Cx as aetiological genes, as they were not found within 
the genetic loci of PFBHII. However, it was intriguing to note that DMPK, encoded by 
the DMPK gene, colocalises with Cx43, a prominent cardiac Cx (Mussini et al., 
1999). Hence, an explanation for the conduction disturbances that are part of the DM 
syndrome could be that functional defects caused by mutated DMPK may affect Cx-
binding. Since DM is characterised by conduction disturbances similar to those in 
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PFHBII -affected individuals, it seemed plausible to hypothesise that other proteins 
that interact with Cxs could contribute to the aetiology of either conduction disorder.  
 
1.10  METHODS TO STUDY PROTEIN-PROTEIN INTERACTIONS 
As discussed in previous sections, cardiac Cx isoforms have, in part, been linked to 
numerous diseases. For instance, Cx40 was associated with the development of 
DCM in mice (Richardson et al., 1999), which is also a clinical manifestation in 
PFHBII-affected individuals (Fernandez et al., 2004). Myotonic dystrophy, 
characterised among other clinical features, by cardiac conduction disturbances, is 
another interesting condition whose causative protein, DMPK co-localises with Cx43 
(Mussini et al., 1999). As mentioned above, this DMPK-Cx43 association is, in fact 
proposed, though not proven, to play a role in the development of cardiac conduction 
disturbances in DM-affected patients (Mussini et al., 1999). Since the causative gene 
of PFHBII has not yet been identified, it seemed plausible to hypothesise that other 
Cxs or Cx-interacting proteins could lead to the development of either of 
thiscondition. 
 
A number of methods have been applied to identify protein interactions in order to 
further understand the biochemical nature of the interactors and their possible roles 
in physiological processes. In the following subsections, principles of the two 
techniques employed in the current study, the yeast-2-hybrid (Y2H) and mammalian-
2-hybrid (M2H) analyses will be discussed. Additionally, advantages and 
disadvantages of both of these techniques will be outlined.  
 
A. YEAST TWO-HYBRID (Y2H) 
The Y2H method, developed by Fields and Song (1989), exploits the principle of 
transcription (Fields and Song, 1989). Yeast two-hybrid uses two protein domains of 
a transcription factor that have specific functions: a DNA-binding domain, that is 
capable of binding to DNA, and an activation domain, that is capable of activating 
transcription of the downstream reporter gene (Figures 1.13 and 1.3) (Ma and 
Ptashne, 1988). The binding domain and the activation domain do not necessarily 
have to be on the same protein. In fact, an engineered protein with a binding domain 
can activate transcription when bound to any other engineered protein containing an 
activation domain (Fields and Song, 1989). 
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Figure 1.13 Normal transcription requires both the DNA-binding domain (BD) 
and the activation domain (AD) of a transcriptional activator (TA) (Sobhanifar, 
2005). 
 
Figure 1.14 Yeast two hybrid transcription.  
The yeast two-hybrid technique measures protein-protein interactions by measuring 
transcription of a reporter gene. If the bait protein and the prey protein interact, then 
their DNA-binding domain and activation domain will come to close proximity to form 
a functional transcriptional activator. The transcriptional activator will then proceed to 
transcribe the reporter gene that is paired with its promoter (Sobhanifar, 2005). 
 
In the Y2H assay, two fusion proteins are created: the bait construct is constructed 
to have a DNA binding domain, commonly derived from the yeast Gal4 protein 
(Chien et al., 1991, Durfee et al., 1993), attached to its NH2-terminus, while the prey 
construct, is fused to an activation domain. These fusion proteins are co-expressed 
in yeast, where a physical interaction between the bait and prey leads to the 
reconstitution of a functional transcription factor, derived from the Gal4 protein 
Bait 
Prey 
Promoter Reporter gene 
Prey 
 
 
Bait 
BD 
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(Chien et al., 1991, Durfee et al., 1993), which binds to the upstream activatory 
sequence of the promoter of the receptor gene (Figure 1.14). Thereafter, 
transcription of the reporter gene occurs. A protein-protein interaction is therefore 
translated into reporter gene activity which can be measured, usually involving 
selectable yeast genes such as HIS3 (Durfee et al., 1993) and LEU2 (Fusco et al., 
1999).  
 
Figure 1.15 Y2H library screening.  
The bait and prey constructs are mated and co-transfected into yeast. A colony in 
which the reporter gene is expressed contains fusion proteins whose bait and prey 
interact, thereby bringing the DNA-binding and activation domains into proximity and 
stimulating the RNA polymerase to drive nutritional reporter gene activation. This in 
turn allows auxotrophic yeasts to grow in selective growth medium. However, if there 
is no interaction between the bait and prey fragment, no growth of the yeast will be 
observed (Adapted from Brown, 2002). 
 
In a typical Y2H experiment, S. cerevisiae cells are transfected with plasmid 
constructs bearing genes usually encoding either the bait or the prey (the latter may 
be individual recombinant clones from a cDNA library) portions of the hybrid proteins. 
The two, bait and prey, yeast strains are mated and the mixtures plated onto primary 
selection media (lacking histidine, tryptophan and leucine) (Figure 1.15). Diploid 
colonies expressing tryptophan (TRP1), leucine (LEU2) and histidine (HIS3) reporter 
genes are then transferred to more stringent selection media (lacking adenine, 
histidine, tryptophan and leucine) and diploid colonies expressing the TRP1, LEU2, 
Reporter gene activation 
Interaction 
between bait 
and prey 
No bait-prey 
interaction 
prey 
bait 
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HIS3 and adenine (ADE2) reporter genes then tested, by nutritional selection. For 
the expression of the MEL1 reporter gene a colourmetric assay which also indicates 
the strength of the bait-prey interaction is used (Fields and Songs, 1989).  
The Y2H technique is one of the most favoured methods for studying protein-protein 
interactions. One of its most prominent benefits is that it mimics an in vivo system 
using the yeast host cell as a “live test tube”. It more closely resembles the higher 
eukaryotic system than most in vitro techniques based on bacterial expression. 
Another advantage to Y2H is that only the cDNA, be that full-length or a partial 
region, of the gene of interest is needed, in contrast to sometimes-high quantities of 
purified proteins needed in classical biochemical techniques (Ma and Ptashne, 
1998). Weak interactions can also be detected since the genetic reporter gene 
strategy results in a significant amplification. Apart from the ability to screen libraries, 
this system also allows for the analysis of specific or suspected interactions (Guthrie 
and Fink, 1991).  
However, in spite of improvements to increase it applicability, the Y2H method has 
numerous disadvantages, one of these being the risk of using artificially engineered 
fusion proteins. The fusion protein might change the actual conformation of the bait 
and/or prey and consequently alter functionalities increasing the possibility of 
obtaining false positives or negatives. This change in conformation might result in a 
limited activity or in the inaccessibility of binding sites (Ma and Ptashne, 1988). 
Another disadvantage of Y2H is that it makes use of yeast, S. cerevisiae, and not 
mammalian cells as a host. At times the bait protein may not fold correctly nor exist 
as a stable protein inside the yeast cells (Ma and Ptashne, 1988). Additionally, 
another disadvantage of assaying protein-protein interaction in a heterologous 
system is that some interactions depend on post-translational modifications, such as 
phosphorylation, that do not occur in yeast (Greener and Perkel, 2005). Since the 
two-hybrid system needs the fusion proteins to be targeted to the yeast nucleus, it 
might be a disadvantage for extracellular proteins or proteins that contain strong 
targeting signals to other subcellualr regions (Greener and Perkel, 2005), as 
transcription would not occur. Furthermore, some proteins might become toxic upon 
expression in yeast. Other proteins might proteolyse essential yeast proteins or 
proteins essential for the system like the DNA-binding domain or the activation 
domain (Greener and Perkerl, 2005).  
From the above discussion, it is evident that the Y2H method, like any other method, 
is not problem-free. In spite of all this, it still is the method of choice for most 
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molecular scientists. Many disadvantages may not be detrimental to the overall 
output of protein-protein studies, as they may be circumvented by conducting any of 
a battery of verification assays, one of which is the M2H technique.  
 
B. MAMMALIAN TWO-HYBRID (M2H)  
The M2H system was developed using a strategy similar to that used in the Y2H 
system (Vasavada et al., 1991). Just as in the Y2H system, a reporter gene 
transcription factor is functionally and physically divided into an activation domain 
and a DNA binding domain. The recombinant vectors that express both the bait and 
prey fusion proteins are co-transfected into the mammalian cell with a reporter 
plasmid (Figure 1.15). So if these fusion proteins interact, the reporter gene will be 
expressed (Figure 1.17).  
 
 
Figure 1.16 In M2H mammalian cells are co-tranfected with three plasmids. 
 p-Bait construct, p-Prey construct and p-Reporter construct, and then incubated to 
allow reporter gene expression (Luo et al., 1997). 
 
    pBait      pPrey pReporter 
BAIT PREY 
REP 
AD 
BD 
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BD
 
Figure 1.17 The principle behind both Y2H and M2H. 
 (A) Gene X is cloned downstream of the binding domain (BD) to form the bait 
construct. Gene Y is cloned downstream of the activation domain (AD) to form the 
prey construct. As indicated in figure 1.15 bait, prey, and reporter constructs are co-
transfected into a mammalian cell line. If protein X interacts with protein Y, the AD is 
brought together with the DNA-binding domain, which will turn on the reporter gene; 
UAS = Upstream activation sequence (Fan and Lui, 2002). 
 
The M2H method has been shown to be useful in verifying protein-protein 
interactions in order to rule out false positives. Protein interactions in mammalian 
cells are said to mimic the in vivo situation better than in yeast cells, as in 
mammalian cells they are believed to assume their native conformation. As 
previously mentioned (1.1.10A), some of the post-translational modifications, such 
as phosphorylation, that do not occur in vitro or in yeast are accommodated by the 
M2H system. Another advantage to using the M2H system is that this assay is less 
time-consuming than the Y2H. In M2H, the reporter gene assay can be completed 
within 48 h of transfection. Quantitative results are also immediately available (Luo et 
al, 1997).  
 
It has been suggested that the M2H exhibits some disadvantages of the Y2H 
methods as both are based on the same principle of transcription. Since M2H makes 
use of hybrid proteins, its output may not necessarily be the true reflection of 
interactions that take place in nature. A significant drawback of M2H is that it can not 
be used for library screen, only known or suspected pair-wise interactions can be 
B 
A 
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tested. Additionally, the hybrid proteins may be misfolded which increases the 
possibility of obtaining false positives or negatives.  
 
1.11  WHOLE EXOME SEQUENCING 
Compared with Sanger sequencing, NGS had been reported to have many 
advantages, including high speed, low cost, less time consuming, high sensitivity, 
need of less amount of sample, and sequencing multiple genes at a higher coverage 
(Garraway, 2013). Whole Exome sequencing (WES), involves exome capture, which 
limits sequencing to the protein-coding regions of the genome, composed of about 
20,000 genes, 180,000 exons, and constituting approximately 1% of the whole 
genome (Choi et al., 2009). 
 
A typical workflow of WES analysis consists of the following steps: raw data quality 
assessment, pre-processing, alignment, post-processing, variant calling, annotation, 
and prioritization (Bao et al., 2014). 
 
Whole exome sequencing (WES) has been used to reveal genetic variants in 
affected individuals with various forms of cardiomyopathies such as hypertrophic 
cardiomyopathy (HCM) as well as dilated cardiomyopathy (DCM) (Table 2). Seidman 
et al, 2001 and Colombo et al., 2008 studied family histories of HCM and DCM 
patients, respectively. Studies by Voelkerding et al., 2010; Dellefave and McNally, 
2010 found mutations of genes encoding sarcomere proteins in HCM etiologies and 
showed a more heterogeneous etiology of DCM (Voelkerding et al., 2010; Dellefave 
and McNally, 2010). Meder et al., 2011 established a comprehensive genetic 
screening in patients with hereditary DCM and HCM in a cost-efficient manner using 
array based subgenomic enrichment systems. They found two microdeletions and 
four point mutations in six patients.  
 
Whole exome sequencing has also been used to characterise the causal gene of 
familial combined hypolipidemia (ANGPTL3) (Musunuru et al., 2010), severe 
hypercholesterolemia (ABCG) (Rios et al., 2011) and familial dilated cardiomyopathy 
(BAG3) (Norton et al., 2011). The use of this technology promises to revolutionise 
genetic research in cardiovascular diseases as it has potential to indentify rare SNPs 
susceptible to cardiovascular diseases (Table 2). 
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Obscurin has been somewhat neglected in these studies, largely because its 
functional role is far from clear. There was an isolated report in 2007 of obscurin 
mutations associated with HCM but this was not followed up for several years. 
Recently, whole exome sequencing methodology (WES) has been used to address 
mutations in OBSCN, the gene for obscurin, and OBSCN variants were found to be 
relatively common in inherited cardiomyopathies. Marston et al.’s (2015) study found 
5 OBSCN unique variants in 4 individual hearts from a group of 30 end-stage failing 
hearts, Xu et al. (2015) found 6 OBSCN unique variants in 74 HCM cases and 
Rowland et al. (2016) found 4 OBSCN unique variants in 335 DCM and LVNC 
patients, of which OBSCN variants were associated with 3 out of 11 LVNC cases 
(Marston, 2017).  
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Table 1. 2: Reported WES approaches in cardiovascular diseases (Rabbani et al., 2014 and Marston, 2017). 
Category Disease (Inheritance) Identified gene Studied subject References 
Cardiomyopathy 
Recessive HCM MRPL44 Two siblings Carroll et al., 2013 
Recessive HCM MTO1 
Two unrelated 
Families 
Ghezzi et al., 2012 
Dominant ARVC DES One family Hedberg et al., 2012 
Recessive HCM Sengers 
syndrome 
AGK One individual Mayr et al., 2012 
Recessive DCM GATAD1 One family Theis et al., 2011, 
Recessive HCM MRPL3 One family Galmiche et al., 2011 
Recessive HCM AARS2 One family Gotz et al., 2011 
Dominant DCM BAG3 One Norton et al., 2011 
DCM OBSCN Four individuals Marston et al., 2015 
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Category Disease (Inheritance) Identified gene Studied subject References 
HCM 
LVNC 
Six individuals 
3 individuals 
Xu et al., 2015 
Rowland et al., 2016 
Heterotaxy 
Cardiovascular 
Recessive SHROOM3 One Tariq et al., 2011 
Familial combined 
hypolipidemia 
Recessive ANGPTL3 Two families Musunuru et al., 201 
Channelopathy 
X-linked intellectual
disability, atrial 
fibrillation, cardiomegaly, 
congestive 
heart failure 
CLIC2 Two males Takano et al., 2012 
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1.12 THE CURRENT STUDY 
Numerous studies have been conducted to date to establish the causative genes of 
cardiac conduction disorders associated with dilated cardiomyopathy (DCM) (Graber 
et al. 1986; Mestroni et al. 1990; Gavazzi et al. 2001; Oropeza and Cadena 2003). In 
some families, a single gene defect has been identified as the cause of the disease. 
However, the causative genes underlying a number of inherited cardiac conduction, 
DCM associated disorders such as Progressive Familial Heart Block Type II (PFBH 
II) remain elusive (Towbin and Bowles, 2002; Antzelevitch 2003; Fernandez et al,
2004). The identification of the causative mutations of these disorders will enable 
precise diagnosis and provide guidelines to effectively treat them.  
Connexins 40, 43 and 45, predominantly expressed in the heart, have been shown 
to exhibit specific as well as shared functions (Section 1.1.6.2). Animal studies and 
even human studies have highlighted that Cxs may substitute for one another if one 
is inactivated (Oyamada et al., 2005, 2013). To date, most studies have focused on 
Cx43; hence the aims of this study which are to: 
1) Assess functional specificity of cardiac Cx45 to further understand its role in
cardiac function and possibly in the development of cardiac conduction diseases.
2) Prioritise ligands that would possibly map to the PFHBII locus as candidate
genes for PFHBII.
3) Identify and prioritise putative PFHBII-causing mutations using whole exome
sequencing (WES).
In search of the PFHBII locus, our research group found by linkage analyses, that 
the specific causative gene for PFHBII was harboured in a 3.9cM region between 
q32.2 and 32.3 on chromosome 1 (Fernandez et al., 2005). Cardiac Cx knock-out 
studies pointed towards the cardiac Cxs as attractive candidate causative genes of 
these cardiac conditions. For instance, Cx40 and 45 knock-out mice presented 
cardiac conditions similar to those of known human disorders (Moreno, 2004), Cx40 
knock-outs presented prolonged atrioventricular conduction and Cx45 knock-out 
mice die at E10 of conduction block symptoms which could be related to the PFHBII 
phenotype. However, no Cx genes were identified in this locus nor did any mutation 
screening identify other causative genes (Fenandez, 2004, PhD thesis – University 
of Stellenbosch).  
Stellenbosch University  https://scholar.sun.ac.za
 48 
 
Nonetheless, it was intriguing to note that DMPK, encoded by the DMPK gene, 
mutations of which were linked to DM, colocalised with Cx43, a prominent cardiac Cx 
(Mussini et al., 1999). Since DM is characterised by conduction disturbances similar 
to those in PFHBII-affected individuals, it seemed plausible to identify Cx ligands as  
causative genes.  
 
As most studies have focused on Cx43, in the present study ligands of the COOH-
terminal domain of cardiac Cx45 were identified in order to assess the specific and 
possibly shared functions of the most prominent Cxs by comparing the ligands of 
Cx45, with those of Cx40 (R. Keyser, 2007, MSc Thesis – University of 
Stellenbosch), as well as known ligands of Cx43. In addition, it was planned that any 
identified ligands that serendipitously mapped to the PFHBII locus would be 
screened for causing disease in members of affected families. The strategy followed 
was to employ the Y2H technique to identify ligands of the COOH-terminal domain of 
Cx45, by screening a cardiac cDNA library. As major differences among the Cx 
isoforms occur in the COOH-terminal domain and because of its participation in 
protein-protein interaction, the COOH-terminal domain of Cx45 was chosen as “bait” 
in a “fishing expedition” of the cardiac cDNA for putative “preys”. Sequences of the 
identified preys were then identified by conducting sequence homology searches 
against sequences in Genbank databases which also enabled us to prioritise them 
according to their chromosomal location, biological relevance and subcellular 
localisation. Verification of true interactors was then attempted by M2H. Whole 
exome sequencing was used to further identify putative causative mutations in PFBH 
II patients.  
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2 MATERIALS AND METHODSPART I: YEAST-TWO HYBRID AND 
MAMMALIAN-TWO 
 
=   (Cx45 COOH-terminal domain) 
DESIGN PRIMERS TO AMPLIFY CYTOPLASMIC TAIL-ENCODING 
REGION OF CX 45 
Clone product into CLONETECH pGBKT7 shuttle vector 
Transform into E. coli and purify plasmid 
VERIFICATION OF FRAME AND INTEGRITY OF INSERT BY 
AUTOMATED SEQUENCING 
Transform plasmid into S. cerevisiae 
PHENOTYPE ASSESSMENT 
Autoactivation of endogenous gene, toxicity test, mating efficiency test 
Y2H MATING Bait construct 
in S. 
cerevisiae 
(Prey) cDNA 
library in S. 
cerevisiae 
TDO (-Trp, -Leu, -His) 
QDO (-Trp, -Leu, -His, -Ade) 
X-a-gal QDO (-Trp, -Leu, -His, -Ade) 
SPECIFICITY TEST (HETEROLOGOUS BAIT MATING) 
SEQUENCING (plasmid in E. coli) 
SEQUENCE HOMOLOGY SEARCHES AND VERIFICATION ASSAYS 
(M2H); PFHBII LOCI SEQUENCE HOMOLOGY SEARCHES 
  
Selection media of 
increasing stringency 
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2.1  DNA EXTRACTION 
2.1.1  Extraction of DNA from human nuclei. 
In order to amplify the region encoding the COOH-terminal domain of Cx45, DNA 
was extracted from 5ml of an anonymous banked blood sample of a subject enrolled 
as a control in a project approved by the University of Stellenbosch ethics 
committee, following a method modified in the Molecules and Genes in Inherited 
Conditions (MAGIC) laboratory (Corfield et al., 1993).  
 
2.2  POLYMERASE CHAIN REACTION (PCR) 
The PCR was conducted in order to amplify regions of DNA fragments to be used in 
the Y2H and M2H screens. Namely, it was firstly used to amplify the region encoding 
the COOH-terminal domain of cardiac expressed Cx45, to be used as bait in the 
Y2H screen of a cardiac cDNA library, from human genomic DNA. Thereafter, PCR 
amplification was used to detect this Cx45 bait fragment in the recombinant Y2H 
plasmid constructed and then to amplify fragments of the prey inserts identified. It 
was also conducted to detect the prey fragments in recombinant M2H vectors. 
 
2.2.1  PRIMER DESIGN 
2.2.1.1 Oligonucleotide primer design and synthesis 
Oligonucleotide primers were designed using sequence data available either from 
the Ensembl database (http://www.ensembl.org) or the Genbank database 
(http://www.ncbi.nlm.nih.gov/Entrez) (see Appendix I for sequences used) or 
Clontech. Several variables were taking into account when the primers were 
designed. Among the most critical were; primer length, annealing temperature (Ta), 
melting temperature (Tm), complementary primer sequences, G/C content and 
polypyrimidine (T, C) or polypurine (A, G) stretches and 3’-end sequence.   
 
These parameters are interdependent, for instance the longer the primer length, the 
higher the Ta , which in turn affects the Tm. To optimise the specificity of the primers 
used and prevent self-annealing, their respective lengths were designed to be 
between 18 and 24 bases. As each PCR contained two primers, they were designed 
to have similar annealing temperatures. Furthermore, the primers were designed 
with no intra-primer homology beyond four base pairs, nor inter-primer homology at 
the 3’ end in order to avoid primer dimer formation. The primers had a base 
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composition of between 45% and 55% GC-content. Additionally, a G or C residue 
was also included at the 3’ end to ensure correct binding due to stronger hydrogen 
bonding between G/C residues. All of these parameters were assessed using a 
computer programme (DNAmanTM version 4 software [Lynnion Biosoft Corp© ]). 
 
2.1.1.2 Connexin 45 oligonucleotide primers 
The region encoding the Cx45 COOH-terminal domain was PCR amplified to 
generate the 444bp Cx45 COOH-terminal domain-encoding fragment (Figure 2.1). 
To ultimately facilitate cloning into the appropriate vector, both primers were 
designed to have engineered restriction enzyme sites on the 5’ ends; NdeI for the 
forward primer and EcoRI for the reverse primer. In addition, these two primers 
included “overhang” nucleotides (9bp) at their 5’ ends to facilitate restriction enzyme 
digestion of the engineered NdeI and EcoRI sites. The reverse primer also contained 
a “stop” codon upstream of the restriction enzyme site. The sequences of the 
primers used for this part of the study are shown in table 2.1. 
 
Table 2.1 Primer sequences and annealing temperatures used for the 
amplification of the COOH-terminal domain of Cx45 gene from genomic DNA. 
Primer 
name 
Sequence Ta   
Cx45-
NdeI(F) 
5’- actgcagaa catatg atgcttcatttagggtttgg-3’ 56 C 
Cx45  
EcoRI(R) 
5’-ATCTCTGCA GAATTC TTA 
AAATCCAGACGGAGGTC-3’ 
56 C 
Abbreviations: °C, degrees Celsius; Ta, annealing temperature; sequences in black 
font represent the sequence of the primer that anneals to the DNA in the PCR 
reaction. The sequences in coloured fonts represent tags for cloning: Blue, 
“overhang” tag; red, EcoRI restriction site; brown, stop codon and green, NdeI 
restriction site, Cx45-NdeI(F); connexin 45 forward primer with engineered NdeI 
restriction site, Cx45-NdeI(F);connexin 45 reverse primer with engineered EcoRI 
restriction site, Cx45  EcoRI(R). 
 
2.2.1.2 Primers for Y2H insert screening  
In order to amplify inserts cloned into Y2H cloning vectors, primers were designed to 
vector-specific sequences flanking the multiple cloning site (MCS) of pGBKT7 Y2H 
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cloning bait vector (BD Bioscience, Clontech, Paulo Alto, CA, U.S.A) (Figure 2.2). 
Another set of primers was designed using vector specific sequences flanking the 
MCS of pGADT7-Rec Y2H cloning prey vector (Figure 2.3) in order to sequence 
ligands or preys identified from the Y2H screen. The specific vector sequences used 
in the synthesis of these primers were obtained from the ClontechTM MatchmakerTM 
vector handbook (www.clontech.com). The sequences of these vector-specific 
primers are shown in table 2.2. 
 
Table 2.2 Primer sequences and annealing temperatures used for the 
amplification of inserts from cloning vectors 
Primer name Sequence Ta (°C) 
pGBKT7(F) 
5’-TCATCGGAAGAGAGTAG-3’ 
 
50 
pGBKT7(R) 
5’-TCACTTTAAAATTTGTATACA-3’ 
 
51 
pGADT7- 
Rec (F) 
5’CTATTCGATGATGAAGATACCCCACCAAACC-
3’ 
68 
pGADT7-Rec 
(R) 
5’-gtgaacttgcggggtttttcagtatctacga-3' 68 
Abbreviations: °C, degrees Celsius; Ta, Annealing temperature; pGBKT7 (F), bait 
cloning vector forward primer; pGBKT7(R), bait cloning vector reverse primer; 
pGADT7-Rec (F), prey vector forward primer and pGADT7-Rec(R), prey vector 
reverse primer. 
 
2.2.1.3 Primers for mammalian two-hybrid analysis (M2H) 
Primers were designed in order to amplify the Cx45-bait insert from recombinant 
pGBKT7 and clone it into the pM GAL4 DNA-binding domain vector for M2H 
screening (section 2.13). Separate sets of primers were designed to amplify Cx45 
putative ligands identified during the course of the study from pGADT7-Rec for 
cloning into the pVP16 GAL4 activation domain vector. The sequence and annealing 
temperatures of these primers are shown in table 2.3. 
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Table 2.3 Primer sequences and annealing temperatures used for the 
amplification of inserts for M2H analysis. 
Primer  
name* 
SEQUENCE Ta(°C) 
NADH-
EcoR1(F) 
5’-ATCTAGTGA GAATTC GCCCACGGACTTACATCC-
3’ 
58 
NADH-
XbaI(R) 
5’-ATCTCTGCA TCTAGA CTA 
GGATCCCGTACGATGCC-3’ 
58 
Myo-
BamH1(F) 
5’-ATCTCTGCA GGATCC GAGCACTAACCACAAACG-
3’ 
54 
Myo- 
MluI(R) 
5’-ATCTCTGCA ACGCGT CTA 
GTATCTACGATTCATCTG-3’ 
53 
Cox1-
EcoRI(F) 
5’-ATCTCTGCA GAATTC ACAGACCGCAACCTCAAC-
3’ 
56 
Cox1-MluI(R) 
5’-ATCTCTGCA ACGCGT CTA 
GTATCTACGATTCATCTG-3’ 
57 
SCF –
EcoRI(F) 
5’-ATCTCTGCA GAATTC GTGTCCAGGCCGGAGCC-3’ 60 
SCF –
HindIII(R) 
5’-ATCTCTGCA AAGCTT CTA 
TCAGTATCTACGATTCATCTG-3’ 
58 
CD63-
EcoRI(F) 
5’-ATGCATCCTG GAATTC 
ATGGCGGTGGAAGGAGGAATG-3’ 
66 
CD63-
HindIII(R) 
5’-ATCTCTGCA AAGCTTCTA 
GTATCTACGATTCATCTGCAG-3’ 
60 
Obs-EcoRI(F) 
5’-ATCTCTGCA GAATTC ATGGGAAAGCAGTGCAGG-
3’ 
56 
Obs-
HindIII(R) 
5’-ATCGACTAC AAGCTT CTA 
GTATCTACGATTCATCTG-3’ 
53 
TX2-EcoRI(F) 
5’-ATCTCTGCA GAATTC 
ATGGCTCAGCGACTTCTTCTG-3 
64 
TX2-
HindIII(R) 
5’-ATCTCTGCA AAGCTT CTA 
GTATCTACGATTCATCTG -3’ 
60 
Abbreviations: °C, degrees Celsius; Ta, annealing temperature; sequences in black 
font represent the sequence of the primer that anneals to the DNA in the PCR 
reaction. *Prey identification; NADH= NADH dehydrogenase subunit IV, Myo = 
Myomegalin, CoxI = cytochrome C oxidase subunit I (CoxI), SCF = SCF apoptosis 
response protein I, CD63 = CD63 antigen, Obs = Obscurin, TX2 = Thioredoxin II. 
The sequence in coloured fonts represents tags for cloning: Blue, “overhang” tag; 
red, HindIII enzyme restriction site; green, EcoRI enzyme restriction site;  
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orange,  MluI enzyme restriction site;  pink,  BamHI  enzyme restriction site;  
purple, XbaI enzyme restriction site and brown, stop codon. 
 
2.2.2  PCR-amplification for generation of Cx45 COOH-terminal domain 
bait fragment.  
The generation of the Cx45 COOH-terminal domain bait fragment (Figure 2.1), from 
100ng control genomic DNA, was performed using PCR amplification. A PCR 
reaction mix was made up consisting of 15μl of an equimolar dNTP mixture (2.5mM 
of each, dATP, dCTP, dGTP and dTTP) solution, supplied by manufacturer (TaKaRa 
Shuzo Co. Ltd, Shiga, Japan), 50μl Ex TaqTM Mg2+-containing 10x reaction buffer, 
supplied by manufacture (TaKaRa Shuzo Co. Ltd, Shiga, Japan), 150ng of each 
primer (Table 2.1) and 395μl ddH2O. A volume of 1μl of template DNA was added to 
an aliquot of 46μl reaction mix. Thereafter, 0.5μl ExTaqTM, supplied by manufacturer 
(TaKaRa Shuzo Co. Ltd, Shiga, Japan) was added. Thermo-cycling was performed 
in a GeneAmp®, PCR system 9700 thermal cycler (P.E Biosystems, Forster, City CA. 
U.S.A) using the following cycling parameters: a single denaturing cycle of 94°C for 
5min, followed by 30 cycles of 94°C for 30s, 49°C for 30s and 72°C for 1min. PCR 
conditions are summarised in table 2.4. 
 
Table 2.4 PCR conditions used for amplification of Cx45 insert (Y2H)  
Primer set 
[MgCl2] 
mM 
TD 
°C 
Time 
sec 
TA 
°C 
Time 
sec 
TE 
°C 
Time 
sec 
Cx45-NdeI(F)/  
Cx45-
EcoRI(R) 
1.5 94 30 49 30 72 150 
Abbreviations: °C, degrees Celsius; MgCl2, magnesium chloride mM, millimolar; sec, 
seconds; TA, annealing temperature; TD, denaturing temperature; TE, extension 
temperature. The thermocycler was set to perform 30 amplification cycles; Cx45-
NdeI(F), connexin 45 forward primer with engineered NdeI restriction site, Cx45-
EcoRI(R), connexin 45 reverse primer with engineered EcoRI restriction site. 
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Cx45 – NdeI(F)
Cx45 – EcoRI(R)
Primer Cx45 – NdeI(F)  5’- ACTGCAGAA CATATG ATGCTTCATTTAGGGTTTGG-3’
Primer Cx45 – EcoRI(R) 5’-ATCTCTGCA GAATTC TTA AAATCCAGACGGAGGTC-3’
A
B
 
Figure 2.1 A. PCR amplification of Cx45 COOH-terminal domain.  
B. Nucleotide sequences of forward (Cx45-NdeI(F) and reverse (Cx45-EcoRI[R]) 
primers obtained from Genbank database http;//www.ncbi.nlm.nih.gov/Entrez). 
 
2.2.3  Bacterial colony PCR 
In order to rapidly identify bacterial colonies harbouring the desired recombinant 
plasmid to be used in Y2H and M2H analyses, bacterial colony PCRs were 
performed, as the vectors used did not allow blue/white selection. In these PCRs, 
instead of using 100ng of genomic DNA as template, a tiny amount of a bacterial 
colony was picked from an agar plate containing the appropriate antibiotic (Appendix 
I), and used as template. Y2H vector-specific primers and prey-specific forward 
primers (M2H) (tables 2.5 and 2.6) were used in conjunction with PCR reaction 
mixtures identical to those described in section 2.2.2 to perform these colony PCR 
amplifications. No lysis of the bacterial cells was required prior to the PCR as the 
high temperatures involved would lyse the cell and release its DNA (template) into 
the PCR mixture. Amplification was performed in a GeneAmp® PCR system 9700 
thermal cycler. The cycling parameters consisted of a single denaturing cycle of 
94°C for 5min, followed by 30 cycles of 94°C for 30s, 50°C for 30s and 72°C for 
444pb 
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1min. PCR amplified products were subsequently separated on a 1% agarose gel for 
verification by electrophoresis (section 2.4.1). 
 
Table 2.5 PCR conditions used for bacterial colony PCR (Y2H) analysis 
Primer set 
 
[MgCl2] 
mM 
TD 
°C 
Time 
sec 
TA 
°C 
Time 
sec 
TE 
°C 
Time 
sec 
pGBKT7(F)/  
pGBKT7(R) 
1.5 94 30 50 30 72 150 
Abbreviations: °C, degrees Celsius; MgCl2, magnesium chloride mM, millimolar; sec, 
seconds; TA, annealing temperature; TD, denaturing temperature; TE, extension 
temperature. The thermocycler was set to perform 30 amplification cycles. 
 
Table 2.6 PCR conditions used for bacterial colony PCR (M2H) analysis 
 Abbreviations: °C, degrees Celsius; MgCl2, magnesium chloride mM, millimolar; 
sec, seconds; TA, annealing temperature; TD, denaturing temperature; TE, 
extension temperature. The thermocycler was set to perform 30 amplification cycles. 
Primer sets of respective preys, NADH= NADH dehydrogenase subunit IV, Myo = 
Myomegalin, CoxI = cychrome C oxidase subunit I (CoxI), SCF = SCF apoptosis 
Primer set 
 
[MgCl2] 
mM 
TD 
°C 
Time 
sec 
TA 
°C 
Time 
sec 
TE 
°C 
Time 
sec 
Cx45F-EcoRI(F)/  
Cx45R-HindIlI(R) 
1.5 94 30 54 30 72 150 
SCF-EcoRI(F)/  
pGADT7-Rec-HindIII(R) 
1.5 94 30 56 30 72 150 
Myo-BamHI(F)/  
pGADT7-Rec-MluI(R) 
1.5 94 30 56 30 72 150 
Obs-EcoRI(F)/ 
pGADT7-Rec-HindIII(R) 
1.5 94 30 56 30 72 150 
NADH-EcoRI(F)/ 
pGADT7-Rec-XbaI(R) 
1.5 94 30 56 30 72 150 
TX2-EcoRI(F)/ 
pGADT7-Rec-HindIII(R) 
1.5 94 30 56 30 72 150 
Cox-EcoRI(F)/ 
pGADT7-Rec-MluI(R) 
1.5 94 30 56 30 72 150 
CD63-EcoRI(F)/ 
pGADT7-Rec-HindIII(R) 
1.5 94 30 60 30 72 150 
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response protein I, CD63 = CD63 antigen, Obs = Obscurin, TX2 = Thioredoxin II, 
and their engineered restriction enzyme sites red, HindIII enzyme restriction site; 
green, EcoRI enzyme restriction site; orange, MluI enzyme restriction site; 
pink, BamHI enzyme restriction site; purple, XbaI enzyme restriction site. 
 
2.2.4  PCR-amplification for mammalian two-hybrid analysis 
The Y2H cloning vector containing the “bait” insert, as well as the vector containing 
putative Cx45-interacting clones isolated in the Y2H screen, were used as templates 
for the PCR amplification of the inserts to be cloned into the M2H vectors (pM and 
pVP-16) for the M2H analysis. Amplification was performed in a 50μl reaction volume 
containing 0.5μl plasmid preparation (section 2.3.1), 150ng of each primer (table 
2.6), 1.5μl of an equimolar dNTP solution, 5μl Ex TaqTM Mg2+-containing 10x reaction 
buffer supplied by the manufacturer, 2U Ex TaqTM  and ddH2O to a final volume of 
50μl. Amplification was performed in a GeneAmp ® PCR system 9700 thermal cycler. 
The PCR conditions for the amplification of the bait-insert and each of the putative 
ligands are shown below (table 2.7). 
 
Table 2.7 PCR conditions used for amplification of inserts for M2H analysis 
Primer set 
 
[MgCl2] 
mM 
TD 
°C 
Time 
sec 
TA 
°C 
Time 
sec 
TE 
°C 
Time 
sec 
Cx45-EcoRI (F)/  
Cx45-HindIII (R) 
1.5 94 30 54 30 72 30 
SCF-EcoRI(F)/  
pGADT7-Rec-HindIII(R) 
1.5 94 30 56 30 72 150 
Myo-BamHI(F)/ pGADT7-
Rec-MluI(R) 
1.5 94 30 56 30 72 150 
Obs-EcoRI(F)/ pGADT7-
Rec-HindIII(R) 
1.5 94 30 56 30 72 150 
NADH-EcoRI(F)/ 
pGADT7-Rec-MluI(R) 
1.5 94 30 56 30 72 150 
TX2-EcoRI(F)/ pGADT7-
Rec-HindIII(R) 
1.5 94 30 56 30 72 150 
Cox-EcoRI (F)/ pGADT7-
Rec-MluI(R) 
1.5 94 30 56 30 72 150 
CD63-EcoRI(F)/ 
pGADT7-Rec-HindIII(R) 
1.5 94 30 60 30 72 150 
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Abbreviations: °C, degrees Celsius; MgCl2, magnesium chloride mM, millimolar; sec, 
seconds; TA, annealing temperature; TD, denaturing temperature; TE, extension 
temperature. The thermocycler was set to perform 30 amplification cycles. 
 
2.3  PLASMID PURIFICATION 
2.3.1  Bacterial plasmid purification1 
Bacterial plasmids to be used in restriction enzyme digests were extracted using a 
standard plasmid purification procedure modified in the MAGIC laboratory. One E. 
coli colony containing the plasmid of interest was picked from an appropriate 
selection plate and inoculated into 10 ml of Luria-Bertani Broth (LB), supplemented 
with the correct antibiotic (Appendix I), in a 50ml polypropylene tube. The culture 
was then incubated at 37°C overnight, while shaking at 250rpm in a YIH DER model 
LM-530 shaking incubator (SCILAB instrument Co LTD., Taipei, Taiwan).  
The following morning, the culture was centrifuged for 10min at 3000rpm in a 
Beckman model TJ-6 centrifuge, after which the supernatant was discarded and the 
pellet was resuspended by gently pippeting in 1ml of cell suspension solution. Two 
millilitres of cell lysis solution was added and the contents were mixed by gentle 
inversion of the tube which was then incubated at room temperature for 5 minutes. 
Two millilitres of neutralisation solution was added to the tube and the contents were 
once again mixed by gentle inversion and thereafter incubated at room temperature 
for 5 minutes. Following this incubation, 5ml of phenol/chloroform/isoamyl alcohol 
(25:24:1 [PCI]) (Sigma, St Louis, MO, USA) was added to the tube and the contents 
mixed by gentle inversion, followed by centrifugation at 3000 rpm for 15 min at 4°C in 
a Multex centrifuge (MSE Instrumentation, England, UK) in order to allow for phase 
separation. The upper clear plasmid-containing top (aqueous) phase was transferred 
into a new sterile 50ml polypropylene tube and approximately 0.7x volume 100% 
isopropanol (Merck, Darmstadt Germany) was added to the tube, which was mixed 
well by gentle inversion. This was followed by centrifugation at 4°C for 45 minutes in 
a Multex centrifuge. After centrifugation, the supernatant was discarded and the 
pellet was washed twice with 2ml ice cold 70% ethanol and then air-dried. The dried 
pellet was resuspended in 100-200μl ddH2O and subsequently 3μl of this plasmid 
preparation was resolved on a 1% SB agarose gel for verification (2.4.1). 1 
                                            
1
 All constituents and make up of solutions used this procedure are in Appendix I 
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2.3.2  Bacterial plasmid purification using Wizard® Purefection Plasmid 
DNA purification kit 2 
To reduce impurities which could interfere with the sequencing reaction, the Wizard® 
Purefection Plasmid DNA purification kit was used to extract and purify bacterial 
plasmids to be transfected into mammalian cells. One E. coli colony containing the 
plasmid of interest was picked from an appropriate selection plate and inoculated 
into 20 ml LB, supplemented with the correct antibiotic, in a 50ml polypropylene tube. 
The culture was incubated at 37°C overnight, while shaking at 250rpm in a YIH DER 
model LM-530 shaking incubator.  
 
The following morning the culture was centrifuged for 10min at 3000rpm in a 
Beckman model TJ-6 centrifuge. The supernatant was discarded and the pellet was 
resuspended gently in 1.25ml resuspension solution (Wizard® Purefection Plasmid 
DNA purification kit, Promega Corp. Madison Wisconsin, U.S.A). Two millilitres of 
cell lysis solution was added and the contents were mixed by gentle inversion of the 
tube which was subsequently incubated at room temperature for 5 minutes. Two 
millilitres of neutralisation solution was added to the tube and the contents were once 
again mixed by gentle inversion and incubated at room temperature for 5 minutes. 
The bacterial lysate was centrifuged at 3000rpm for 30 min and the supernatant 
transferred to a 15ml polypropylene tube. Two hundred and fifty microlitres of 
endotoxin removal resin was added to the tube and mixed thoroughly. This was 
followed by a 10 min incubation at room temperature, vortexing the mixture 
periodically for approximately 5 seconds using a Snijders model 34524 press-to-mix 
vortex (Snijders Scientific, Tilburg, Holland). The tube was then placed onto a 
MagniSilTM Magnetic Separation Unit and the solution was allowed to clear for 
approximately 30 sec. The tube was kept on the magnet and the supernatant was 
transferred to a new 15ml polypropylene tube.  
 
One millilitre of 5M guanidine thiocyanate was added to the supernatant-containing 
tube and then mixed vigorously (to allow binding of the DNA to the magnetic 
particles). To this, 0.75ml MagnesilTM Paramagnetic particles was added, mixed 
thoroughly and then incubated at room temperature for 2min. The tube was placed 
onto the MagnisilTM Magnetic Separation Unit and the solution was allowed to clear 
for 30sec. The supernatant was discarded and after removing the tube from the 
magnet, the particles were washed by adding 1ml 4/40 wash solution. The particles 
were completely resuspended in the wash solution by vortexing using a Snijders 
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model 34524 press-to-mix vortex for at least 10sec. The wash solution helps remove 
extraneous proteins, such as nucleases, from the DNA. The tube was once again 
placed on the MagnisilTM Magnetic Separation Unit and the solution allowed to clear 
for 30 seconds. The supernatant was discarded and the particles were washed twice 
more with the 4/40 wash solution. Following the final wash, the tube was placed on 
the MagnisilTM Magnetic Separation Unit and the solution allowed to clear. The 
supernatant was discarded and after the tube was removed from the magnet, 1.2ml 
double distilled H2O (ddH2O) was added to the particles and mixed vigorously. The 
tube was incubated for 1min at room temperature and then returned to the 
MagnisilTM Magnetic Separation Unit. The solution was allowed to clear and the 
supernatant containing the DNA was carefully transferred to a new 15ml 
polypropylene tube. The volume of supernatant was measured and the DNA 
precipitated by adding 0.5 volumes of 7.5M ammonium acetate, per measured 
volume and 2.5 volumes of 96% ethanol to the combined volume of the supernatant 
and ammonium acetate. The solution was mixed well by inversion of the tube. This 
was followed by centrifugation at 14000 rpm for 15 min in a Beckman Microfuge Lite. 
The supernatant was removed and the DNA pellet washed with 70% ethanol before 
centrifuging at 14000 rpm followed by removal of the supernatant. The pellet was 
then air-dried for 5-10min to remove all the residual ethanol, after which the DNA 
was resuspended in 100μl ddH2O. Subsequently the DNA concentration was 
determined by electrophoretically separating an aliquot of DNA adjacent to a DNA 
marker standard in a 1% agarose gel and visually assessing the concentration. 2 
                                            
2 All products used in this purification procedure were supplied by the manufacturer (Promega Corp. Madison Wisconsin, 
U.S.A) 
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2.3.3  3 Yeast genomic DNA purification 
Yeast cells containing the DNA of interest were inoculated into 1ml synthetic dropout 
(SD) medium containing the appropriate dropout supplement (BD Bioscience, 
Clontech, Paulo Alto, CA, U.S.A) and incubated overnight at 30°C shaking at 250rpm 
in a shaking incubator. The following morning, 4ml YPDA (a blend of yeast extract, 
peptone, and dextrose supplemented with adenine) was added to the culture which 
was incubated for an additional 4 hours at 30°C. Thereafter, 1.5ml of the culture was 
transferred into a 2ml Eppendorf microfuge tube, which was centrifuged at 14000rpm 
for 30sec in a Beckman Microfuge Lite. The supernatant was discarded and to the 
pellet was added 200μl yeast lysis buffer, 200μl PCI and 0.3g sterile 450-600μm 
glass beads. The yeast cells were milled by vortexing this mixture for 2.5min using a 
Snijders model 34524 press-to-mix vortex, followed by centrifugation at 14000rpm 
for 5min at room temperature Beckman Microfuge Lite (Beckman Instruments Inc., 
CA, USA) for phase separation. The aqueous phase was transferred to a new, sterile 
1.5ml microfuge tube. 
 
Subsequently the DNA was precipitated by adding 20μl of 3M NaAc (pH 6.0) and 
500μl 95% ethanol, after which the mixture was incubated at -20°C for 30 min. 
Following incubation, the mixture was centrifuged at 14000rpm for 15 min at room 
temperature in a Beckman Microfuge Lite (Beckman Instruments Inc., CA, USA). 
The supernatant was discarded and the pellet washed twice with 1ml 95% ethanol, 
before being air-dried and resuspended in an appropriate volume of ddH2O.  
 
2.4  GEL ELECTROPHORESIS 
2.4.1  Agarose gel electrophoresis 
Agarose gel electrophoresis was used either to visualise PCR-amplified fragments or 
plasmid preparations for verification of their presence and expected size (section 
2.2.3). 
 
2.4.1.1 Agarose gel electrophoresis for the visualisation of PCR-amplified products 
In order to verify that the PCR amplifications were successful, the amplification 
productswere electrophoretically separated as follows: 8μl PCR product was mixed 
with 1μl bromophenol blue loading dye. Each sample was then loaded into separate 
wells of a 1-2% (depending on the size of the amplified fragment) horizontal agarose 
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gel of 7x9x1 cm dimensions, containing 1μg/ml ethidium bromide and 1xTBE buffer. 
A molecular size marker of either bacteriophage λ DNA digested with PstI (λPst) 
(Promega, Madison WI, USA) or a 100bp ladder (Promega, Madison WI, USA) was 
co-electrophoresed with all the PCR amplified products. Electrophoresis was 
performed at 10V/cm for 20min in 1xSB running buffer. Following electrophoresis, 
the DNA fragments were visualised on a long wave 3UV trans-illuminator (UVP, Inc. 
Upland, CA, U.S.A) and photographs were obtained using an ITC Polaroid camera 
and Sony video-graphic printer (Sony Corporation, Shinagawa-ku, Tokyo,Japan).  
 
2.4.1.2 Agarose gel electrophoresis for the visualisation of plasmids isolated 
from E. coli 
One to five microlitres of plasmid isolated from E. coli was mixed with 1μl of 
bromophenol blue loading dye and electrophoresed on a 1% horizontal agarose gel 
of 7x9x1cm dimensions, containing 1μg/ml ethidium bromide and 1xSB  buffer. The 
λPst size marker was co-electrophoresed with all the purified plasmids. 
Electrophoresis occurred at 6V/cm for 30-45min in 1xSB buffer. Following 
electrophoresis, plasmids were visualised on a long wave 3UV trans-illuminator 
(UVP, Inc. Upland, CA, U.S.A) and photographs were obtained using an ITC 
Polaroid camera and Sony video-graphic printer (Sony Corporation, Shinagawa-ku, 
Tokyo, Japan). 
 
2.5 5 Restriction enzyme digestion for cloning 
2.5.1  Restriction digests for cloning inserts into pGBKT7 for Y2H analysis 
To clone the PCR-generated Cx45 COOH-terminal fragment into the pGBKT7 vector 
(Figure 2.2), for Y2H analysis, both the insert and vector were sequentially double-
digested with NdeI and EcoRI (Promega, Madison WI, USA). The digests were 
prepared in a 100μl reaction volume as follows: 50μl insert DNA (100ng/μl) or 20μl 
pGBKT7 vector DNA was mixed with 5μl NdeI (10u/μl), 10μl restriction enzyme 
buffer D (Promega, Madison WI, USA) and the appropriate volume of ddH2O to 
make volume up to 100ul (Insert, 35μl; vector, 65μl). The mixtures were incubated at 
37°C for 3h. 
 
Following this, the samples were purified using the GFX® DNA purification kit 
(AmershamPharmacia Biotech, New Jersey, USA), as discussed in section 2.3.2, 
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with the only exception being that instead of gel electrophoresis and subsequent 
excision of DNA from the gel for purification, the samples were purified directly.  
 
The samples were subsequently eluted from the GFXTM column in 50μl ddH2O and 
mixed with 5μl EcoRI (12u/μl), 10μl restriction buffer H (Promega, Madison WI, USA) 
and 35μl ddH2O. Subsequently, the samples were incubated at 37°C for 3 hours, 
after which they were again purified using the GFXTM DNA purification kit 
(AmershamPharmacia Biotech, New Jersey, USA). Double-digested pGBKT7 was 
subsequently treated with calf intestinal alkaline phosphatase (CIP) (section 2.6.3) to 
prevent the vector from annealing to itself, while double-digested insert was used 
directly in ligation reactions. 
 
2.5.2  Restriction digests for cloning inserts into pM and pVP-16 for M2H 
analysis 
In order to clone the PCR-generated fragments (section 2.6.2) into the pM and pVP-
16 vectors (Figure 2.4 and Figure 2.5, respectively), for M2H analysis, both the insert 
and vector were sequentially double-digested with appropriate 5’ and 3’ restriction 
enzymes (Promega, Madison WI, USA). The digests were prepared in a 100μl 
reaction volume as follows: 50μl insert DNA or 20μl appropriate vector DNA (pM for 
Cx45 domain insert, pVP-16 for putative ligand insert) was mixed with 5μl restriction 
enzyme, 10μl restriction enzyme buffer (Promega, Madison WI, USA) and the 
appropriate volume of ddH2O (insert, 35μl; vector, 65μl). The mixtures were 
incubated at 37°C for 3h. Following this, the samples were purified using the GFXTM 
DNA purification kit (AmershamPharmacia Biotech, New Jersey, USA). The samples 
were then eluted in 50μl ddH2O and mixed with 5μl SalI (test enzyme
3 ), 10μl 
restriction buffer D (Promega, Madison WI, USA) and 35μl ddH2O. Subsequently, the 
samples were incubated at 37°C for 3 hours, after which they were again purified 
using the GFXTM DNA purification kit (AmershamPharmacia Biotech, New Jersey, 
USA). Double-digested vectors were then treated with calf intestinal alkaline 
phosphatase (CIP) (Section 2.6.3) prior to being used in ligation reactions, while 
                                            
3
 
Test enzyme is used to detect whether the plasmid or the DNA fragment of interest has additional unexpected restriction sites, the presence of which 
jeopardise subsequent experiments. This enzyme should not linearise the DNA fragment at all 
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double-digested insert was used directly in ligation reactions. For cloning of prey 
insert into pVP16, the same protocol was followed as shown above.  
 
2.6  GENERATION OF Y2H AND M2H CONSTRUCTS 
2.6.1 2.6.1 Y2H constructs 
After the restriction enzyme digestion  of the PCR amplified Cx45 COOH-terminal 
fragment, it was cloned into the pGBKT7 bait-vector (Figure 2.3) and, after 
verification of the integrity of the sequence and conservation of the GAL4 DNA-BD 
reading frame by automated sequencing, transformed (section 2.10.2) into the S. 
cerevisiae strain AH109. This construct was used to screen a CLONTECH 
MATCHMAKER pre-transformed adult human cardiac cDNA library, comprising adult 
cardiac cDNAs cloned into the pGADT7-Rec (Figure 2.3) prey-vector and 
transformed into the S. cerevisiae strain Y187 (section 2.10.2). 
 
2.6.2  M2H constructs 
Subsequent to the Y2H analysis, the Cx45 bait-insert was cloned into the pM GAL4-
DNA binding domain vector, while putative Cx45-interacting clones were cloned into 
the pVP16 GAL-activation domain vector (Figure 2.5). The integrity of the sequence 
and conservation of the GAL4 DNA-BD and GAL4-activation domain reading frame 
was verified by automated sequencing. 
 
2.6.3  Alkaline phosphatase treatment of vector 
To prevent the vector to be used in Y2H and M2H cloning re-circularising by self-
ligation, following double restriction enzyme digestion (section 2.5.1), the ends of the 
linearised plasmid was CIP (calf intestine phosphatase)-treated to remove the 5’ 
phosphate groups. This was accomplished by mixing 50μl of the digested vector with 
1μl CIP (1u/μl) (Promega, Madison WI, USA), 10ul CIP buffer (Promega, Madison 
WI, USA) and 38μl ddH2O. The sample was incubated at 37°C for 30 min, after 
which another 2μl CIP was added and the mixture incubated for a further 30min. 
Following this, 2μl 0.5M EDTA was added and the sample was incubated at 65°C for 
20 minutes to inactivate the enzyme. The vector was subsequently purified using the 
GFXTM DNA purification kit (AmershamPharmacia Biotech, New Jersey, USA) 
(section 2.3.2). 
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2.6.4  DNA ligation 
DNA ligations were performed in order to generate the Y2H bait constructs to be 
used in Y2H analysis and M2H bait and prey constructs for M2H analysis. In general, 
2μl of the double-digested insert (section 2.5.1) was added to 1μl of CIP-treated, 
double-digested vector. To this mixture, 5μl 2x T4 DNA ligase buffer (Promega, 
Madison WI, USA), 5U T4 DNA ligase and ddH2O, to a final volume of 10μl, was 
added. The sample was then incubated for 16 hours at 4°C. Following incubation, 
5μl of the sample was transformed into the bacterial strain DH5α (section 2.10.1) 
and plated onto LB agar plates containing the appropriate antibiotic. After incubation 
of the plates, successful ligation reactions were confirmed by bacterial colony PCRs 
(section 2.2.3.). Control ligations were also run for at different insert-to-vector ratios 
to assess optimal ligation aliquots. 
 
2.7  BACTERIAL STRAINS, YEAST STRAINS AND CELL LINES4 
2.7.1  Bacterial strains 
To facilitate the selection and purification of Y2H constructs, ligation reactions 
(section 2.6.4) were transformed into the E. coli DH5α strain. Transformed bacterial 
colonies were selected on the basis of their ability to grow on LB agar plates 
containing selection antibiotics (Appendix I), and recombinant plasmids identified by 
colony PCR (section 2.2.3). When selecting for recombinant bait vector pGBKT7, 
kanamycin was used as a selection antibiotic, while ampicillin was used when 
selecting for recombinant prey vector pGADT7-Rec, pM and pVP16.  
 
                                            
4
 
Genotypes of bacterial strains, yeast strains and cell lines used are in Appendix I. 
 
pGBK7T-F 
A 
B pGBKT7-
R 
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Figure 2.2 Restriction map and multiple cloning site (MCS) of pGBKT7 Y2H bait 
vector. a).  
The positions of the kanamycin resistance gene (kan ), TRP1 and GAL4-BD coding 
sequences, f1 bacteriophage and pUC plasmid origins of replication, the truncated S. 
cerevisiae ADH1 promotor sequence (PADH1), the T7 RNA polymerase promoter, the 
T7 and c-Myc epitope tag are indicated on the map. b) Nucleotide sequence of the 
pGBKT7 MCS. The positions of all unique restriction enzyme recognition sequences, 
stop codons in the T7 terminator sequence, the GAL4-BD coding sequence, the T7 
promoter sequence, c-Myc epitope tag and the positions of pGBKT7-F and pGBKT7-
R screening primers and sequencing primers are indicated on the sequence. (Taken 
from Clontech MATCHMAKER vectors handbook).  
 
 
 
pGBKT7-F 
 
pGBKT7-R 
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Figure 2.3 Restriction map and multiple cloning site (MCS) of pGADT7-Rec 
Y2H prey vector. a) 
The positions of unique restriction sites are indicated in bold. The position of the 
ampicillin resistance gene (Ampr), LEU2 and GAL4-AD coding sequences, and 
pBR322 plasmid origins, the S.cerevisiae ADH1 promoter, S.cerevisiae ADH1 
termination sequence, Lox sites (Lox 1 and Lox 2), the Heamagglutinin (HA) epitope 
tag and the MCS are indicated on the map. b) Nucleotide sequence of the pGADT7-
Rec MCS. The positions of all unique restriction sites, stop codons, the position of 
the final codon (881) of GAL4-AD coding sequence, the positions of the pGADT7-
Rec-F and pGADT7-Rec-R primers and the HA epitope tags are all indicated in the 
map. (Taken from Clontech MATCHMAKER vectors handbook). 
 
 
pGADT7-Rec-F 
 
pGADT7-Rec-R 
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Figure 2.4 Restriction map and multiple cloning site (MCS) of pM M2H GAL4 
BD vector. a)  
The positions of unique restriction sites are indicated in bold. The position of the 
ampicillin resistance gene (Ampr), GAL4-BD coding sequences, the SV40 promoter 
and SV40 polyA transcription termination sequence and the MCS are indicated on 
the map. b) Nucleotide sequence of the pM MCS. The positions of all unique 
restriction sites, stop codons, the position of the GAL4-BD coding sequence and the 
position of the pM sequencing primer are all indicated in the map. (Taken from 
Clontech MATCHMAKER Two-Hybrid Assay Kit User Manual). 
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Figure 2.5 Restriction map and multiple cloning site (MCS) of pVP M2H GAL4-
AD vector.  
The positions of unique restriction sites are indicated in bold. The position of the 
ampicillin resistance gene (Ampr), GAL4-AD coding sequences, the SV40 promoter 
and SV40 poly A transcription termination sequence and the MCS are indicated on 
the map. b) Nucleotide sequence of the pM MCS. The positions of all unique 
restriction sites, stop codons, the position GAL4-AD coding sequence and the 
position of the pVP16-F and pVP16-R primers are indicated on the map. (Taken from 
Clontech MATCHMAKER Two-Hybrid Assay Kit User Manual). 
 
2.7.2  Yeast strains 
The pGBKT7 bait construct was transformed into the S. cerevisiae strain AH109, 
while all the prey clones present in the pre-transformed CLONTECH cDNA library 
used in the Y2H analysis had been transformed into the S. cerevisiae strain Y187 by 
the supplier (BD Bioscience, Clontech, Paulo Alto, CA, U.S.A). 
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2.7.3  Cell lines 
The pM and pVP-16 constructs were co-transfected into a human cardiac (H9C2) 
cell line for M2H analysis together with the pG5SEAP vector, which is a reporter 
vector that contains the secreted alkaline phosphatase (SEAP) reporter gene 
downstream and under the control of a GAL4-responsive element (Figure 2.6). 
 
2.8  GENERATION OF E. coli DH5α COMPETENT CELLS 
 An aliquot of E. coli DH5α frozen (-70°C) glycerol stock was inoculated into 10ml 
LB-media. The culture was then incubated overnight at 37°C in a YIH DER model 
LM-530 shaking incubator (SCILAB instrument CO. Ltd, Taipei, Taiwan) at 
approximately 200rpm. Following incubation, a 1ml aliquot of this culture was 
inoculated into a 2l Erlenmeyer flask containing 200ml LB media. This culture 
was then incubated at room temperature for 24 hours, while shaking at 200rpm, 
to mid log phase (OD600nm=0.6) on a Labcon orbital shaker (Labcon Pty, Ltd, 
Maraisburg, RSA). At this point, the culture was decanted into 4x 50ml 
polypropylene tubes and centrifuged at 3000rpm for 15 min at 4°C in a Multitex 
centrifuge (MSE instruments, England). The supernatant was removed and 8ml 
of ice-cold CAP buffer used to resuspend the pellet. The cells were re-pelleted by 
centrifugation at 3000rpm for 15 min at 4°C in a Multitex centrifuge (MSE 
instruments, England). The supernatant was discarded and the pellet was 
resuspended in 4ml of ice-cold CAP buffer. The suspended cells were 
subsequently transferred into 1.5ml microfuge tubes in 500μl aliquots and snap 
frozen by immersion in liquid nitrogen. The cells were then stored at -70°C until 
they were needed. 
 
2.9 CULTURING OF THE H9C2 CELL LINE 
2.9.1  Culture of H9C2 cells from frozen stocks 
2.9.1.1 Thawing the cells 
Frozen H9C2 cells, a kind gift from Prof Janet Hapgood, Dept Biochemistry, 
University of Stellenbosch, were thawed rapidly by immersing the vial containing the 
frozen stock in a 37°C waterbath (Memmert®, Schwabach, Germany) for 10min. 
Once the cells were thawed, the outside of the vial was immediately sterilized with 
70% ethanol.  
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2.9.1.2  Removing DMSO from stocks and culturing cells 
As the frozen stocks contained DMSO, it was necessary to remove the DMSO for 
maximum viability of the cells upon plating, as follows. One millilitre of growth 
medium (GeneJuice) (Appendix I), pre-warmed to 37°C, was added to the thawed 
stock and mixed by gentle pipetting. The mixture was transferred to a 12ml Greiner 
tube (Greiner Bio-one, Frickenhausen, Germany) and another 5ml growth medium 
was added. The cells were then pelleted by centrifugation at 10 000rpm for 1min 
using a Sorval® GLC-4 General Laboratory centrifuge (Separations Scientific, 
Johannesburg, South Africa) followed by removal of the supernatant. The pellet was 
resuspended in another 5ml growth medium and the cells were once again 
centrifuged at 10 000rpm for 1 min using a Sorval® GLC-4 General Laboratory 
centrifuge. Following this, the cells were resuspended in 10ml growth medium and 
transferred into a T25 culture flask. The flask was gently swirled in order to distribute 
the cells evenly over the growth surface of the flask. The flask was then incubated at 
37°C in a Farma termosteri-cycle 5% carbon dioxide humidified incubator (Farma 
International, Miami, Florida, U.S.A).  
 
2.9.2  Subculturing of H9C2 cells 
Cell cultures were subcultured every 2-4 days when they reached approximately 
80%-90% confluency. Briefly, the growth medium was removed from the flask as the 
cells were washed with sterile phosphate buffered saline (PBS) containing no 
calcium or magnesium (Appendix I). To this, 2ml of trypsin (Highveld Biological, 
Lyndhurst, South Africa) was added to facilitate the detachment of the cells from the 
growth surface of the flask. After 3min, 5ml growth medium was added and the cells 
were gently resuspended. The cells from one flask were then transferred into 4 
flasks each containing 10ml of growth medium. This procedure was conducted by 
Mrs Lundi Korkie and would like to extend my appreciation for her assistance. 
 
2.10  TRANSFORMATION AND TRANSFECTION OF PLASMIDS INTO 
PROKARYOTIC AND EUKARYOTIC CELLS 
2.10.1  Bacterial plasmid transformation 
Prior to the transformation, an aliquot of competent E. coli DH5α was removed from 
the -70°C freezer and allowed to thaw in ice for 20-30 min. Once the cells had 
thawed, 1μl plasmid DNA or 3-5μl of the ligation reaction (section 2.6.4) was added. 
This mixture was then incubated on ice for 20-30 min after which were placed in a 
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Lasec 102 circulating water-bath (Lasec Laboratory and Scientific Company Pty Ltd, 
Cape Town, R.S.A) at 42°C for exactly 45s. The sample was then removed from the 
water-bath and left at room temperature for 2min. Next, 1ml of LB media was added 
to the mixture and the sample was incubated for 1h at 37°C, while shaking at 
200rpm in a YIH DER model LM-530 shaking incubator shaking (SCILAB instrument 
CO. Ltd, Taipei, Taiwan). Following this incubation step, 200μl of the sample was 
plated onto LB agar plate containing the appropriate selection antibiotic (Appendix I). 
The remaining transformation reaction mixture was centrifuged at 14000rpm for 2min 
in a Beckman Microfuge Lite, the supernatant was discarded and the pellet 
resuspended in 200μl LB media in order to concentrate the transformation mixture. 
This was then also plated onto the appropriate LB-agar plate. The plates were then 
incubated, inverted, for 16h at 37°C in a model 329 stationary CO2 incubator (Former 
Scientific, Marieta, Ohio, U.S.A). 
 
2.10.2  Yeast Plasmid transformation 
The yeast strain to be transformed was streaked from frozen stocks onto YPDA agar 
plate. These plates were then incubated at 30°C for 2-3 days in a Sanyo MIR262 
stationary ventilated incubator (Sanyo, Electronic Company Ltd, Ora-Gun, Japan). 
Following incubation, a scraped yeast colony representing a volume of 20-50μl were 
picked and resuspended in 1ml sterile ddH2O in a sterile 2ml tube. The cells were 
then re-pelleted by centrifugation at 13000rpm for 30sec in a Beckman Microfuge 
Lite. The supernatant was removed and the pellet was resuspended in 1ml 100 mM 
lithium acetate (LiAc) and incubated for 5 min at 30°C in a MIR262 stationary 
ventilated incubator. The cells were again pelleted by centrifugation at 13000 rpm for 
20s in a Beckman Microfuge Lite and all the LiAc was removed. Next, 240μl of 50% 
polyethylene glycol (PEG), 36μl 1M LiAc, 25μl of 2mg/ml heat-denatured and snap-
cooled sonicated herring sperm DNA (Promega, Madison WI, USA), 10-20μl 
recombinant pGBKT7-Cx45 and ddH2O were added to a final volume of 350μl. The 
sample was then mixed by vortexing using a Snijders model 34524 press-to-mix 
vortex (Snijders Scientific, Tilburg, Holland) for at least 1 min and incubated at 42°C 
for 20-30 min in a Lasec 102 circulating water-bath (Lasec Laboratory and Scientific 
Company Pty Ltd, Cape Town, R.S.A). Following incubation, the cells were pelleted 
by centrifugation at 13000rpm in a Beckman Microfuge Lite (Beckman Instruments 
Inc, CA, U.S.A) and all the supernatant was removed. The cells were resuspended in 
250μl sterile Millipore ddH2O. One hundred and fifty microlitres of this sample was 
plated onto the appropriate selection plate and incubated inverted at 30°C for 2-5 
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days in a Sanyo MIR262 stationary ventilated incubator (Sanyo, Electronic Company 
Ltd, Ora-Gun, Japan). 
 
2.10.3  Transfection of H9C2 cells 
Forty-eight hours before transfecting the cells, approximately 1-3 x 104 cells 
(determined from the haemocytometer) per well were plated in complete growth 
media in a 24-well tissue culture plate and incubated at 37°C in a 5% Farma-
thermosteri-cycle carbon dioxide humidified incubator (Farma, international, Miami, 
Florida, U.S.A). Two days later, the cells were visualised under a Nikon TMS light 
microscope (Nikon, Tokyo, Japan) to determine the level of confluence. Cells were 
only transfected once they reached approximately 80% confluence. For each 
transfection performed, 100μl of serum-free medium was aliquoted into a sterile 
1.5ml eppendorf tube. Three microlitres GeneJuice® (EMD Biosciences, Darmstadt, 
Germany) was added to each tube. This mixture was thoroughly vortexed using a 
Snijders model 34524 press-to-mix vortex and incubated at room temperature for 5 
minutes. A total of 1μg of the four plasmids combined (pM-Cx45, pVP16-putative 
ligand, pSV-β-galactosidase and pG5SEAP reporter vector [Figure 2.6]) (table 2.8) 
was added to the mixture and mixed gently by pipetting. The 
GeneJuice/DNA/medium was incubated at room temperature for 15min. The entire 
volume of the mixture was then added drop-wise to the cells in the growth medium. 
The culture plates were gently rocked back and forth in order to evenly distribute the 
drops across the surface of the plate. The cells were incubated at 37°C, 5% carbon 
dioxide humidified incubator (Farma, international, Miami, Florida) for 48 hours. The 
cells were transferred to eppendorf tubes, subsequently pelleted by centrifugation at 
13000rpm in a Beckman Microfuge Lite and 1ml of the supernatant transferred into a 
sterile eppendorf tube. The supernatants were stored at -20°C until needed for 
subsequent assays (section 2.13). This procedure was conducted by Mrs Lundi 
Korkie and would like to extend my appreciation for her assistance. 
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Figure 2.6 Map of pG5SEAP reporter vector.  
This vector contains 5 GAL4 binding sites and an adenovirus E1b minimal promoter 
sequence upstream of the secreted alkaline phosphatase (SEAP), as indicated on 
the map. 
 
 
Figure 2.7 Map of pSV- pSV-β-galactosidase vector. 
This vector contains the SV40 promoter and enhancer which drive transcription of 
the bacterial lacZ gene, which in turn, is translated into the β-galactosidase enzyme. 
 
2.11  ASSESMENT OF Y2H CONSTRUCTS 
2.11.1 Phenotypic assessment of S. cerevisiae strains 
Prior to being transformed, each of the S. cerevisiae strains (See appendix I for 
genotype) used in the Y2H analysis was assessed phenotypically. This involved 
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plating strains AH109 and Y187 onto agar plates lacking essential amino acids, ie., 
agar plates SD-Ade, SD-Trp, SD-His, SD-Leu and SD-Ura. Concurrently, S. cerevisiae 
AH109 and Y187 transformed with recombinant pGBKT7 and pTD1.1 plasmids were 
assessed for the autoactivation of the endogenous reporter genes of the GAL4 
system, by growing them on all of the above-mentioned media.  
 
2.11.1  Toxicity tests of transformed cells 
In order to proceed with the Y2H assay, it was important to establish whether the 
Cx45-bait construct had any markedly toxic effect on its host S. cerevisiae strain, 
AH109. To achieve this, a growth curve of AH109 transformed with the pGBKT7-bait 
construct was generated and subsequently compared to a growth curve of AH109 
yeast transformed with non-recombinant pGBKT7. These two growth curves were 
set up concurrently and under the same experimental conditions. 
 
The two growth curves were generated by growing each of the transformed yeast 
strains to stationary phase in SD-Trp in a 50ml polypropylene tube at 30°C in a YIH 
DER model LM-530 shaking incubator shaking at 200rpm. Following this incubation, 
a 1:10 dilution of each primary culture was made in SD-Trp and incubated for an 
additional 24h in a 50ml polypropylene tube at 30°C in a YIH DER model LM-530 
shaking incubator shaking at 200rpm. Every 2 hours, over a period of 8 hours during 
this incubation, a 1ml aliquot of the culture was taken and its OD600nm was measured. 
An overnight (24h) reading was also taken. A linearised graph of the log of these 
OD600nm readings versus time was constructed and the slopes of the graphs 
generated for the recombinant and non-recombinant transformants were compared. 
 
2.11.2  Testing the mating efficiency  
In order to determine the effect that the Cx45-bait construct had on the mating 
efficiency of AH109, small scale matings were performed. In these mating 
experiments, the S. cerevisiae AH109 transformed with pGBKT7-Cx45-bait construct 
was mated with the prey host strain, S. cerevisiae Y187 transformed with the non-
recombinant prey vector pGADT7-rec (Clontech). Concurrently, control matings were 
also performed in which the S. cerevisiae AH109 transformed with non-recombinant 
pGBKT7 or the control pGBKT7-53 vector was mated with the prey host strain, S. 
cerevisiae Y187 transformed with the non-recombinant prey vector pGADT7-rec.  
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The experimental procedures were as follows: 
Each of the yeast strains used in the mating efficiency experiments was plated onto 
the appropriate nutritional selection plates (AH109 pGBKT7-Cx45, AH109 pGBKT7 
and AH109 pGBKT7-53 on SD-Trp plates; Y187 pGADT7-rec and Y187 pTD.1.1 on 
SD-L plates). These plates were incubated for 2-5 days at 30˚Cin a Sanyo MIR262 
stationary ventilated incubator (Sanyo, Electronic Company Ltd, Ora-Gun, Japan). A 
single colony from these agar plates was used for each the test mating experiments; 
which was performed in 1ml YDPA media in a 2ml microfuge tube. The matings were 
incubated overnight at 30°C, shaking at 200rpm, in a YIH DER model LM-530 
shaking incubator (SCILAB instrument CO. Ltd, Taipei, Taiwan). Following the 
overnight incubation, serial dilutions (1:10; 1:100; 1:1000 and 1:10000) of the mating 
cultures were plated onto SD-Leu, SD-Trp and SD-Leu-Trp agar plates and incubated for 
4-5 days at 30° in a Sanyo MIR262 stationary ventilated incubator (Sanyo, Electronic 
Company Ltd, Ora-Gun, Japan). After the incubation period, the colonies on each 
plate were counted and used to calculate the mating efficiency using the formulae 
below: 
 
Colony forming unit (cfu) X 100ul/ml         =    Number of viable cfu/ml 
Volume plated (ul) X dilution factor 
 
Then,       Number of viable cfu/ml of diploids (SD-Leu,-Trp )     X 100 =    % mating 
effiency 
                 Number of viable cfu/ml of limiting partner 
 
Where, limiting partner has lower cfu count on either SD-Leu, or SD-Trp 
 
2.12  Y2H ANALYSIS 
2.12.1  The adult human cardiac cDNA library 
A pre-transformed human MATCHMAKER heart cDNA Library (BD Bioscience, 
Clontech, Paulo Alto, CA, U.S.A) consisting of S. cerevisiae Y187 transformed with a 
normal, adult heart cDNA library constructed in pGADT7-Rec, was used in the Y2H 
library assay. This library was constructed from a pool of 3 Caucasian males, 1 aged 
33 years, the other two aged 55 years. The library was XhoI-(dT)15 primed and 
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contains approximately 1.15x107 independent clones cloned into the pGADT7-Rec 
through EcoRI and XhoI sites. The average insert size for this library is 2.0kb with a 
range of between 0.5 and 3.0kb (ClontechTM MatchmakerTM vector handbook) or 
(www.clontech.com). 
 
2.12.2  Establishment of bait culture 
A colony of S. cerevisiae AH109 transformed with the Cx45-bait construct was 
streaked out onto SD-Trp plates. Four of the resultant yeast colonies were inoculated 
into four separate 500ml Erlenmeyer flasks, each containing 50ml SD-Trp media. The 
reason for producing four bait cultures was to facilitate the pooling of the initial 
cultures, thereby allowing the generation of a final bait culture with a titre of at least 
1x1010, i.e. 100-fold excess of bait to prey to facilitate high mating efficiency. The 
four initial cultures were incubated at 30°C overnight, while shaking at 200rpm in a 
YIH DER model LM-530 shaking incubator. Following overnight incubation, the 
cultures were transferred into individual 50ml polypropylene tubes and the cells 
pelleted by centrifugation at 3000rpm for 10min at room temperature in a Beckman 
Microfuge Lite. The supernatants were discarded and the four pellets were 
resuspended together in 50ml SD-Trp medium following which the suspension was 
transferred to a single 500ml Erlenmeyer flask and the culture was incubated for a 
further 16h at 30˚Cin a YIH DER model LM-530 shaking incubator, shaking at 200 
rpm. After incubation, the titre of the bait culture was estimated by measuring the 
OD600nm of a 1ml aliquot of the bait culture. This estimation was subsequently 
confirmed by means of a haemocytometric cell count. 
The bait culture was centrifuged at 3000rpm at room temperature for 10min in a 
Beckman Microfuge Lite to pellet the cells, the supernatant was removed and the 
pellet resuspended in ml SD-Trp medium. An appropriate number of 10μl aliquots of 
this culture were removed for control mating experiments. 
 
2.12.3  Haemocytometric cell count 
Haemocytometric cell count using a Neubauer haemocytometer was performed to 
determine the titre of bait culture used in the library mating experiment. Prior to 
aliquoting the sample onto the haemocytometer, a glass coverslip was placed over 
the counting surface. Approximately 50μl of a 1 in 10 dilution of bait culture was then 
pippeted into one of the wells. This allowed for the area under the coverslip to be 
filled with the sample through capillary action. The counting chamber was 
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subsequently placed on a microscope stage and the counting area was brought into 
focus under low magnification. The number of cells per millilitre was determined 
using the following formula: 
 
number of cells/ml = number of cells x dilution factor x 104 (a constant used 
because the depth of the haemocytometer is 0.1mm) 
 
2.12.4  Library mating 
A 1ml aliquot of the pre-transformed adult human cardiac cDNA library was removed 
from the -70°C freezer and thawed at room temperature. Once thawed, the library 
aliquot was vortexed using a Snijders model 34524 press-to-mix vortex and 10μl 
aliquoted into a sterile 1.5μl microfuge tube for library titering. The pGBKT7-Cx45 
transformed AH109 pellet was then resuspended in 45ml 2x YPDA media 
supplemented with 10μg/ml kanamycin (Kan) in a 2L Erlenmeyer flask). 
Subsequently, the remaining 990μl of the library culture was added to this 
Erlenmeyer flask. This mating culture was incubated at 30°C overnight, while 
shaking at 200rpm in a YIH DER model LM-530 shaking incubator. 
 
After the overnight incubation, the entire mating culture was transferred into a sterile 
50ml polypropylene centrifuge tube and the cells pelleted by centrifugation in at 
3000rpm for 5min in a Multex centrifuge, and the supernatant subsequently 
removed. The Erlenmeyer flask in which the library mating was performed was 
rinsed twice with 40ml 2x YPDA containing 10μg/ml Kan. Each time the flask was 
rinsed, the 2x YPDA medium was used to resuspend the cell pellet and the cells 
then re-pelleted by centrifugation at 3000rpm for 10min at room temperature in a 
Multex centrifuge. Following the final centrifugation step, the supernatant was 
removed and the pellet resuspended in 15ml 0.5x YPDA containing 10μg/ml Kan. 
 
Serial dilutions of 100μl aliquots (1:10; 1:100; 1:1000; and 1:10000) of this cell-
suspension were plated onto 90mm SD-L, SD-W and SD-L-W agar plates in order to 
determine mating efficiency. Two hundred and 50 microlitres aliquots of the rest of 
the culture was plated onto each of 59 140mm TDO (media lacking leucine, 
trytophan and histidine) plates (250μl culture/plate for14.9ml culture = 59 plates). 
The TDO plates were incubated, inverted, at 30°C for 2 weeks in a Sanyo MIR262 
stationary ventilated incubator (Sanyo, Electronic Company Ltd, Ora-Gun, Japan).  
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2.12.5  Establishing a library titre 
The serial dilutions of the mating culture plated onto the 90mm SD-Leu, SD-Trp and 
SD-Leu/Trp- agar plates were inverted and incubated in a Sanyo MIR262 stationary 
ventilated incubator for 4 days. Colony counts were performed on the SD-Leu, SD-Trp 
and SD-Leu-Trp plates after the 4 day incubation in order to calculate the mating 
efficiency of the library mating and the number of library plasmids screened. 
 
2.12.6  Control matings 
Control matings were set up concurrently with library matings in order to determine 
whether the recombinant Cx45 construct (transformed into S. cerevisiae AH109) had 
any negative effect on the ability of the transformed AH109 strain to mate with the 
library strain (Y187). A 10μl aliquot of the bait culture and a single test prey- (S. 
cerevisiae strain Y187 transformed with pTD 1.1 control vector) colony were co-
inoculated in 1ml 0.5x YPDA containing 10μg/ml kanamycin in a 2ml centrifuge tube. 
This culture was subsequently incubated for 24h at 30°C in a DER model LM-530 
shaking incubator, shaking at 200 rpm. Following incubation, serial dilutions (1:10; 
1:100; 1:1000; 1:10000) were plated onto SD-Lue, SD-Trp and SD-Leu-Trp agar plates 
and incubated for 4 days in a Sanyo MIR262 stationary ventilated incubator. 
Following this, colony counts were done and the mating efficiency was calculated. 
 
2.12.7  Detection of activation of nutritional reporter genes 
2.12.7.1 Selection of transformant yeast colonies 
Yeast transformed with the bait construct to be used in Y2H analysis was plated onto 
SD-Leu, SD-Trp and SD-Leu-Trp agar plates. Following incubation of these plates for 4-6 
days in a Sanyo MIR262 stationary ventilated incubator at 30˚C, transformant yeast 
colonies were picked and used in small and large scale bait cultures and library 
matings. 
 
2.12.7.2 Selection of diploid yeast colonies containing putative interactor peptides 
In order to identify yeast colonies in which an interaction between the bait- and prey-
fusion peptides had taken place, yeast colonies were plated onto TDO (lacking 
leucine, histidine, tryptophan) plates as well as QDO (media lacking leucine, 
histidine, tryptophan and adenine) plates. Growth of the yeast cells on TDO plates 
signified the transcriptional activation of the HIS3, nutritional reporter gene, while 
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growth on the QDO plates indicated that both the HIS3 and ADE2, nutritional 
reporter genes had been transcriptionally activated. The activation of these genes in 
these diploid yeast cells is indicative of an interaction between the bait and prey 
peptides. 
 
Briefly, the library mating culture was plated directly onto 58 140mm TDO agar 
plates and incubated in a Sanyo MIR262 stationary ventilated incubator for 2 weeks 
at 30˚C. The growth of these colonies on the TDO plates was monitored every 2 
days and colonies were picked and restreaked onto TDO and QDO plates in order to 
test for the activation of HIS3 and ADE2 nutritional reporter genes. These plates 
were incubated for 3-6 days at 30°C in a Sanyo MIR262 stationary ventilated 
incubator.  
 
2.12.8  Detection of activation of colourimetric reporter genes 
X-α-Galactosidase assay 
X-α-galactosidase assays were performed in order to test for the activation of the 
MEL1 reporter gene by the specific interaction between specific bait and prey 
peptides. Briefly, yeast colonies in which the HIS3 and ADE2 reporter genes have 
been activated, as determined by their growth on QDO agar plates, were replicated 
from QDO plates onto Hybond N+ nylon membranes. These membranes were 
subsequently placed colony-side up onto a QDO plate impregnated with 20mg/ml X-
α-Gal solution (BD Biosciences, Clontech, Palo Alto, CA, U.S.A). The plates were 
subsequently incubated at 30°C in a Sanyo MIR262 stationary ventilated incubator 
for three to five days. Following incubation, the intensity of the blue colour of yeast 
colonies that had activated the MEL1 reporter gene was assessed. 
 
2.12.9  Rescuing prey plasmids from diploid colonies. 
In order to identify the interactor proteins, each individual prey needed to be isolated 
from the diploid colonies. To this end, plasmid DNA was isolated from each of the 
diploid yeast cells following the protocol described in section 2.3.1 and transformed 
into E. coli strain DH5α as described in section 2.10.1. The transformants were 
plated onto LBamp plates which only allows for the growth of transformants containing 
the prey constructs. These prey constructs were subsequently transformed into the 
yeast strain Y187. 
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2.12.10  Interaction specificity test 
To test whether the interactions detected by Y2H analysis, through the activation of 
nutritional and colourimetric reporter genes, were specific interactions between the 
pGBKT7-Cx45-bait and a particular prey peptide, interaction specificity tests were 
used. Y187 colonies expressing the specific prey peptide were individually mated 
with the yeast strain AH109, transformed with the pGBKT7-Cx45-bait construct, 
AH109 transformed with non-recombinant pGBKT7, AH109 transformed with the 
pGBKT7-53 control bait-plasmid, encoding murine p53, supplied by the manufacturer 
(BD Biosciences, Clontech, Palo Alto, CA, U.S.A) and AH109 transformed with a 
heterologous bait, encoding the brain expressed protein reelin (a kind gift from Dr 
Craig Kinnear). After the resulting diploid clones were selected, these clones were 
streaked onto TDO and QDO selection plates to test for the activation of nutritional 
reporter genes, thereby testing whether the prey-peptides were able to interact with 
these heterologous baits as well as with the pGBKT7-Cx45-bait (Figure 2.8). 
 
Clones that interacted specifically with the pGBKT7-Cx45-bait, as determined by the 
interaction specificity tests, were considered putative true interactors. The inserts of 
these putative interactors were then sequenced to determine their identities.  
 
 
Figure 2.8. Diagrammatic representation of the heterologous bait mating.  
The baits and preys were streaked in parallel lines on 140mm –leu [A] and –trp 
plates [B] respectively. [C] illustrates the mating of bait and prey, perpendicularly to 
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each other. Baits and preys were allowed to mate on a YPDA plate overnight at 300C 
[D] before an aliquot of the cross over region between bait and prey was streaked 
onto a –leu/-trp plate [E]. Following incubation at 300C for 4 days an aliquot of yeast 
growth on this plate was streaked on TDO and QDO plates respectively [F]. These 
plates were incubated at 300C for 4 days then a further 3 days. On these days the 
yeast growth on each plate was scored (Reproduced from A. Ramburan, 2005 – 
report).   
   
2.13  M2H analysis 
The M2H analysis was performed using the MatchmakerTM Mammalian Assay Kit 2 
(BD. Biosciences, Palo Alto, U.S.A.). This kit includes the pM, pVP16 and pG5SEAP 
vectors (figs. 2.4, 2.5 and 2.6, respectively). The H9C2 cells used for the M2H 
analysis were cultured and transfected as described in sections 2.9.1 and 2.10.3 
respectively. Expression of the secreted alkaline phosphatase (SEAP) reporter gene 
(SEAP) on the pG5SEAP reporter vector (Figure 2.6) occurs when there is an 
interaction between the fusion proteins generated by the pM and pVP16 constructs 
that were co-transfected with the reporter vector. Whether or not the SEAP reporter 
gene was activated and the strength of ligand binding was determined using the 
Great EscAPeTM chemiluminescent Detection Kit (BD Biosciences, Clontech, Palo 
Alto, CA, U.S.A) by measuring the SEAP activity in the culture medium using a 
chemiluminescent substrate. 
 
2.13.1  Secreted alkaline phosphatase (SEAP) reporter gene assay  
Fifteen microlitres of each culture medium supernatant from transfected H9C2 cells 
to be assayed was aliquoted into 4 separate wells of a white opaque 96-well flat-
bottom microtitre plate (PerkinElmer Life And Analytical Sciences, Inc Boston, MA, 
U.S.A.). To this, 45μl of 1X dilution buffer (BD Biosciences, Clontech, Palo Alto, CA, 
U.S.A ) was added and the plate incubated at 65°C for 30 min in a water-bath 
(Memmert ®, Schwabach, Germany). Following the incubation, the plate was left on 
ice for 3min to cool down the samples. The samples were then allowed to equilibrate 
to room temperature before 60μl assay buffer (BD Biosciences, Clontech, Palo Alto, 
CA, U.S.A) was added to each well. 
 
The chemiluminescent substrate (CSPD) was then prepared by making a 1:20 
dilution of the CSPD (BD Biosciences, Clontech, Palo Alto, CA, U.S.A) in 
Stellenbosch University  https://scholar.sun.ac.za
 84 
 
chemiluminescent enhancer (BD Biosciences, Clontech, Palo Alto, CA, U.S.A). The 
diluted substrate was then added to each well and the plate was incubated for 10 
min at room temperature. The SEAP activity was then determined by reading the 
chemiluminescent signal every 10 minutes for a period of 2 ½ hours using a Bio-
Tek® Synergy HT plate luminometer (Winooski, Vermont, U.S.A.). 
 
Several control assays were included as comparisons for each experiment as shown 
in table 2.8. The reading obtained for the untransfected control represents the 
background SEAP signal of the H9C2 cells used in the experiments, while the basal 
control reading corresponds to basal level of SEAP activity in the experiments 
resulting from non-recombinant pM and pVP16 transfection. The GAL4 DNA-B 
control and the VP16 AD controls shown in table 2.8 were included in order to 
determine whether the Cx45 construct or each of the putative ligands used in the 
experiments function autonomously as SEAP reporter gene transcriptional 
activators. Positive control assays were also included in the experiment. The pM3-
VP16 positive control plasmid (table 2.8) encodes a fusion of the GAL4 DNA-binding 
domain and VP16 activation domain and therefore gives very strong SEAP 
expression when co-transfected with pG5SEAP. The co-transfection of the individual 
pM53, pVP16T and pG5SEAP was also included in the experiment as another 
positive control. The pM53 expresses a fusion of the GAL4 DNA binding domain to 
the mouse p53 antigen, while the pVP16T expresses a fusion of the VP16 activation 
domain to the Simian Virus 40 large T-antigen which is known to interact with p53 
and therefore produces strong SEAP expression. An additional, control vector, pSV-
β-Galactosidase, was included in all transfections the assay in order to monitor the 
transfection efficiencies of the mammalian cells.  
 
2.14  Automated DNA sequencing  
Automated DNA sequencing of the cloned inserts was performed at the Core 
Sequencing Facility of the Department of Genetics at the University of Stellenbosch, 
RSA on an ABI PrismTM 377 or an ABI PrismTM 3100 automated sequencer (P.E. 
Applied Biosystems, Forster City, CA, U.S.A). The Cx45-bait construct was 
sequenced using the both of the primers designed to amplify the COOH-terminal 
domain fragment. While the cloned prey inserts from the Y2H screen were 
sequenced, the vector specific primers were used especially to assess that the preys 
were in the correct reading frame. The M2H constructs on the other hand were 
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sequenced using the forward prey specific and the vector specific primers, also to 
ensure that the correct reading frame was maintained.  
 
Table 2.8 Transfections of tests and controls to be used in the SEAP and β-
galactosidase  assay of M2H analysis of putative Cx45-ligands 
Transfection 
(5:5:1:1) 
GAL4 DB- 
plasmid 
(μl) 
VP16 
Activation 
plasmid(μl) 
Promoter(μl) 
(SEAP) 
Promoter(μl) 
(pSV-β-gal) 
Experiment  1 pM-Cx45 
(2.2) 
pVP16-MYO 
(1.9) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
Experiment  2 pM-Cx45   
(2.2) 
pVP16-OBS  
(2.5) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
Experiment  3 pM-Cx45   
(2.2) 
pVP16-CD63  
(2.9) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
Experiment  4 pM-Cx45   
(2.2) 
pVP16-COX  
(2.2) 
pG5SEAP 
(2.3) 
pSV- β-gal 
(2.3) 
Experiment   5 pM-Cx45   
(2.2) 
pVP16-TX2 
(1.8) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
Experiment  6 pM-Cx45   
(2.2) 
pVP16-NADH 
(2.6) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
Experiment  7 pM-Cx45   
(2.2) 
pVP16-SCF 
(2.7) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
Untransfected 
control 
None None None None 
GeneJuice 
control 
None 
 
None None None 
Basal Control pM              
(1.5) 
pVP16  
(2.8) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
GAL4 DNA-B 
control 
pM-Cx45    
(2.2) 
pVP16  
(2.8) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
VP16 AD 
control (1) 
pM              
(1.5) 
pVP16-MYO 
(1.9) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
VP16 AD 
control (2) 
pM              
(1.5) 
pVP16-OBS  
(2.5) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
VP16 AD 
control (3) 
pM              
(1.5) 
pVP16-CD63  
(2.9) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
VP16 AD 
control (4) 
pM              
(1.5) 
pVP16-COX  
(2.2) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
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Transfection 
(5:5:1:1) 
GAL4 DB- 
plasmid 
(μl) 
VP16 
Activation 
plasmid(μl) 
Promoter(μl) 
(SEAP) 
Promoter(μl) 
(pSV-β-gal) 
VP16 AD 
control (5) 
pM              
(1.5) 
pVP16-TX2 
(1.8) 
pG5SEAP(2.3) pSV-β-
gal(2.3) 
VP16 AD 
control (6) 
pM              
(1.5) 
pVP16-NADH 
(2.6) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
VP16 AD 
control (7) 
pM              
(1.5) 
pVP16-SCF 
(2.7) 
pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
Positive 
control (1) 
pM3-VP16 
(2.8) 
None pG5SEAP 
(2.3) 
pSV-β-gal 
(2.3) 
Positive 
control (2) 
pM53         
(1.8) 
pVP16-T  
(0.9) 
pG5SEAP 
(2.3) 
pSV-β-ga 
l(2.3) 
The ratio of pM:pVP16:pReporter:pSV-β-gal used in the transfections was 5:5:1:1 
 
2.15  ANALYSIS OF Cx45 BAIT AND PUTATIVE LIGANDS  
2.15.1  Sequence homology searches 
Sequence analyses were done using the ChromasPro computer program 
(Techelysium Pty Ltd, Helensvale, Queensland, Australia) to verify the sequence 
integrity of the Cx45-bait fragment generated by PCR-amplification (section 2.2.2), 
as well as to identify Y2H putative interactor prey clones isolated during Y2H library 
screening. The nucleotide sequence of the fragment encoding the Cx45 COOH-
terminal domain as determined by automated sequencing was compared to the 
Cx45 cDNA and mRNA sequences obtained from the Genbank database 
(www.ncbi.nlm.nih.gov/Entrez). The sequences obtained for the Y2H prey 
constructs, through automated sequencing, were BLAST-searched against the 
GenBank database using both BLASTP and BLASTN (www.ncbi.nlm.nih.gov/Entrez) 
in order to assign identity to them (section 2.15). The BLASTP programme was used 
to determine the relationship of the translated ORF query sequence against protein 
sequences of different proteins in the database, while the BLASTN programme was 
to compare the nucleotides of query DNA sequence with sequences in the database. 
The BLASTP and BLASTN results of each prey were then compared to assess 
whether they identified the same protein. This comparison was also useful in 
assessing whether the protein identified was translated in the correct reading frame. 
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2.15.2  Prioritisation of identified putative ligands as PFHBII candidate 
genes 
After their identification, all putative Cx45 preys were assessed for the possibility of 
being PFHBII causative genes. All genes which mapped to the locus PFHBII are 
considered disease-causing candidate genes because of their chromosomal 
location. However, some are functionally more attractive candidates, particularly if 
they exhibit additional features, such as expression in the heart, association with 
heart function and physiology, involvement in cardiac disease (particularly 
conduction disturbances) and cell-cell communication. Genes that fulfilled most of 
these criteria were prioritised for the further verification studies. Prioritisation of these 
ligands was most importantly to assess the functional specificities of the different 
cardiac Cxs in cardiac function, by comparing the ligands of Cx45 with known 
ligands of Cx43 as well as ligands of Cx40 which were identified by R. Keyser, 2007 
(MSc Thesis  Univerisity of Stellenbosch). 
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PART II: WHOLE EXOME SEQUENCING 
2.16  STUDY PARTICIPANTS 
PFHBII has been described in one family only (Fig 2.9) (Brink and Torrington, 1977). 
Clinical records and family history of 24 members of the PFHBII family were 
previously collected and filed for a long-term study. These individuals were examined 
and described in the original PFHBII study (Brink and Torrington, 1977), and the 
clinical data was collected as part of an ongoing study (Fernandez et al., 2004, Yako 
et al., 2007). Affected and unaffected individuals that were entered into the current 
study are shown in Table 2.9. 
Figure 2.9: A four-generation pedigree of the PFHBII-affected family. 
The roman figures represent the four generations of the family, squares indicate 
males; circles indicate females. Open symbols indicate individuals of unknown 
clinical status; N indicates unaffected individuals; solid symbols indicate PFHBII-
affected subjects; diagonal lines indicate deceased individuals; question marks 
indicate individuals of unknown clinical status; arrow shows the proband. The 
numbers represent identification numbers of family members and those that were 
analysed by Yako et al., 2007, (both affected and unaffected) are indicated by 
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asterisks. The family members analysed in the current study are marked by the red 
box also detailed below in figure 2.10.  
Family trees, or a preliminary pedigree structure of individuals entered into the study, 
were traced by Sr Althea Goosen, if the family had a history of the FHC. In addition, 
a detailed history and clinical records of the probands and their relatives, where 
possible, were also obtained by Sr Goosen to establish the frequency of sudden 
deaths and disease-related deaths. Probands with clinical features and a history of 
PFBH II, or any individuals who demonstrated PFHB II-like symptoms upon 
examination, were continuously identified, informed of the PFHB II mutation 
screening project, and given the opportunity to participate if they so wished. 
 
 
 
Figure 2.10: PFHB II family members analysed in the current study.  
Solid circle = affected female, solid square = affected male, open circle = unaffected 
female, open square unaffected male.  
 
Table 2.9: List of PFHB II patients sent for whole exome sequencing. 
Patient ID Sex Date of birth Clinical Diagnosis 
PID_9862 F 20.07.1962 PFHB II 
PID_9864 M 13.07.1979 PFHB II 
PID_9863 F 16.04.1988 PFHB II 
PID_9865 F 04.07.1981 Healthy daughter of PID_9862 
ID = Identity; F = Female; M = Male; PFHBII = Progressive familial heart block type 
2. 
PID_9862 
PID_9864 
PID_9863 PID_9865 
Stellenbosch University  https://scholar.sun.ac.za
 90 
 
2.17  WHOLE EXOME SEQUENCING 
2.17.1  DNA PURIFICATION 
2.17.1. Extraction of nuclei from whole blood 
Blood from three 5ml EDTA tubes per patient was transferred into a 50ml Falcon 
tube. The tube was then filled to 20 ml with ice-cold lysis buffer (appendix I). After 
gently inverting the tubes a few times, the sample was incubated on ice for 5-10 min. 
The sample was then centrifuged at 2500-3000 rpm at room temperature in a 
Beckman model TJ-6 centrifuge (Scotland, UK). The supernatant was discarded and 
the pellet was resuspended in 20ml, ice-cold lysis buffer, followed by another round 
of incubation and centrifugation. The supernatant was discarded and the pellet 
resuspended in DNA extraction buffer (appendix I), after which the nuclei were either 
immediately used for DNA extraction, or stored at -70°C until DNA was required. 
  
2.17.2. Extraction of DNA from nuclei 
To the freshly prepared or thawed nuclei, 100ml of proteinase K (10μg/ml) was 
added and the mixture was incubated overnight at 37°C. After this step, 2ml distilled 
water, 500ml 3M sodium-acetate (appendix I) and 25ml phenol/chloroform (appendix 
I) were added to the sample. The tubes were subsequently inverted and mixed 
gently for 10 min on a Voss rotator (Voss of Maldon, England) at 4°C. The mixture 
was then transferred to a glass Corex tube so that the aqueous phase could be 
clearly distinguished from the organic phase, followed by centrifugation in a Sorvall 
RC-5B refrigerated super-speed centrifuge (rotor SS 34, Dupont Instruments) at 
8000 rpm for 10 min at 4°C. 
  
The upper aqueous phase, containing the DNA, was transferred to a clean Corex 
tube using a sterile plastic pasteur pipette, while taking care not to disturb the 
interface or the organic phase. Approximately 25ml chloroform/octanol (appendix I) 
was added to the aqueous phase after which the tube was closed with a 
polypropylene stopper and gently inverted for 10 min. This mixture was centrifuged 
at 4°C, followed by the removal of the upper aqueous phase as described earlier. 
The DNA was then ethanol precipitated by adding two volumes of ice-cold 96% 
ethanol and inverting gently until DNA strands appeared as a white precipitate. 
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The DNA strands were removed using a yellow-tipped Gilson pipette and placed in a 
clean, 1.5ml Eppendorf microfuge tube. One millilitre 70% ethanol was then added to 
the DNA and the mixture centrifuged in a Beckman microfuge for 3 min at 13000 
rpm. The ethanol was carefully decanted and the 70% ethanol wash repeated one 
more time in order to remove any excess salts. After careful removal of most of the 
ethanol, the DNA pellet was air-dried for 30-60 min at room temperature by inverting 
the Eppendorf microfuge tube on Carlton paper. Two hundred microlitres Tris-EDTA 
(appendix I) buffer was added and the DNA was resuspended, initially by stationary 
incubation at 37°C overnight and subsequently by gentle mixing in a Voss rotator  at 
4°C for a further 3 days. This was followed by stationary incubation at 4°C until the 
DNA had been fully resuspended. 
  
After 1-2 weeks, when the DNA had completely resuspended in the buffer, the 
optical density (OD) of the DNA was determined in a Milton Roy series 120i 
spectrophotometer (USA) at 260nm (OD260). The DNA concentration, in mg/ml, was 
determined by diluting 10ml of DNA in 500ml of TE and multiplying the measured 
OD260  by a factor of 2.5, while the purity of the DNA was monitored by the 
OD260//OD280 ratio, which should be approximately 1.8 for pure DNA. 
  
2.17.3. Exome capture and sequencing  
Library preparation for sequencing was carried out using the Ion AmpliSeq™ Exome 
RDY Kit and the Ion Xpress™ Barcode Adaptors 1–16 Kit (Life Technologies, 
Carlsbad, California, United States). The DNA template for sequencing was 
prepared on the Ion Chef system using the Ion PI™ Hi-Q™ Chef Kit and the Ion PI™ 
Chip Kit v3. Sequencing was carried out on the Ion Proton™ (Thermo Fisher, 
Carlsbad, California, United States) at the Central Analytical Facility (CAF) at 
Stellenbosch University, Stellenbosch, South Africa. 
 
2.17.4. Read mapping, variant detection and functional annotation 
Sequences were aligned to the human reference genome, hg19 using TMA (version 
4.4.11-1) in the ion-analysis workflow on the Torrent Suite (version 4.4.3). Base 
quality score recalibration, indel realignment and variant calling were performed 
using the variantCaller (version 4.4.3.3) plugin on the Torrent Suite and variant 
annotation was performed. Variant prioritization was performed using TAPERTM, a 
custom-designed, in-house method and variants in a homozygous recessive state or 
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compound heterozygous state were prioritized as potential candidate variants. In 
brief, TAPERTM 1) submits VCF files to an online variant caller, 2) removes all 
synonymous and non-frameshift variants, 3) removes all variants with a frequency of 
greater than 1% if present in the 1000 Genomes Project or Exome Sequencing 
Project 6500, 4) removes all variants with negative GERP+++ scores, 5) removes all 
variants with FATHMM scores greater than 0.1, 6) removes X and Y chromosome 
variants (if the pedigree does not indicate sex-linked inheritance) and lastly 7) 
identifies associated disorders for prioritised genes. Only variants associated with 
cardiomyopathies as well as those linked to Cx 45 ligands identified in this study 
were investigated for potentially disease causing variants in PFHB II cases. 
 
 
Figure 2.11: Overview of filtering process used to determine potential disease-
causing variants.  
These filtering steps were used to predict which of the identified variants might be 
disease-causing. SNVs = Single nucleotide variants; 1KGP = 1000 Genomes 
Project; ESP = Exome Sequencing Project; FATHMM = Functional analysis through 
hidden Markov models; GERP = Genome evolutionary rate profile, TAPER = Tool for 
Automated selection and Prioritization for Efficient Retrieval of sequence variants. 
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2.18  IN SILICO VARIANT PREDICTIONS  
In the current study, MutationTaster2 (MT2; http://www. mutationtaster.org/), 
PolyPhen-2 (PP-2; http://genetics.bwh. harvard.edu/pph2/) and Sorting Tolerant 
From Intolerant (SIFT; http://sift.jcvi.org/) were used to predict the functional and 
structural consequences of each of the variants of interest. These specific tools were 
chosen since they are commonly used, and their efficacy has been proven 
(Adzhubei et al., 2010; Gnad et al, 2013; Ng and Henikoff, 2003; Venselaar et al., 
2010). Several studies have used these four tools to predict the effects of amino acid 
exchanges on protein structure and function. Most have reported a very useful 
improvement in their understanding of biological pathways in which these proteins 
are situated, and thus a more effective design of downstream laboratory-based 
experiments, based on the results of these tools (Alipoor et al., 2016; Hassan et al., 
2016; de Voer et al., 2016; Atik et al., 2015; Costa et al., 2016; Akhoundi et al., 2016; 
Stoll et al., 2016; Kinnersley et al., 2016).  
 
2.18.1  MutationTaster2  
MT2 rapidly and effectively evaluates the potential of DNA variations to cause 
disease by using reputable analysis tools and combining information from several 
biomedical databases. It takes into account splice-site changes, alterations that can 
influence mRNA expression, evolutionary conservation and loss of protein features. 
A Bayes classifier is used to predict the diseasecausing potential of each variant 
(Schwarz et al., 2010) by calculating the probability of variants to be rare disease 
causing mutations or innocuous polymorphisms based on characteristics of each 
variant and the results of all applied tests. In order to make these predictions, the 
occurrence of all individual features for known disease causing mutations or 
common polymorphisms are studied in a large set of >100 000 known disease 
mutations from HGMD Professional and >6 million harmless SNPs and Indel 
polymorphisms from the 1KGP (Schwarz et al., 2014) .  
 
2.18.2  PolyPhen-2 
PP-2 uses a collection of structure- and sequence-based automatically-selected 
predictive features to compare properties of a mutant allele to that of a wild-type 
allele. It (1) determines how probable the two alleles are to inhabit the specific site of 
interest; (2) how different the mutated protein is from the wild-type protein; and (3) if 
the altered allele originated at a hypermutable site (Schmidt et al. 2008). These 
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features are used to determine the functional importance of the alteration using a 
Bayes classifier (Adzhubei et al., 2010). PP-2 has been trained and tested using two 
pairs of datasets: HumDiv and HumVar. HumDiv consists of 6 321 differences 
between human proteins and closely related mammalian homologs assumed to be 
non-damaging, and 3 155 alleles in UniProt classified as influencing protein function 
and stability and causing Mendelian diseases. HumVar contains all mutations from 
UniProt classified as disease-causing and ~9 000 non-synonymous non-
diseasecausing SNPs. 
 
A comparative study found PP-2 to be superior to two other predictive tools Gnad et 
al., 2013; , Bromberg et al., 2008; Yue et al., 2006). HumVar is usually less accurate 
in its predictions due to the inclusion of mildly deleterious alleles in its dataset. 
However, HumVar is more appropriate for diagnosing Mendelian diseases, while 
HumDiv is used for dense mapping of regions identified via GWAS, to evaluate rare 
alleles and to analyze natural selection (Adzhubei et al., 2010) PP-2 is the most 
prominent prediction tool currently available that uses sequence as well as structural 
protein information to make predictions (Adzhubei et al., 2010). 
 
2.18.3  SIFT  
SIFT predicts whether protein function is affected by amino acid variations based on 
the extent of amino acid conservation in closely related protein families (Ng  and 
Henikoff, 2002). It interrogates protein databases to create a dataset of protein 
sequences functionally related to a protein of interest. An alignment built from these 
homologous sequences is used to determine the likelihood for each of the 20 amino 
acids to exist at a position of interest. The probability of the most common amino 
acid is used to normalize these probabilities, which is referred to as the SIFT scores 
(Altschul et al., 1997) Positions associated with low levels of conservation tolerate 
most alterations, while conserved positions do not. The confidence with which these 
predictions are made is indicated by conservation values of 0 (all amino acids can fill 
position) to log220 (only 1 amino acid is observed) (Ng and Henikoff, 2002). SIFT 
does not use protein structure to evaluate the consequence of an amino acid 
alteration.  
 
A comparative study between PP-2, MT2 and SIFT found that MT2 is the most 
accurate and sensitive of these tools, while HumVar of PP-2 is the most specific. 
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These tools are each clearly quite effective. However, individually, any of them can 
lead to mislabeled variants and thus result in either false negative or false positive 
identification of potentially disease-causing variants. By using a combination of all 
these tools, we aimed to mitigate this. 
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3.1  IDENTIFICATION OF CX45 COOH-TERMINAL LIGANDS BY YEAST TWO-
HYBRID (Y2H) ANALYSIS 
3.1.1  Construction of DNA binding-domain target fusion protein (the bait 
fragment) 
The Cx45 COOH-terminal encoding domain was successfully amplified by PCR 
using custom designed primers (section 2.1.1.1). The size of product obtained 
corresponded to the expected size (approximately 450bp) of the COOH-terminal 
encoding domain of Cx45 (www.ncbi.org.gov) as shown below in figure 3.1. 
 
  
 
Figure 3.1 PCR-amplified product of the Cx45 COOH-terminal encoding. 
PCR-amplified product of the Cx45 COOH-terminal encoding to be used as bait, 
electrophoretically separated on a 2% agarose gel. Lane 1- 100 bp ladder, lane 2- 
Cx45 COOH-terminal encoding PCR product. 
Colony PCR reactions (section 2.2.3) performed to assess successful cloning of the 
Cx45 COOH-terminal encoding fragment into pGBKT7 revealed that only two 
colonies out of a total of 100 potential recombinants assessed contained the 
recombinant Cx45-pGBKT7 plasmid representing a 2% success rate, based on the 
size of the products viewed (figure 3.2). 
 
   1              2        
   450bp    
  1,517bp 
600bp 
 500bp    
   400bp    
  300bp    
100bp    
200bp    
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Figure 3.2 A representative sample of colony PCR products electrophoretically 
separated on a 0.5% agarose gel.  
Lanes 1 to 13, non-recombinant bait vector (pGBKT7) (7,5 kilobases [Kb]); lane 14, 
recombinant Cx45-pGBKT7.  
Restriction enzyme analyses of the two recombinant plasmids detected by colony 
PCR, verified the incorporation of the Cx45-bait fragment into pGBKT7. As expected, 
the recombinant plasmid, Cx45-pGBKT7, was linearised by both EcoRI and NdeI but 
not by the test enzyme SfiI (figure 3.3).   
 
 
Figure 3.3 Linearised recombinant plasmids analysed in duplicate after 
restriction enzyme digestions.  
Lanes 1 to 8 = recombinant plasmids; lanes 1, 5 and 9 = undigested; lanes 2 and 6 = 
digested with EcoRI; lanes 3 and 7, = digested with NdeI; lanes 4 and 8 = digested 
with SfiI; lanes 9, 10 and 11= non-recombinant plasmids; sample in lane 9 = 
undigested; lanes 10 and 11 = digested with EcoRI and NdeI, respectively.  
 
3.1.2  Integrity of bait construct  
Automated sequencing of the insert contained in one of the two recombinant 
plasmids identified (figure 3.3) confirmed full correct sequence of Cx45 COOH-
terminal domain and integrity and conservation of the GAL4 DNA-BD reading frame 
(Appendix V for sequence homology alignment). 
  
3.1.3  Phenotype assessment of Saccharomyces cerevisiae strains 
Tests based on nutritional selection markers (Ade, Trp, His, Leu, Ura) confirmed the 
correct phenotype of transformed and untransformed S. cerevisiae strains AH109 
Recombinant Cx45-pGBKT7 
(7,9Kbp) 
1     2     3        4      5       6      7      8      9      10    11     12    
13   14   
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and Y187. Thus, untransformed strains AH109 and Y187 failed to grow on SD-Ade, 
SD-Trp, SD-His, SD-Leu but grew on SD-Ura, implying their viability for transformation and 
subsequent Y2H analysis (table 3.1). Additionally, these nutritional selection tests 
confirmed the inability of the recombinant Cx45-pGBKT7 bait vector to autoactivate 
the endogenous reporter genes of the Y2H system. Thus, transformed S. cerevisiae 
AH109 (Cx45-pGBKT7) failed to grow on SD-Ade, SD-His and SD-Leu  but grew on both 
SD-Trp and SD-Ura while S. cerevisiae Y187 (pTD1.1) grew only SD-Leu  and SD-Ura 
(table 3.1). 
  
Table 3.1 Phenotypic assessment of S. cerevisiae colonies for the non-
activation of Y2H endogenous reporter genes 
Strain SD-Ade SD-Trp SD-His SD-Leu SD-Ura 
S. cerevisiae 
AH109 
 
- - - - + 
S. cerevisiae 
Y187 
 
- - - - + 
S. cerevisiae 
AH109 (Cx45-
pGBKT7) 
- + - - + 
S. cerevisiae 
Y187 (pTD1.1) 
- - - + + 
- , No growth observed, +, growth observed, SD-Ade = Single dropout medium 
(adenine-deficient); SD-Trp= tryptophan deficient, SD-His= histidine deficient; SD-Leu= 
leucine deficient; SD-Ura= uracil deficient, Cx45-pGBKT7 = bait control, pTD1.1 = 
prey control. 
 
3.1.4  Expression of Cx45-pGBKT7 bait construct 
3.1.4.1 Toxicity test 
Growth rates derived from concurrently generated curves for transformed S. 
cerevisiae AH109 (Cx45-pGBKT7), transformed S. cerevisiae AH109 (non-
recombinant pGBKT7) and untransformed AH109 (figure 3.3) showed the Cx45-
COOH terminal fragment to be slightly toxic to its host strain S. cerevisiae AH109, 
considering that the growth rate of untransformed S. cerevisiae AH109 was slightly 
higher. However since, S. cerevisiae AH109 transformed with the Cx45-pGBKT7 bait 
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construct grew at the same rate as S. cerevisiae AH109 transformed with the non-
recombinant pGBKT7 plasmid, Cx45 was not excluded as bait for the Y2H screen 
(figure 3.4).  
 
 
 
Figure 3.4 Comparative growth rates of S. cerevisiae AH109, S. cerevisiae 
AH109 (pGBKT7), S. cerevisiae AH109 (Cx45-pGBKT7).  
Growth rate, as determined from the slopes of the respective curves, of S. cerevisiae 
AH109 transformed with Cx45-pGBKT7 construct, in comparison to that of S. 
cerevisiae AH109 with the non-recombinant pGBKT7 plasmid (pink and dotted blue 
lines), as well as untransformed S. cerevisiae AH109 (aqua line).   
 
3.1.4.2 Mating efficiency test 
Comparative small scale matings of S. cerevisiae AH109 transformed with the Cx45-
pGBKT7 bait construct and S. cerevisiae Y187 transformed with pTD1.1 (prey 
control vector) revealed that the mating efficiency5 was well above the threshold of 
2% (table 3.3) making Cx45 a viable bait for the Y2H screen.  
 
 
                                            
5
 Mating efficiency determined from the formula in section 2.11 
Growth curve of AH109, AH109+GJA7 and AH109+BGKT7 grown on YPDA and SD -
Trp media
5 10 15 20 25 30
-2.0
-1.5
-1.0
-0.5
0.0
0.5
AH109
GJA7
GBKT7
Time(hrs)
L
o
g
 O
D
6
0
0
Untransformed 
AH109   (non-
recombinant pGBKT7) AH109 (Cx45-
pGBKT7) 
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Table 3.2 Total number of colonies per growth medium 
Growth Medium SD-Trp SD-Leu SD-Leu/-Trp 
Dilution factor 
 
10-1 10-2 10-3 10-1 10-2 10-3 10-1 10-2 10-3 
(CONTROL 
MATING) 
Y187 (pTD1.1) x 
AH109(pGBKT7) 
  
 
TN
C 
 
TNC 
 
108
8 
 
TNC 
 
TNC 
 
209
6 
 
TNC 
 
23 
 
7 
(TEST MATING) 
Y187 (pTD1.1)  x 
AH109 (Cx45-
pGBKT7) 
 
 
TN
C 
 
 
153
6 
 
151 
 
TNC 
 
TNC 
 
595 
 
TNC 
 
76 
 
15 
-TNC= Too numerous to count; SD = single dropout medium; SD-Trp = Tryptophan 
deficient, SD-Leu = Leucine deficient; SD-Leu/-Trp = Leucine and tryptophan deficient. 
 
Table 3.3 Mating efficiency determined from colony forming units of S. 
cerevisiae grown on SD-Trp, SD-Leu and SD-Leu,Trp   
Mating Mating efficiency (%) 
(CONTROL MATING) 
Y187 (pTD1.1) x AH109(pGBKT7) 
2.6 
(TEST MATING) 
Y187 (pTD1.1)  x AH109 (Cx45-pGBKT7) 
4.9 
 
3.1.5  Y2H analysis to identify ligands of Cx45 COOH-terminal domain 
3.1.5.1 Y2H screen  
The initial selection of putative Cx45 ligands on TDO growth medium, 371 clones 
containing ligands were obtained which were later reduced to 154 on QDO growth 
medium (table 3.4). Some of these clones from the latter selection presented white 
colonies while others presented pink colonies, the latter indicating poorer adenine 
expression. In spite of this, the pink colonies were selected mainly for comparative 
purposes.  
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Table 3.4 Total number of colonies obtained from the Y2H screen  
Growth medium Selection marker 
# of S. cerevisiae 
colonies obtained 
TDO 
 
TRP1, LEU2, HIS3 371 
QDO 
 
TRP1, LEU2, HIS3, ADE2 154 
 
Table 3.5 Growth scores of 154 sequentially identified colonies. 
Growth scores of 154 sequentially identified colonies of putative ligands from the 
library screened by the (MEL1) α-galactosidase assay as well as their growth scores 
on TDO and QDO plates 
Clone # TDO 
(R&S) 
QDO 
(R&S) 
Colony phenotypea 
QDO (Ade) 
QDO (α-gal) 
 
1 4 4 white 2 
4 4 4 white 3 
5 4 4 white 3 
8 4 3 pink - 
9 4 3 pink 3 
12 4 3 pink 4 
13 4 2 pink 3 
21 4 3 pale pink 3 
25 4 3 pale pink 1 
27 4 3 pale pink 2 
33 4 3 pink - 
35 4 4 white 2 
38 4 3 pink - 
47 4 3 pink 2 
49 4 2 pink - 
51 4 3 pink - 
52 4 2 pink 4 
53 4 3 pink 2 
55 4 3 pink 2 
59 4 4 pink 3 
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Clone # TDO 
(R&S) 
QDO 
(R&S) 
Colony phenotypea 
QDO (Ade) 
QDO (α-gal) 
 
60 4 3 pink 1 
61 4 2 pink - 
65 4 4 white 3 
66 4 2 pink 1 
67 4 4 pink 1 
69 4 3 pink - 
70 4 4 white 2 
71 4 4 pink 1 
72 4 4 pink 1 
74 4 2 pink - 
78 4 3 pink - 
79 4 3 pink - 
80 4 3 pink - 
81 4 3 pink - 
83 4 3 pink - 
84 4 4 white - 
85 4 4 white 1 
87 4 3 pink 1 
88 4 4 pink 1 
91 4 3 white 1 
93 4 4 pink 3 
97 4 4 pink 1 
98 4 3 pink 1 
99 4 3 white 1 
102 4 3 pink 2 
103 4 3 white 3 
105 4 3 pink 1 
106 4 3 white 3 
108 4 2 white 3 
114 4 3 white 3 
115 4 4 pink 3 
116 4 4 pink 3 
119 4 3 pink 1 
120 4 4 pink 3 
124 4 3 pink - 
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Clone # TDO 
(R&S) 
QDO 
(R&S) 
Colony phenotypea 
QDO (Ade) 
QDO (α-gal) 
 
125 4 3 pink 3 
127 4 3 white 3 
128 4 4 pink - 
130 4 2 white 4 
131 4 3 white 3 
133 4 4 pink 3 
136 4 4 pink 1 
138 4 3 white 3 
139 4 4 white 1 
146 4 3 white 2 
147 4 3 white 4 
148 4 3 pink 2 
149 4 3 pink 1 
150 4 3 pink 1 
151 4 4 pink 3 
152 4 4 pink 2 
154 4 4 white 4 
155 4 3 white 3 
157 4 4 pink 3 
161 4 3 pink 1 
167 4 3 white 3 
168 4 4 white 2 
173 4 3 white 2 
174 4 4 white 3 
175 4 4 white 1 
179 4 4 pink - 
180 4 3 pink 3 
181 4 3 pink 3 
182 4 4 pink 3 
183 4 4 white 2 
185 4 4 pink 2 
188 4 3 white 3 
189 4 3 white 4 
199 4 3 pink 3 
201 4 3 pink 1 
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Clone # TDO 
(R&S) 
QDO 
(R&S) 
Colony phenotypea 
QDO (Ade) 
QDO (α-gal) 
 
202 4 3 white - 
203 4 4 pink 3 
207 4 2 white - 
208 4 2 pink 1 
211 4 4 pink 1 
214 4 4 pink - 
218 4 3 white 2 
220 4 2 white 2 
225 4 3 white 2 
226 4 4 pink 4 
227 4 3 white 1 
232 4 3 pink - 
233 4 3 white 3 
234 4 3 white 4 
235 4 3 pink - 
236 4 2 white 3 
237 4 3 white 3 
238 4 2 white 2 
242 4 4 white - 
245 4 3 pink 1 
249 4 3 pink 2 
250 4 4 pink 3 
252 4 2 white 1 
253 4 3 white - 
254 4 2 white 3 
256 4 3 pink 3 
266 4 3 white 1 
267 4 2 white 2 
271 4 4 white 3 
272 4 4 white 4 
273 4 4 white 4 
277 4 4 white 2 
279 4 4 white 2 
280 4 3 white 2 
282 4 4 white - 
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Clone # TDO 
(R&S) 
QDO 
(R&S) 
Colony phenotypea 
QDO (Ade) 
QDO (α-gal) 
 
285 4 4 white 2 
286 4 4 white 3 
289 4 4 white 3 
301 4 4 pink 2 
304 4 4 white 1 
306 4 4 white 1 
314 4 3 white 3 
315 4 3 white 3 
316 4 3 white 2 
318 4 3 white 3 
328 4 4 pink 2 
330 4 4 white 2 
331 4 4 pink 2 
332 4 3 pink 2 
336 4 3 white 3 
340 4 3 white 3 
342 4 3 white 1 
343 4 2 pink 2 
346 4 3 white 2 
347 4 3 white 1 
348 4 3 white 4 
349 4 4 white 2 
352 4 3 white 3 
354 4 2 white 4 
359 4 3 white 3 
362 4 2 white 3 
364 4 2 white 2 
371 4 3 white 2 
Clones in black were excluded from further testing; those highlighted in red were 
included in the subsequent specificity test (heterologous bait mating). Scores of 4, 3, 
2, 1 on TDO and QDO denote the robustness and size (R&S) of colony, indicating 
strength of bait/prey interaction, (4) most robust (1) least robust; white colonies, 
strong adenine producers; pink colonies, weak adenine producers. On QDO-X-α-
galactosidase, scores of 4, 3, 2, 1 indicate the intensity of the blue colour presented 
by each colony; (4) dark blue, (1) light blue, (-) indicate no blue colour observed. a 
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phenotype of S. cerevisiae on QDO. Cells highlighted in purple = primary interactors; 
cells highlighted in blue = secondary interactors. 
Table 3.6 Heterologous bait mating of prey clones tested against Cx45-
pGBKT7, pGBKT7, pGBKT7-53 and Reeler –pGBKT7  
 DAY4 
 
DAY7 
Clone # 
 
α-
gal 
Cx45 pGBK
T7 
pGBK-
53 
Reele
r 
Cx45 pGBK
T7 
pGBK
-53 
Reele
r 
1 2 4 - - - 4 - - - 
4 3 3 3 4 4 - 4 4 4 
5 3 4 4 4 4 4 4 1 - 
6 3 4 4 4 3 3 - 1 - 
12 4 4 4 4 4 2 - - 4 
21 3 4 4 4 3 4 1 1 - 
27 2 4 4 4 3 2 1 2 - 
33 3 4 3 4 2 3 - 1 - 
35 2 4 2 4 4 3 - - - 
52 4 4 2 4 4 4 - - 3 
55 2 3 1 4 3 3 - - - 
60 1 3 3 4 3 4 - 4 4 
65 2 4 4 4 3 3 1 1 - 
70 2 4 3 4 3 1 2 4 - 
85 1 4 2 4 4 - - 4 4 
87 1 3 2 4 3 - - 4 - 
88 1 3 2 4 3 - - 4 4 
93 3 4 2 4 3 4 - - - 
97 1 4 3 4 2 - - 4 4 
98 1 4 2 4 4 4 - 4 4 
99 1 4 3 4 2 1 1 4 - 
102 2 3 1 4 2 - - - 1 
103 3 3 1 4 4 4 - - - 
106 3 3 1 4 1 - - - - 
108 3 3 1 4 1 - - - - 
114 3 2 2 4 2 - - - - 
115 3 4 3 4 4 - - - - 
116 3 4 4 4 3 3 - - - 
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 DAY4 
 
DAY7 
Clone # 
 
α-
gal 
Cx45 pGBK
T7 
pGBK-
53 
Reele
r 
Cx45 pGBK
T7 
pGBK
-53 
Reele
r 
120 3 4 1 4 2 4 - 1 - 
125 3 4 2 4 3 - - - - 
127 3 3 1 4 2 - - - - 
130 4 3 1 4 2 - - - - 
133 3 4 4 4 3 3 2 1  
136 2 2 3 4 3 2 1 3 - 
138 3 2 1 4 3 3 - - - 
139 1 2 3 4 3 - 4 4 - 
146 2 4 4 4 2 3 - 4 2 
147 4 3 1 4 1 - - - - 
148 2 3 2 4 3 - 4 4 4 
150 2 4 3 4 2 2 - 4 - 
154 4 4 4 4 4 4 3 2 3 
157 4 4 4 4 4 4 3 2 3 
167 3 3 1 4 4 2 - - - 
168 2 2 1 4 2 - - - - 
173 2 4 3 4 4 4 4 4 4 
175 1 3 3 4 2 1 - 4 - 
180 3 4 2 4 4 3 - - - 
181 3 3 2 4 3 - - - - 
185 2 3 1 4 1 - - - - 
188 3 2 4 3 - - - -  
189 4 2 1 4 3 - - - - 
203 3 4 3 4 4 4 - - - 
211 1 3 1 4 2 - - - - 
218 2 3 1 4 3 4 - - - 
225 2 3 1 4 1 - - - - 
226 4 4 4 4 3 4 - - - 
233 3 1 - 2 - - - - - 
234 4 1 1 4 2 - - - - 
236 3 3 3 4 2 - - - - 
237 3 3 1 4 2 - - - - 
238 2 3 2 4 2 2 - 4 1 
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 DAY4 
 
DAY7 
Clone # 
 
α-
gal 
Cx45 pGBK
T7 
pGBK-
53 
Reele
r 
Cx45 pGBK
T7 
pGBK
-53 
Reele
r 
245 1 4 3 4 3 3 - 4 - 
249 2 3 3 4 3 - - 3 2 
254 3 2 1 4 1 - - - - 
256 3 4 3 4 4 2 - - 4 
267 2 3 2 4 3 - - - - 
273 1 3 3 4 3 2 - 3 - 
279 2 4 2 4 3 - - - - 
280 3 3 1 4 4 - - - 4 
288 2 3 1 4 1 - - -  
289 3 4 4 4 3 3 - - - 
301 2 4 4 4 3 3 - 4 - 
306 1 3 3 4 3 2 - 3 - 
314 3 1 1 4 2 - - - - 
315 3 3 1 4 4 3 - - - 
316 2 3 3 4 3 1 - 4 4 
318 3 1 1 4 2 - - - - 
328 2 4 3 4 3 3 - - - 
330 2 3 1 3 1 - - - - 
331 2 4 1 4 3 3 - - - 
332 2 1 1 4 2 - - - - 
336 3 2 1 4 2 - - - - 
342 1 4 3 4 2 3 - 4 - 
344 4 3 2 4 2 - - - - 
346 2 1 1 4 1 - - - - 
347 1 3 3 4 2 1 - 4 - 
349 2 1 1 4 2 - - - - 
352 3 4 2 4 3 - - - 4 
359 3 3 2 4 2 - - 1 - 
364 2 2 2 3 2 - - - - 
(-) Negative indicates no S. cerevisiae growth while a score of 1 to 4 indicates 
robustness and size of colony, in increasing order of growth. Preys highlighted in 
purple were selected for sequencing. 
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3.1.5.2 Detection of activation of colourimetric MEL1 reporter gene (X-α-
Galactosidase assay) 
The blue colour presented by some colonies indicated the activation of the MEL1 
reporter gene of the GAL4 reporter system. Thus, the intensity of the blue colour and 
robustness (tables 3.5 and 3.6) of the colonies obtained from the X-α-galactosidase 
(X- α-Gal) assay gave an indication of the strength strength of the interaction 
between Cx45 and its possible ligands. Colonies with scores of 4 and 3 were 
grouped as primary Cx45 interactors, while those with scores of 2 were grouped as 
secondary interactors. Fifty-eight (scoring 1 or 0) of these colonies were excluded 
from further analysis, as they did not produce any blue colour, suggesting their 
inability to activate the MEL1 reporter gene (table 3.6). 
 
3.1.5.3 Interaction test 
Ninety-six preys of the original 154 colonies (table 3.6) from the QDO-X-α-
galactosidase assay were screened for specificity of their interaction with Cx45, by 
the heterologous bait mating assay. These preys showed varying degrees of 
interaction; preys such as clones 154 and 173 interacted with all four heterologous 
baits, others like clones 102 and 218 interacted only with brain expressed reelin, 
while preys such as clones 189 and 346 showed no interaction. Out of all the preys 
screened in this round, only nineteen showed a relatively specific interaction with 
Cx45. These also included preys with a slight interaction with pGBKT7-53. However, 
this was not totally unexpected as pGBKT7-53 has a tendency to interact with most 
preys (BD biosciences Clonetech user manual, 2005) (table 3.7).  
 
Table 3.7 Total number and growth scores of colonies of putative ligands from 
the α-galactosidase assay 
 Primary interactors Secondary interactors  
Growth 
score 
 
4 3 2 
 
1 0 
Total # of 
colonies 
15 49 35 32 26 
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3.1.6  Sequence homology searches 
After conducting a battery of screening assays (sections 2.12.7 and 2.12.8), twenty-
five (clones 1, 6, 21, 33, 35, 52, 55, 102, 103, 116, 120, 130, 138, 139, 154, 157, 
167, 180, 289, 218, 226, 234, 315, 328, and 331) putative preys of Cx45 were 
selected for sequencing (table 3.8). These preys consisted of the nineteen Cx45 
specific preys as well as another six randomly chosen clones (21, 102, 139, 154, 
157, and 234) from the heterologous bait mating assay, for comparative purposes. 
Satisfactory sequencing results were obtained for most of the inserts. However, after 
several rounds of plasmid extraction, purification and sequencing, four clones 
continuously produced sequences of poor quality and were therefore excluded from 
further experiments. The genes harboured in each of the remaining twenty-one were 
then identified, by conducting sequence homology alignments - comparing their 
sequences with those in the Genbank databases (www.ncbi.org/BLAST) (The 
sequence alignments on which the identification of clones was based are shown in 
Appendix V). This allowed the identification of the following encoded proteins: - 
phosphodiesterase 4D interacting protein (myomegalin), cytochrome C oxidase 
subunit I, thioredoxin 2 precursor, solute carrier family member 25, HtrA serine 
peptidase 3, Alu subfamily SB1 sequence, ubiquitin specific protease 42, 
hypothetical protein FLJ14981, NADH dehydrogenase subunit 4, Homo sapiens 
CD63 antigen, obscurin-RhoGEF (also known as myosin light chain kinase) and SCF 
apoptosis response protein 1. Ultimately, seven of these ligands were prioritised as 
putative ligands of Cx45, based on their subcellular localisation, potential interaction 
with Cxs in general, as well their relevance to cardiac function (Table 3.9).   
 
As shown in table 3.9, the majority of the putative ligands represented mitochondrial 
proteins (10), while the rest represented cytoplasmic (3), extracellular (1) and 
nuclear proteins (3). Some of the ligands such as, mitochondrial cytochrome C 
oxidase subunit 1 were represented by more than one clone, suggesting the possible 
authenticity of their interaction. Chromosomal localisation of the encoded proteins 
also determined the inclusion of a particular protein as a candidate causative gene 
for PFHBII. However, none of the identified ligands were found to be situated inthe 
PFHBII locus. Initially myomegalin was viewed as a particularly interesting functional 
candidate as it is located on chromosome 1q12.1, but it was excluded as the putative 
causative gene for PFHBII (1q32.2 – 32.2) because it lay outside the defined interval 
(figure 3.5). Nevertheless it was prioritised as a putative Cx45 ligand based on its 
subcellular localisation and biological relevance to cardiac function. 
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Table 3.8 Blast-search data obtained using NCBI alignments 
Prey 
# 
In-frame ORF protein hit  
(BLASTP) 
Accession # 
(E-value) 
Genomic hit  
 (BLASTN) 
Accession #  
(E-value) 
1 
Phosphodiesterase 4D 
interacting protein isoform 4 
(Myomegalin) 
NP_001002810 
(0.0) 
Homo sapiens 
phosphodiesterase 4D 
interacting protein, 
transcript variant 4, 
mRNA 
NM_001002810 
(0.0) 
6 
Cytochrome C oxidase 
subunit I  
YP_214942.1 
(2e-97) 
Homo sapiens isolate 
IND23 mitochondrion 
DQ246833.1 
(0.0)  
21 
Cytochrome C oxidase 
subunit I 
AAP89662.1 
(9e-133) 
Homo sapiens 
mitochondrial DNA 
AP008389.1 
(0.0) 
35 Thioredoxin 2 precursor  
NP_036605.2 
(3e-90) 
Homo sapiens 
thioredoxin 2  
NM_012473.3 
(0.0) 
55 
Solute carrier family 25 
(mitochondrion) 
AAH63643.1 
(8e-85) 
Homo sapiens solute 
carrier family 25, 
adenine nucleotide 
translocator member 4 
BC063643.1 
(0.0) 
103 
Cytochrome C oxidase 
subunit I  
AAP89662.1 
(3e-99) 
Homo sapiens isolate 
B15mitocondrion    
AY713995.1 
(0.0) 
116 
Cytochrome C oxidase 
subunit I  
AAU02594.1 
(1e-65) 
Homo sapiens isolate 
IND23 mitochondrion   
DQ246833.1 
(0.0) 
120 
HtrA serine peptidase 3 
[Homo sapiens] 
AAH34390.1 
(2e-101) 
Homo sapiens HtrA 
serine peptidase 3 
BC034390.1 
(0.0)  
33 
 
Cytochrome C oxidase 
subunit I  
YP_214942.1 
(2e-97) 
Homo sapiens isolate 
IND23 mitochondrion 
DQ246833.1 
(0.0) 
130 No significant hit  - 
Homo sapiens clone 
SCb-41A3    
AC005826. 
(0.0) 
138 
Cytochrome C oxidase 
subunit I  
 
AAP91157.1 
(5e-126) 
Homo sapiens isolate 
IND18 mitochondrion  
DQ246828.1 
(0.0) 
 
139 
Cytochrome C oxidase 
subunit I  
AAU13071.1 
(3e-140) 
Homo sapiens isolate 
IND18 mitochondrion 
DQ246828.1 
(0.0) 
157 
 Alu subfamily SB1 
sequence  
P39189 
(3e-26) 
Homo sapiens BAC 
clone RP11-124A7 
from 4, complete 
sequence 
AC095043.3 
(9e-198) 
167 
Ubiquitin specific protease 
42     
EAL23715.1 
(1e-30) 
 Homo sapiens 
ubiquitin specific 
peptide  
NM_032172.1 
(2e-109) 
328 
R31167_1, partial protein 
[Homo sapiens]  ( 
hypothetical protein 
FLJ14981) 
AAD24592.1 
(1e-158) 
Homo sapiens MPN 
domain containing 
protein      
AC027793.9 
(2e-07) 
180 
NADH dehydrogenase 
subunit 4  
AAP48162.1 
(5e-48) 
Homo sapiens isolate 
C180 mitochondrion 
AY713999.1 
(0.0) 
234 
CD63 antigen [Homo 
sapiens]  
NP_001771.1 
(7e-42) 
Homo sapiens CD63 
antigen (melanoma) 
NM_001780.3 
(0.0) 
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Prey 
# 
In-frame ORF protein hit  
(BLASTP) 
Accession # 
(E-value) 
Genomic hit  
 (BLASTN) 
Accession #  
(E-value) 
289 
NADH dehydrogenase 
subunit 4  
AAO67017.1 
(5e-48) 
Homo sapiens isolate 
C180 mitochondrion 
AAO67017.1 
(5e-48) 
218 
hypothetical protein 
FLJ14981 
NP_080806.2 
(3e-137) 
full-length cDNA clone 
CS0DI076YF      
CR610197.1 
(0.0) 
315 
Obscurin, cytoskeletal 
calmodulin binding protein     
CAH71673.1 
(1e-35) 
  
Homo sapiens 
obscurin, cytoskeleton 
NM_052843.2 
(3e-157) 
331 
SCF apoptosis response 
protein 1    
NP_060948.2   
(5e-93) 
Homo sapiens 
chromosome 20 open 
reading frame  35      
NM_018478.2 
(0.0) 
93 
Ubiquitin specific protease 
42   
NP_115548.1 
(1e-31) 
Homo sapiens mRNA 
for ubiquitin 
AJ601395.1 
(7e-108) 
- E-values denote the degree of homology between the reference sequence and the query sequence; values less than 
zero (0) mark high degree of homology 
 
Table 3.9 Putative ligands prioritised according to function, subcellular 
localisation and chromosomal location 
In-frame Protein 
hit 
Primary function 
Subcellular 
localisation 
Chromosomal 
location 
Clone 
# 
Total # of 
preys 
identified as 
containing 
the same 
clone 
Phosphodiestera
se 4D interacting 
protein 
(myomegalin) 
Required for protein 
transport from the 
ER to the golgi 
complex. Thought to 
be present on 
vesicles operational 
between the ER and 
the golgi complex.  
Cytoplasmic 1q12.1 1 1 
Thioredoxin 2 
precursor  
Anti-apoptosis and 
regulation of 
mitochondrial 
membrane potential, 
suggested to be 
involved in the 
resistance of anti-
tumour agents, also 
possesses a dithiol-
reducing activity 
Mitochondrial 
inner 
membrane 
22q13.1 35 1 
Solute carrier 
family 25 
(mitochondrial 
carrier; adenine 
nucleotide 
translocator), 
Catalyses the 
exchange of ADP 
and ATP across the 
mitochondrial inner 
membrane 
Mitochondrial 
inner 
membrane 
5q31 55 1 
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In-frame Protein 
hit 
Primary function 
Subcellular 
localisation 
Chromosomal 
location 
Clone 
# 
Total # of 
preys 
identified as 
containing 
the same 
clone 
member 4* 
HtrA serine 
peptidase 3* 
Protease that 
regulates the 
availability of insulin-
growth factors (Igfs) 
by cleaving Igf-
binding proteins. 
This protein is a 
secreted enzyme 
that is proposed to 
regulate the 
availability of (Igfs) 
by cleaving IGF-
binding proteins. It 
has also been 
suggested to be a 
regulator of cell 
growth. 
Extracellular 4q16.1 120 1 
Aldehyde 
dehydrogenase 7 
family, member 
A1* 
Aldehyde 
metabolism 
Unknown 9q21.13 130 1 
Homo sapiens 
CD63 antigen 
(melanoma) 
 
Member of 
tetraspanin family. 
Mediates signal 
transduction events 
in the regulation of 
cell development, 
activation, growth 
and motility. 
Associated with 
Hermansky-Pudlak 
syndrome and 
tumour progression 
 
Plasma 
membrane 
12q12-q13 234 
1 
 
 
 
 
 
 
 
 
Ubiquitin specific 
protease 42*      
Unknown 
 
Nucleus 7p22.1 167, 93 2 
Obscurin-
RhoGEF also 
known as myosin 
light chain kinase 
Contains 68 Ig 
domains, 2 
fibronectin domains, 
1 
calcium/calmodulin-
binding domain, 1 
RhoGEF domain with 
an associated PH 
domain, and 2 
serine-threonine 
kinase domains. 
Belongs to the family 
of giant sacormeric 
Cytoplasm 1q42.13 315 1 
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In-frame Protein 
hit 
Primary function 
Subcellular 
localisation 
Chromosomal 
location 
Clone 
# 
Total # of 
preys 
identified as 
containing 
the same 
clone 
signaling proteins 
that includes titin 
and nebulin, and 
may have a role in 
the organization of 
myofibrils during 
assembly and may 
mediate interactions 
between the 
sarcoplasmic 
reticulum and 
myofibrils 
 
 SCF apoptosis 
response protein 
1 
Protein-binding, 
transport 
 
Cytoplasm 20q13.12 331 1 
 NADH 
dehydrogenase 
subunit 4  
Electron carrier 
activity 
 
Mitochondrial 
matrix 
5q11.1 
180, 
289 
2 
Cytochrome C 
oxidase subunit I 
Mitochondrial 
electron transport 
 
Mitochondrial 
inner 
membrane 
16q22-qter 
139, 
138, 
116, 
103, 
33, 
21,6 
6 
Hypothetical 
protein 
LOC68047* 
Transcription activity 
 
Nucleus 19p13.3 
318, 
328 
2 
 Proteins highlighted in blue are mitochondrial, proteins of other subcellular localisation are in red, green is unknown *  
Proteins excluded from verification analyses 
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Figure 3.5 Chromosomal location of myomegalin (1q12.1) and obscurin 
(1q42.1) 
 
3.2  MAMMALIAN TWO-HYBRID (M2H) ANALYSIS 
3.2.1  Generation of M2H constructs 
The M2H constructs generated consisted DNA fragments encoding the seven 
prioritised preys identified from Y2H (Myomegalin, CD63-antigen, SCF-apoptosis 
response protein 1, NADH dehydrogenase subunit IV, Thioredoxin 2, Obscurin and 
Cytochrome C oxidase subunit) as well as the Cx45 COOH-terminal domain. The 
constructed Cx45 bait-insert was successfully cloned into the pM GAL4-DNA binding 
domain vector, while inserts encoding the putative Cx45-ligands (PCR products of 
which are presented in figure 3.6) were cloned into the pVP16 GAL-activation 
domain vector. The integrity of the sequences and conservation of the GAL4 DNA-
BD and GAL-activation domain reading frame was verified by automated sequencing 
(sequence traces in Appendix V). 
 
 
 
 
 
D1S70 
D1S505 
PFHBII locus 
(2.85Mb) Myomegalin 
Obscurin 
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Figure 3.6 PCR amplification of inserts encoding putative Cx45 ligands 
electrophoretically separated on a 1% agarose gel.  
Sharp bands represent approximate sizes of PCR products of prioritised Cx45 
ligands. Lane 1, Myomegalin (400bp); lane 2, CD63-antigen (300bp); lane 3, SCF-
apoptosis response protein 1 (350bp); lane 4, NADH dehydrogenase subunit IV 
(250bp); lane 5, Thioredoxin 2 (430bp); lane 6, Obscurin (650bp); lane 7 Cytochrome 
C oxidase subunit I (420bp).  
 
3.2.2  Secreted alkaline phosphate (SEAP) assay 
The SEAP data was inconclusive as the enzyme activity for two of the negative 
controls (lanes 19 and 20) and the basal control (lane 18) was higher than that for 
the positive control (lane 16) (fig 3.7). The beta-galactosidase assays indicated that 
the transfection efficiency of H9C2 cells was poor (data not shown). Thus it was 
impossible to draw conclusions from the M2H assays and time constraints prevented 
optimisation of the technique. 
 650 
430 
 
230 
100 
    1         2         3         4          5          6         7 
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Figure 3.7 Box plot of secreted alkaline phosphate (SEAP) activity normalised 
to β-galactosidase activity of co-transfected H9C2 human cardiac cells.  
The SEAP activity of each experiment was compared to its corresponding control 
assay as well as the basal control (lane 15) SEAP activity levels using ANOVA. Lane 
1 (myomegalin); lane 2 (myomegalin control);  lane 3 (obscurin); lane 4 (obscurin 
control); lane 5 (CD63-antigen); lane 6 CD-63 (antigen control); lane 7 (cytochrome 
C oxidase subunit 1); lane 8 (cytochrome C oxidase subunit 1 control); lane 9 
(thioredoxin 2); lane 10 (thioredoxin 2 control); lane 11 (NADH dehydrogenase 
subunit 4); lane 12 (NADH dehydrogenase subunit 4 control); lane 13 (SCF 
apoptosis response protein 1); lane 14 (SCF apoptosis response protein 1 control); 
each sample and its control are adjacent to each other; lane 15 (negative control – 
gene juice); lane 16 (positive control – pM3-VP16);  lane 17 (pM53 and pVP16-T); 
lane 18 (basal control); lane 19 (pM-Cx45 and pVP16); lane 20 (SEAP vector); lane 
21 (β-gal vector). 
 
3.3  WHOLE EXOME SEQUENCING  
WES was used to identify putative PFHBII-causing variants in four PFHBII patients. 
The total amount of variants identified in each patient ranged between 36 000 and 39 
000 (Table 3.9).  
            1      2      3      4     5      6      7      8     9     10   11   12    
13    14   15   16   17    18    19   20   21 
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After filtration a total of 1258 variants for PID_9862, 1290 for PID_9864, 1324 for 
PID_9863 and 1240 for PID_9865 were identified as possibly disease-causing. After 
removing all variants homozygous in either of the parents, only one variant of the 
remaining variants was located in a functionally relevant gene according to OMIM 
and NCBI (Table 3.10). The gene associated with this variant was obscurin due to its 
clinical linkage to dilated cardiomyopathy, of the clinical traits of PFHB II and only 
this one was investigated further. 
 
Table 3.10: Variants identified in thePFHB II patients after WES. 
 PID_9862 PID_9864 PID_9863  PID_9865  
Total variants 37668 37263 38520 36653 
All synomous and non-
frameshifts removed 
27348 27026 28029 26482 
Remove all variants with a 
frequency >1 % in 1KGP 
26687 26375 27358 25862 
Remove all variants with a 
frequency >1 % in ESP6500 
26649 26337 27321 25824 
Remove all variants with 
negative GERP +++ scores 
1467 1432 1463 1413 
Remove all variants with 
positive FATHMM scores 
293 294 297 299 
Novel variants 103 132 117 109 
Variants with rs numbers 288 287 291 295 
1KGP = 1000 Genomes Project; ESP = Exome Sequencing Project; GERP = 
Genomic Revolutionary rare profiling; FATHMM = Functional Analysis Through 
Hidden Markov Models; rs = Reference single nucleotide polymorphism 
 
Table 3.11: Potentially disease causing variant identified in functionally 
relevant genes in PFHB II patients 
Patient Gene Heterozygous variants rs ID 
PID_9862 OBSCN 
c.2721_2722CA:p.A908T 
c.2997_2998CA:p.A1000T 
rs386640006 
PID_9864 OBSCN 
c.2721_2722CA:p.A908T 
c.2997_2998CA:p.A1000T 
rs386640006 
PID_9865 OBSCN 
c.2721_2722CA:p.A908T 
c.2997_2998CA:p.A1000T 
rs386640006 
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rs IDs: Reference single nucleotide polymorphism cluster identities; OBSCN = 
obscurin 
 
A potentially disease-causing variant situated in PFHB II-causing genes was 
identified in three of the investigated patients (Table 3.10), which was found to be 
heterozygous.  
 
3.4  IN SILICO VARIANT PREDICTIONS 
SIFT, MutationTaster2 (MT2) and PolyPhen-2 (PP-2) were used to predict the 
probability that each identified sequence variant is disease-causing. None of the 
metrics from the prediction tools used in this study could be obtained for the variant 
identified in the study, strenghthening the possibility of it being a disease-causing 
variant.  
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4.1  IDENTIFICATION OF CX45 COOH-TERMINAL TAIL LIGANDS BY YEAST 
TWO-HYBRID (Y2H) 
Protein-protein interactions have gained a great deal of attention since most 
biological functions are regulated by protein interactions and several techniques, 
such as co-immunoprecipitation, surface plasmon resonance, cytokine-receptor-
based interaction trap, Y2H and M2H analyses, for identifying different ligands of 
chosen proteins have been developed (Fields and Song, 1989; Vasavada et al., 
1991, Schuk, 1997, Eyckerman et al., 2001). The technology has evolved greatly 
over the years, to also include array-based Y2H whose advantage has been shown 
to the direct identification of interacting protein pairs without further downstream 
experiments (Mehla et al., 2015).  
 
4.1.1  Construction of DNA binding target fusion protein choice of bait 
fragment 
Among the different domains of Cx45, the cytoplasmic COOH-terminal domain (150 
amino acids) was chosen as the bait fragment because the major differences in 
amino acid sequence among the different Cxs occur in this domain (figures 1.1 and 
4.1), which suggests functional specificity, and because it is known to participate in 
protein-protein interactions (Goodenough et al., 1996; Evans and Martin, 2002). 
Another domain of the Cx45 protein which could have been used as bait was the 
cytoplasmic loop, as it is also a region which shows less amino acid sequence 
homology among the Cx isoforms (Causier, Davies, 2001 and Oyamada et al., 2005, 
2013), and again may facilitate specific functions. Despite the absence of any reports 
of its involvement in protein-protein interactions, it may have yielded novel and 
biologically relevant interactors and could be considered in subsequent screens. The 
full length Cx45 was not used as bait because the transmembrane domains could 
possibly have prevented the Cx45-GAL4-DNA-BD proteins from translocating to the 
nucleus where interaction with GAL4-AD-prey fusion occurs thereby driving 
transcription of reporter genes occurs in the Y2H technique (Causier, Davies, 2001, 
Oyamada et al., 2005, 2013).  
 
Cx40     MGDWSFLGNFLEEVHKHSTVVGKVWLTVLFIFRMLVLGTAAESSWGDEQADFRCDTIQPG    60 
Cx43     MGDWSALGKLLDKVQAYSTAGGKVWLSVLFIFRILLLGTAVESAWGDEQSAFRCNTQQPG    60 
Cx45   -MSWSFLTRLLEEIHNHSTFVGKIWLTVLIVFRIVLTAVGGESIYYDEQSKFVCNTEQPG      59 
Cx40         CQNVCYDQAFPISHIRYWVLQIIFVSTPSLVYMGHAMHTVRMQEK------------R 106 
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Cx43       CENVCYDKSFPISHVRFWVLQIIFVSVPTLLYLAHVFYVMRKEEK--------------L 106 
Cx45       CENVCYDAFAPLSHVRFWVFQIILVATPSVMYLGYAIHKIAKMEHGEADKKAARSKPYAM 119 
 
Cx40       KLREAERAKEVRGSGSYEYPVAEKAELSCWE----------EGNGRIALQG-TLLNTYVC 155 
Cx43       NKKEEE-LKVAQTDGVNVDMHLKQIEIKKFKYGI-------EEHGKVKMRG-GLLRTYII 157 
Cx45       RWKQHRALEETEEDNEEDPMMYPEMELESDKENKEQSQPKPKHDGRRRIREDGLMKIYVL 179 
 
Cx40       SILIRTTMEVGFIVGQYFIYGIFLTTLHVCRRSPCPHPVNCYVSRPTEKNVFIVFMLAVA 215 
Cx43       SILFKSIFEVAFLLIQWYIYGFSLSAVYTCKRDPCPHQVDCFLSRPTEKTIFIIFMLVVS 217 
Cx45       QLLARTVFEVGFLIGQYFLYGFQVHPFYVCSRLPCPHKIDCFISRPTEKTIFLLIMYGVT 239 
 
Cx40       ALSLLLSLAELYHLGWKKIRQRFVKPRQ--HMAKCQLS------GPSVGIVQSCTPPPDF 267 
Cx43       LVSLALNIIELFYVFFKGVKDRVKGKSDPYHATSGALSPAKDCGSQKYAYFNGCSSPTAP 277 
Cx45       GLCLLLNIWEMLHLGFGTIRDSLNSKRRE-LEDPGAYNYPFTWNTPSAPPGYNIAVKPDQ 298 
 
Cx40       NQCLENGPGGKFFNPFSNN--------MASQQNTDNLVTEQVR-GQE-QTPGEGFIQ-VR 316 
Cx43       -LSPMSPPGYKLVTGDRNNSSCRNYNKQASEQNWANYSAEQNRMGQAGSTISNSHAQPFD 336 
Cx45       IQYTELSNAKIAYKQNKAN--------TAQEQQYGSHEENLPADLEALQREIRMAQERLD 350 
 
Cx40       YGQKPEVPNGVSPGHRLPHGYHSDKRRLSKASSKARS----DDLSV 358 
Cx43       FPDDNQNSKKLAAGHELQPLAIVDQRPSSRASSRASSRPRPDDLEI 382 
Cx45       LAVQAYSHQNNPHGPREKKAKVGSKAGSNKSTASSKSGDGKTSVWI 396 
 
Figure 4.1 Alignments of human connexins 
Cx40 (226 to 357 aa), Cx43 (255 to 382 aa) and Cx45 (245 to 396 aa) polypeptides 
highlighting variations in amino acid sequences among their COOH-termini (in 
coloured font) as well as regions of high homology; NH2-termini (highlighted in pink) 
and extracellular loops 1 and 2 (highlighted in orange and purple, respectively). 
Multiple sequence alignments were performed by use of the ClustalW BLAST 
programme.  
 
4.1.2  Phenotype assessment of S. cerevisiae strains 
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It has been reported that bait proteins sometimes interfere with mating if they are 
highly homologous to proteins involved in yeast mating (Schultz et al., 1995). 
However, the mating efficiency of S. cerevisiae AH109 transformed with the Cx45-
pGBKT7 bait construct and S. cerevisiae Y187 transformed with pTD1.1 (4.9% 
shown in table 3.3) was high enough to rule out toxicity due to the presence of the 
Cx45-bait construct.  
 
4.1.3  cDNA-cardiac library screen 
Since the cDNA-cardiac library was constructed from males who died of accident 
trauma (BD Bioscience, Clontech, Paulo Alto, CA, U.S.A), it is possible that some 
biologically relevant protein interactions were not screened for, as some proteins 
may have not been expressed at time the RNA was extracted. However, the proteins 
identified in this study (table 3.6) give an indication of the possible interactions of 
Cx45 with other proteins and enabled us to make an initial assessment of the range 
of specific and overlapping roles played by the selected Cxs. 
 
4.1.4  Clones excluded from or included in M2H analysis 
Clones excluded from further verification studies by M2H analysis included 
sequenced prey clones encoding proteins likely to be expressed at locations where 
an interaction with a Cx would be unlikely, such as the nucleus and the extracellular 
matrix (table 3.4). Initially in this study, mitochondrial proteins, such as NADH 
dehydrogenase subunit 4, cytochrome C oxidase and thioredoxin 2, would have 
been omitted as putative candidate ligands of Cx45, on the rationale that these 
mitochondrial proteins form part of a list of known false positives (which includes 
ribosomal proteins, cytochrome oxidase, mitochondrial proteins, proteasome 
subunits, ferritin, tRNA synthase, Zn finger proteins, vimentin) that are frequently 
found in a Y2H screen, independent of the bait used (van Criekinge, Beyaert, 1999 
and Lievens et al., 2009). However, they were thereafter prioritised based on 
findings from a recent study by Boengler and colleagues (2005) who presented 
evidence for the presence of Cx43 in the mitochondrial matrix, near the inner 
membrane, suggesting another as yet unidentified role for Cxs other than cell-cell 
communication. 
 
In addition to identifying the ligands, sequence homology and BLAST searches 
allowed the determination of likely subcellular localisations, constituent domains and 
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the biological relevance of the putative ligands; all features significant in the 
prioritisation of the ligands. Furthermore, the number of clones identified as the same 
protein was assumed to be suggestive of the importance of the interaction, as in the 
case of cytochrome C oxidase (table 3.9). 
 
It was also intriguing to note that out of the six randomly chosen clones sequenced 
for comparative purposes; four (clone 21, 102, 139 and 234), showed significant 
interaction. In fact, all four had a strong interaction with Cx45, and a slight interaction 
with other preys. Clones 154 and 157, both strongly interacting with all four preys in 
the specificity assay (table 3.7) gave insignificant BLAST results, which further 
warranted their exclusion as Cx45 interactors. 
 
4.1.5  Proteins prioritised as possible Cx45 ligands 
The candidature of each of the seven prioritised putative ligands of Cx45 will be 
discussed, with a focus on the arrangement of the constituent domains, their 
possible relevance in Cx interactions and their potential involvement in cardiac 
function. These putative ligands of the Cx45 COOH-terminal domain ranged from 
mitochondrial to cytoplasmic proteins (Table 3.9) and were identified as thioredoxin 
2, NADH dehydrogenase subunit IV, cytochrome C oxidase subunit I, SCF apoptosis 
response factor 1, Homo sapiens CD63 antigen, phosphodiesterase 4D interacting 
protein (also known as myomegalin) and  obscurin-RhoGEF (also known as myosin 
light chain kinase). It is interesting to note that through whole exome sequencing 
(WES), obscurin was identified as a potential PFHB II causative gene.  
 
A. Thioredoxin 2 (TRX2) 
Thioredoxin 2, a mitochondrial inner membrane protein which belongs to the 
thioredoxin family, is a member of a class of small multifunctional 12kDa proteins 
present in both prokaryotes and eukaryotes. They control cellular redox states and 
protect the cell against oxidative damage. Thioredoxins are characterised by the 
redox active site Trp-Cys-Gly-Pro-Cys. Mammalian TRX2, a potential ligand of Cx45, 
is encoded by a nuclear gene but is directed to the mitochondrion by an NH2-
terminal mitochondrial presequence (Smeets et al., 2005, Lee et al., 2013). Spyrou 
and co-workers showed that recombinant rat liver TRX2 possessed dithiol-reducing 
activity. In the presence of thioredoxin reductase and NADPH, TRX2 reduced the 
interchain disulfide bridges of insulin, a well-known thioredoxin test substrate 
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(Spryrou et al., 1997). Based on the interaction of TRX2 and the disulfide bridges of 
insulin, it is tempting to speculate that Cx45 interacts with TRX2, as connexons are 
joined by disulfide bonds. However, since only the COOH-terminal domain of the Cx 
sequence was used as bait, and although this interaction may occur in vivo, it cannot 
underlie the bait:prey interaction in Y2H, as no disulphide bonds were present in the 
bait. 
 
Nonetheless, Damdimopoulos and colleagues (2002, Huang et al., 2015) showed 
that human embryonic kidney cells over-expressing TRX2 were resistant to cell 
death caused by etoposide, a topoisomerase II poison, and more sensitive to 
rotenone, an inhibitor of complex I of the mitochondrial respiratory chain. Over-
expression of TRX2 in this cell system also seemed to increase the mitochondrial 
membrane potential. Furthermore, treatment with oligomycin (an inhibitor of ATP 
synthase) reversed the effect of rotenone and decreased the membrane potential, 
suggesting that TRX2 interferes with the activity of ATP synthase. Consequently, 
Damdimopoulos et al. (2002, Huang et al., 2015) concluded that TRX2 interacts with 
specific components of the mitochondrial respiratory chain and plays a role in the 
regulation of the mitochondrial membrane potential.  
Thus, TRX2, as an electron carrier involved in regulating membrane potential, can 
be suggested to interact with the COOH-terminal domain of Cx45. Although the 
mechanism through which this interaction occurs and relevance thereof are not 
clear, it is possible that the two proteins work closely in regulating energy potential in 
cells, particularly cardiac cells.  
B. NADH dehydrogenase subunit IV (NADH IV) 
NADH dehydrogenase subunit IV (NADH 1V) is one of seven transmembrane 
subunit components of the NADH ubiquinone oxidoreductase (NQO) complex I 
(Shoffner and Wallace, 1995, Arizmendi et al., 1992; Wallace et al., 1994) located in 
the mitochondrial outer membrane. This reductase complex I accepts electrons from 
NADH, transfers them to ubiquinone (coenzyme Q10) and uses the energy released 
to pump protons out across the mitochondrial inner membrane. NADH 
dehydrogenase subunit IV is thought to be the part of hydrophobic component of 
complex I (Powis and Montfort, 2001). 
The function of the putative interaction between NADH dehydrogenase subunit IV 
and Cx45 is not understood. However, findings from a study presented by Boengler 
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and colleagues in 2005, where they found traces of Cx43 in the mitochondrial matrix 
near the inner membrane can be extrapolated to suggest another function of Cx45, 
apart from cell-cell communication. It is also not clear how the Cx isoform is imported 
into the mitochondrial matrix but it could be speculated to be through the action of 
translocases which present cytosolic proteins to mitochrondrial receptors and 
transport them further into the mitochondrial matrix though a series ATP-dependant 
reactions as shown in figure 4.2 (Mokranjac and Neupert, 2005). 
 
 
 
Figure 4.2 Proposed mechanism of protein import into the mitochondrion.   
 
Receptors within the membrane-integrated TIM23 (translocase of the inner 
membrane) complex recognise the precursor proteins as they appear at the outlet of 
the TOM (translocase of the outer membrane) complex which then delivers them to 
the translocation channel. The motor part of the complex then takes the 
presequence as it enters the matrix face of the translocation channel to the 
mitochondrial heat shock protein (mtHsp70) via through a series of ATP-dependant 
reactions after which the protein is released into the mitochondrial matrix (adapted 
from Mokranjac and Neupert, 2005). 
The p49/STRAP (or SRFBP1) proteins was also identified as a cofactor of serum 
response factor that contributes to the regulation of SRF target genes in the heart 
(Zhang et al., 2008). 
 
 C. Cytochrome C oxidase subunit I 
TO
M 
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Cytochrome C oxidase subunit I is one of three mitochondrial DNA-encoded subunits 
of respiratory complex IV, located within the mitochondrial inner membrane. 
Complex IV is the third and final set of enzymes of the electron transport chain of 
mitochondrial oxidative phosphorylation. It collects electrons from reduced 
cytochrome C oxidase and transfers them to oxygen to create water. The energy 
released is used to transport protons across the mitochondrial inner membrane. 
Complex IV is composed of 13 polypeptides. Subunits I, II, and III are encoded by 
mtDNA, while subunits IV, Va, Vb, VIa, VIb, VIc, VIIa, VIIb, VIIc, and VIII are nuclear-
encoded (Kadenbach et al., 1983; Shoffner and Wallace, 1995).  
Proton translocation in Complex IV involves four electrons to reduce oxygen and four 
protons taken up from the matrix side of the mitochondrial membrane for the 
formation of water. Four more protons are vertically translocated from the matrix to 
the cytosolic side of the membrane. Evidence is accumulating that proton 
translocation is linked to electron transfer at the binuclear oxygen binding site, which 
has been extended to suggest that proton translocation is associated with proximal 
ligand exchange between tyrosine and histidine on cytochrome a3 (Rousseau et al., 
1993).  
 
Cytochrome C oxidase has been associated with the development of cardiovascular 
disease. Wisloff and colleagues (2005) hypothesised that artificial selection of rats 
based on low and high intrinsic exercise capacity would yield models that also 
differed for cardiovascular disease risk. Indeed, after eleven generations, rats with 
low aerobic capacity scored higher on cardiovascular risk. The decrease in aerobic 
capacity was associated with decreases in the amounts of transcription factors 
required for mitochondrial biogenesis and in the amounts of oxidative enzymes in 
skeletal muscle. Wisloff et al. (2005) found that the amounts of peroxisome 
proliferative activated receptor, gamma (PPARG) coactivator-1-alpha, ubiquinol-
cytochrome C oxidoreductase core 2 subunit, cytochrome C oxidase subunit I, 
uncoupling protein-2, and ATP synthase H+-transporting mitochondrial F1 complex 
were markedly reduced in the low capacity runner rats in comparison with the high 
capacity runners. The decline in these proteins was consistent with the hypothesis 
that reduced aerobic metabolism plays a causal role in the development of the 
differences between the low capacity runner and high capacity runner rats. It was 
thus concluded that impairment of mitochondrial function, as a result of sequence 
variants in genes encoding proteins that regulate pathway that facilitate 
mitochondrial processes, may be associated with reduced fitness in cardiovascular 
and metabolic disease (Wisloff et al. 2005). It can therefore be proposed that Cx45, 
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as one of the prominent cardiac Cx isoforms, is involved as a ligand in processes in 
which cytochrome C oxidase functions.  
 
D. SCF (stem cell factor) apoptosis response protein 1 
The SCF apoptosis response protein 1 is a cytoplasmic protein which is mainly 
composed of the dysbindin domain, which binds to alpha- and beta-dystrobrevins, 
components of the dystrophin-associated protein complex in both muscle and non-
muscle cells. Dysbindin itself is a component of the biogenesis of lysosome-related 
organelles complex 1. SCF apoptosis response protein 1 is involved in migration, 
adhesion, proliferation and survival of germ cells by prtecting them from apoptosis. It 
is also central in blood-forming tissue where Cx43 and Cx45 were found to also play 
a regulatory role in blood coagulation (Rosendaal and Krenacs, 2000; Cancelas et 
al., 2000). SCF apoptosis response protein 1 has been associated with Hermansky-
Pudlak syndrome (HPS), a genetically heterogeneous disorder characterised by 
oculocutaneous albinism, prolonged bleeding and pulmonary fibrosis due to 
abnormal vesicle trafficking to lysosomes and related organelles, such as 
melanosomes and platelet dense granules (Hoffman and Valencia, 2004). The 
involvement of SCF apoptosis in migration and adhesion and its putative association 
with Cx45 suggest a role of Cx45 in exporting molecules from the cell, working as 
part of a multiprotein complex. 
 
E. CD63-antigen 
The CD63-antigen is a glycoprotein expressed strongly during early stages of tumour 
progression. It has four transmembrane domains and three N-glycosylation sites and 
has been associated with membrane structures (Metzelaar et al., 1998) and 
Hermansky-Pudlak syndrome (HPS), as has SCF apoptosis response protein 1. 
Nishibori and colleagues (1993) used immunofluorescence with anti-CD63 and anti-
granulophysin antibodies to demonstrate deficiency of these proteins in HPS and 
was the first to report a protein present in platelet dense granules, lysosomes, and 
melanocytes, but deficient in a patient with HPS. Clarification as to whether 
deficiency in CD63 is the primary defect in HPS still needs to be determined in 
patients with this disorder. That the primary defect resides in the CD63 gene was 
made unlikely by the demonstration by Fukai et al. (1995) that the HPS gene maps 
to chromosome 10, not chromosome 12, where CD63 lies. 
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Gwynn et al. (1996) found that the cDNA encoding mouse CD63 detects two closely-
related sequences that map to different regions of the mouse genome. One locus 
maps to mouse chromosome 10, in a region that shares synteny with chromosome 
12, where human CD63 maps. The second locus maps to mouse chromosome 18 in 
a region that bears no homology to known human CD63-related genes. No platelet 
storage pool deficiency disorder has been mapped to these regions of either mouse 
chromosome 18 or human chromosome 12. The association between Cx45 and 
CD63 is illusive, but it may be speculated to be linked to the CD63-antigen in the 
same fashion that SCF apoptosis response protein 1 interacts with this Cx isoform, 
ie., as part of a multicellualr complex. It is intriguing to discover that Cx45 has a 
possible association with two different proteins involved in the same disorder which 
could be due to the specificity of the function of this Cx isoform. 
 
F. Phosphodiesterase 4D interacting protein also known as myomegalin 
Myomegalin is a protein which interacts with 3, 5 cyclic adenosine monophosphate 
(cAMP) phosphodiesterase (Verde et al. 2000). Phosphodiesterases, myomegalin 
interactors, generally regulate the local concentration of cAMP within cells, ultimately 
activating the cAMP-dependent protein kinase (PKA) which signals cellular 
compartmentalisation (Huston et al., 2006). The interaction of Cx45 with myomegalin 
suggests a possible role of myomegalin as a scaffolding protein in the 
phosphorylation of Cx45 by cAMP dependant kinase. 
 
It is interesting to note that phosphodiesterase inhibitors have been linked to heart 
failure and cardiac arrhythmias in mice. Additionally, phosphodiesterase knock-out 
mice have been reported to present dilated hearts with normal muscle structure, a 
clinical feature present in DCM patients (as reviewed by Lehnart et al., 2005). It is 
also possible that Cx45, along with myomegalin, plays a role in the development of 
cardiac disorders particularly due to the involvement of myomegalin in cAMP 
regulation, an important step in ATP generation. Myomegalin was also found to be 
involved in the phosphorylation of cardiac myosin binding protein C (Uys et al., 
2011).  
 
G. Obscurin 
Obscurin is an interesting candidate as it was first identified as a Cx 45 ligand 
through Y2H studies and later shown through WES to be a potential causative gene 
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for PFBH II. Obscurin has been somewhat neglected as a potential player in the 
development of cardiomyopathies, largely because its functional role is far from 
clear. The development of WES enabled researchers to look into the function of this 
protein as well as the various roles it plays in the development of inherited 
cardiomyopathies. 
 
The obscurin gene, expressed in both both cardiac and skeletal muscles, is located 
on chromosome 1.42q13 and spans more than 150 kb and contains over 80 exons 
that encode a protein of approximately 720 kDa (Bowman et al. 2007; Fukuzawa et 
al. 2008; Kontrogianni-Konstantopoulos et al. 2006; Shriver et al. 2015). The 
encoded protein contains 68 Ig domains, two fibronectin domains, one 
calcium/calmodulin-binding domain, one Rho guanine nucleotide exchange factor 
(GEF) domain with an associated PH domain, and two serine-threonine kinase 
domains. This protein belongs to the family of giant sarcomeric signaling proteins 
that includes titin and nebulin, and it is speculated that these proteins may have a 
role in the organisation of myofibrils during assembly and may mediate interactions 
between the sarcoplasmic reticulum (SR) and myofibrils. Obscurin surrounds the 
myofibrils at the level of Z-disk and M-band, where it is suitably positioned to 
participate in their assembly and integration with the elements of the SR. In fact, 
studies by Kontrogianni-Konstantopoulos et al. (2006, 2014) showed obscurin to 
indeed play a role in the assembly and organisation of the sarcomeres and 
sarcoplasmic reticulum. The importance of its COOH-domain was also discovered in 
this study. Obscurin is also suggested to serve as a kinase anchor protein. It could 
play a role in the phosphorylation of Cx45 by cAMP dependant kinase, which 
normally requires a scaffolding protein such as obscurin (Wei et al., 2004).  
 
Obscurin has been found to interact with various ligands suggesting diversity in its 
functional role. Within the sarcomere at the level of the M-band, mammalian 
obscurins interact with titin, myomesin, ankyrin-B, Ras homolog gene family, 
member A (RhoA), and slow skeletal myosin binding protein C variant 1 (sMyBP-
Cv1) (Perry et al. 2013). In C. elegans at the M-band, UNC-89 interacts with copine 
domain protein atypical-1 (CPNA-1), UNC-15 (paramyosin), small CTD-
phosphatase-like-1 (SCPL-1), four and a half LIM domains protein 9 (LIM9/FHL), 
maternal effect lethal 26 (MEL-26), and Rho1 (Gieseler et al. 2016; Qadota et al. 
2008; Warner et al. 2013; Wilson et al. 2012) and Drosophila obscurins interact with 
Ball and multiple Ankyrin repeats single KH domain (MASK) at the M-band 
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(Katzemich et al. 2015). In addition, mammalian obscurins interact with the NH2-
terminus of titin and Ran-binding protein 9 (RanBP9) at Z-discs (Bowman et al. 
2008), small ankyrin- 1 at the SR (Kontrogianni-Konstantopoulos et al. 2003), and 
ankyrin-B at costameres (Randazzo et al. 2013). At the ID of mammalian cardiac 
muscle, obscurin polypeptides interact with N-cadherin and Na+/K+ ATPase (Hu and 
Kontrogianni- Konstantopoulos, 2013).  
 
Other ligands of mammalian obscurins include calmodulin and calcium/calmodulin-
dependent protein kinase I (CaMKII), both of which promiscuously localize 
throughout myocytes; consequently, the location and function of the interaction 
between obscurins and these proteins remain elusive. Calmodulin interacts with the 
IQ motif of obscurins, which localizes to M-bands of developing and adult heart and 
skeletal muscles, as well as to the sarcolemma and neuromuscular junction of 
skeletal muscles (Carlsson et al. 2008). 
 
The obscurin variants found so far seem to be distributed throughout the molecule 
(figure 4.3), mostly with no apparent connection to any functional domain. Arimura et 
al. (2007) have proposed that the R4344Q mutation affects binding of obscurin to Z-
line titin (domains Z9-Z10), and Marston et al. (2015) noted obscurin 
haploinsufficiency but did not measure any functional properties. The best clues to 
the physiological function of obscurin are provided by the obscurin knockout mouse 
model (Lange et al. 2009); however, the effects of knockout have only been fully 
studied in skeletal muscle rather than in cardiac muscle and no cardiac defect was 
reported. In skeletal muscle, absence of obscurin results in disorganisation of 
microtubules at the sarcolemma and delocalisation of dystrophin at costameres. 
More striking abnormalities appear with intense exercise, including fibre damage, 
atrophy and degeneration which revert when exercise is stopped (Randazzo et al. 
2017). It was proposed that the absence of obscurin causes the failure of the muscle 
sarcolemma to support the mechanical stress of intensive chronic contraction. In the 
heart, this may be manifested as development of a hypo-contractile heart under 
stress which could trigger DCM. 
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Figure 4.3: Obscurin structure and cardiomyopathy-associated mutations.  
Top gene structure, showing the exons and alternative splicing that yields obscurin A 
or B. Middle schematic domain structure of obscurin B. Adapted from Marston 
(2017). 
4.1.6  Limitations of the Y2H method 
Despite the isolation and identification of putative ligands of Cx40 in the present 
study, some caveats of the methodology must be considered. Since in Y2H analysis, 
combinations of protein-protein interactions are assayed, the possibility of identifying 
artefactual partners exists. It is also possible that both proteins (bait and prey), 
although able to interact in the Y2H assay, are never in close proximity to each other 
within the cell. The two proteins could be expressed in different cell types, or even 
when found in the same cell they could be localised in different subcellular 
compartments. Moreover, interacting proteins can be expressed at different time 
points in the cell cycle (Greener and Perkel, 2005), giving a false impression of 
interactions occurring in physiological systems. For this reason, further assays were 
undertaken in an attempt to strengthen the candidature of the selected ligands. 
 
4.2  MAMMALIAN TWO-HYBRID (M2H) ANALYSIS 
M2H was the method chosen to verify the putative interactions between the Cx bait 
and selected preys. However, in the present study, the high SEAP activity in the 
negative controls (figure 3.7) is inexplicable and has made it impossible to derive any 
statistical correlations between the regions encoding the Cx45 COOH-terminal 
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domain and identified putative ligands. The higher SEAP activity in the controls can 
be speculated to be due to cellular endogenous phosphate or experimental error. 
Another contributory factor could be the cell line used. A cardiac myocyte cell line 
(H9C2) was used, as the aim was to mimic the in vivo cardiac milieu as far as 
possible. However, these cells proved difficult to transfect, a problem that was 
encountered by other workers in the group. Thus further studies were therefore 
needed, either to optimise transfections with this line, or to investigate use of another 
cell line. It may also be necessary to conduct further assays such as co-
immunoprecipitation and surface plasmon resonance, among others, in order to 
verify the authenticity of protein interactions identified (Phizicky and Fields, 1995; Wu 
and Brand, 1994; Wilson and Hastings, 1998). However, due to time constraints we 
were unable to conduct these verifications.  
 
As highlighted in the previous section, the M2H method also does not offer all the 
answers to protein interactions as it is also reliant on interactions occurring in 
nucleus and on GAL4 domains.  
 
4.3 A SPECULATIVE MODEL OF CX45 PROTEIN-PROTEIN INTERACTIONS 
AND FUNCTIONAL SPECIFICITIES IN RELATION TO CX40 AND CX43 
Based on the prioritised Cx45 ligands, described above, it can be speculated that 
this isoform participates in a number of physiological processes, ranging from energy 
transport in cells to blood coagulation. Just like Cx43 (Wei et al., 2004), it can 
function as a member of a multi-protein network in energy production required in 
cardiac function (section 1.1.5.1). Its proposed interaction with proteins such as 
myomegalin and obscurin further supports this assumption, as these proteins serve 
as scaffolding or anchoring proteins for kinases. Additionally, it can be deduced that 
these interactions, although not specific, play a role in the gating of Cx45 channels.  
 
It is also interesting to note the distribution of Cx 45 throughout the heart. Its 
prominence in the atrioventricular node and the Purkinje Fibres suggests an 
association with the development of PFHB II whose other clinical characteristic is 
complete heart block at an atrioventricular nodal level. The Purkinje Fibres, 
influenced by the electrical discharge from the SA node could also be affected by Cx 
45 protein interactions and can contribute to the development of cardiac diseases 
Stellenbosch University  https://scholar.sun.ac.za
 135 
 
such as PFHB II. The newly found association of Cx 45 with obscurin is worth 
investigating further.   
 
As the above findings are based on Cx43 studies, it is possible that the two isoforms, 
Cx43 and Cx45, have overlapping roles. Co-localisation of Cx43 with blood 
coagulation factors such as SCF apoptosis response protein 1, and the newly 
proposed association of SCF apoptosis response protein 1 with Cx45 in the present 
study, also suggests that these two cardiac Cxs have similar cellular functions. The 
association of both SCF apoptosis response protein 1 and CD63-antigen in HPS 
also suggests that the two proteins share functional roles, especially since they both 
interact with Cx45 (Nishibori et al.; 1993; Hoffman and Valencia, 2004). 
 
Based on the organisation of the constituent domains of the mitochondrial proteins 
prioritised (thioredoxin 2, NADH dehydrogenase subunit 4 and cytochrome C 
oxidase), it can be speculated that these ligands interact with Cx45 in a similar 
manner. Connexin 45 possibly recognises the transmembrane domain (present in all 
three identified mitochondrial proteins) to adhere to the target protein, and by fusing 
its COOH-terminus with the NH2-terminus of the mitochondrial protein, it is 
transported into the mitochondrial matrix (Wilcox et al., 2005). Additionally, since 
these mitochondrial proteins play a major role in energy production via the electron 
transport chain, and that energy production is an integral part in cardiac function, it 
can be speculated that Cx45 as part of the gap junction channel co-facilitates the 
electron transport with these ligands. Although the mechanism through which these 
protein interactions affect cardiac function is unknown, it also tempting to assume 
that they may contribute to the aetiology of some cardiac disorders. 
 
It is also evident that Cxs have specific functions, as assessed in a study by R. 
Keyser (Identification of ligands of cardiac Cx40 and their possible association with 
the development of the cardiac conduction disorders, progressive familial heart block 
type I and type II [PFHBI and PFHBII]), where ligands of the COOH-terminal domain 
of cardiac Cx40 were identified. In fact, Cx40 was found to interact mostly with 
cytoplasmic proteins. However, the possibility of shared functions between the two 
cardiac Cxs (Cx40 and Cx45) can not be totally excluded, as Cx40 was found have 
an interaction with NADH dehydrogenase subunit 6 (R. Keyser, 2007, MSc Thesis – 
University of Stellenbosch Keyser, 2007). NADH dehydrogenase subunit 6 is part of 
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the NADH dehydrogenase complex which also consists of NADH dehydrogenase 
subunit 4 (figure 4.2), a putative ligand of Cx45 (unpublished data - Nxumalo, 2018).  
 
4.4  PFHBII POTENTIAL CANDIDATE GENES – THE SEARCH CONTINUES 
Another facet of this study was to investigate if the identified ligands play a role in the 
development of PFHBII. In spite of the reports linking mutations in genes that encode 
ion channels (Benson, 2004), energy metabolism proteins (Blair et al., 2001) and 
cardiac structural proteins to the development of cardiac conduction disorders, none 
of the ligands identified in this study showed a possible association with either of 
these disorders through chromosomal position.  
 
BLAST-searches indicated that the ligands (which included energy metabolism 
proteins such NADH dehydrogenase subunit IV, cytochrome C oxidase subunit I and 
thioredoxin II and cardiac structural proteins – myomegalin and obscurin) did not lie 
in the locus ofPFHBII. It is possible that mutations in other proteins that interact 
closely with these ligands are involved as cause of this disorder. It is possible that 
future cascade studies may identify them. 
 Interestinglythe PFHBI gene was identified in a collaboration between our group and 
two groups in Germany (Corfield personal communication- 2007). Of significance is 
the fact that the candidate gene was indirectly identified in astudy conducted by R 
Keyser (Identification of ligands of cardiac Cx40 and their possible association with 
the development of the cardiac conduction disorders, progressive familial heart block 
type I and type II [PFHBI and PFHBII],by its functional homology to a putative ligand 
of Cx40. This data validates the strategy applied in thisstudy to identify new PFHB II 
candidate genes.  
 
All the recent studies on obscurin variants have involved whole exome sequencing 
with the unique variants being identified by comparison with large reference 
databases, such as Exacs and EVS, and their pathogenicity predicted using 
algorithms such as SIFT. This approach, based on small populations, may be biased 
in patient ethnicity and other factors. It is recognised that such conclusions may give 
a false positive association of disease with variants especially in a large protein 
(Walsh et al. 2017). Variants that cause chain termination, as found in the Rowland 
et al. (2016) and Xu et al. (2015) studies, are more likely to be pathogenic than 
missense mutations; however, none of the current studies on OBSCN variants have 
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any family history showing the variant segregating with the disease, which is 
required to confirm causality.  The only study that has directly investigated the 
obscurin molecule in heart muscle with identified mutations was Marston et al.’s 
(2015) study of familial DCM; where obscurin haploinsufficiency was demonstrated 
for all the obscurin variant samples compared with familial DCM with mutations 
identified in other genes or in donor heart samples (Marston, 2017). This, therefore, 
increases the confidence that obscurin variants and familial DCM are linked in this 
particular group of samples from patients who had transplants for end-stage heart 
failure. It would be beneficial to screen PFHBII patients for obscurin variants, 
particularly due the gene’s clinical linkage to DCM.  
 
Conclusion 
The array of putative Cx45 ligands identified in this study suggests a diversity of 
processes in which Cxs participate apart from cell-cell communication. The 
unexpected interaction of the COOH-terminal domain of Cx45 with mitochondrial 
proteins further shows that the role of Cxs in cellular and physiological processes is 
not fully understood. Although cardiac proteins were identified, it was however 
difficult to make a direct link between these proteins and the development of cardiac 
conduction disorders. Therefore, more studies need to be conducted in order to 
further elucidate the function of Cxs, as channel proteins and possibly regulatory 
proteins, in physiological processes and in the development of physiological 
disorders – including cardiac conduction disorders- either directly through these 
proteins themselves, or through their ligands. In the absence of additional data, we 
cannot exclude the possibility that the observed variants are simply bystander effects 
and that the true disease-causing mutation is elsewhere. Despite limited 
investigations, mutations in the obscurin gene are emerging as significant in a range 
of cardiomyopathies. Obscurin mutations may be causative of HCM, DCM and LVNC 
and other cardiomyopathies such as PFHBII, or they may work in concert with other 
variants in the same or other genes to initiate the pathology. 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 138 
 
APPENDIX I 
 
1. DNA EXTRACTION SOLUTIONS 
 
Cell lysis buffer 
Sucrose                              0.32M 
Triton-X-100                                 1% 
MgCl2                               5mM 
Tris-HCl                             10mM 
H2O                                   1L 
 
3M NaAc 
NaAc.3H2O (Merck)                              40.18g 
ddH2O                                 50ml 
Adjust pH to 5.2 with glacial acetic acid and adjust volume to 100ml with ddH2O 
 
DNA extraction buffer 
NaCl                               0.1M 
Tris-HCl                             0.01M 
EDTA (pH8)                           0.025M 
SDS                              0.5% 
Proteinase K                        0.1mg/ml 
 
T.B.E-BUFFER (10x stock) 
Tris-HCl                             0.89M 
Boric Acid                             0.89M 
Na2EDTA (pH8)                             20Mm  
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2. BACTERIAL PLASMID PURIFICATION SOLUTIONS 
 
Cell Resuspension Solution 
50mM Tris-HCL, pH 7.5                  2.5ml 1M Tris 
10mM EDTA               1ml 0.5M EDTA 
Make up to 50 ml with H2O 
 
Cell lysis solution 
0.2M NaOH               2.5ml 4M NaOH 
1% SDS                                   5ml 
Make up to 50ml with H2O 
 
Nutralization solution 
1.32M KOAc, pH 4.8           13.2ml 5M KOAc 
Make up to 50ml with H2O 
 
3. YEAST PLASMID PURIFICATION SOLUTIONS 
 
Yeast lysis buffer 
SDS                                 1% 
Triton X-100                                 2% 
NaCl                           100mM 
Tris (pH8)                             10mM 
EDTA (pH8)                               1mM 
 
4. ELECTROPHORESIS SOLUTIONS  
 
10% Ammoniumpersulphate (APS) 
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APS                                    10g 
ddH2O                               100ml 
 
T.B.E-Buffer (10x stock) 
Tris-HCl                             0.89M 
Boric Acid                             0.89M 
Na2EDTA (pH8)                             20mM 
 
T.A.E Buffer 
Tris-HCl                             0.89M 
Boric Acid                             0.89M 
Na2EDTA (pH8)                             20mM 
 
SDS-Page esolving gel buffer (4x) 
Tris base                               109.2g 
ddH2O                                330ml 
10%SDS                                  24ml 
pH to 8.8 using 1N HCL 
Make up to 600ml using ddH2O 
 
5. LOADING DYES 
 
Bromophenol blue 
Bromophenol blue           0.2% (w/v) 
Glycerol                     50% 
Tris (pH8)                  10mM 
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6. MOLECULAR SIZE MARKER (LAMBDA PstI) 
 
Bacteriophage Lambda DNA (250g)                  100l 
Buffer M (Boerhinger Mannhein)                            15l 
PstI (Boerhinger Mannheim)                                  11l 
H2O                                        32l 
Incubate at 37C for 2 hours followed by heat inactivation at 65C for 5 minutes. 
Load 2l onto polyacrylamide gels. 
 
7. PCR BUFFER 
 
10x NH4 PCR buffer (BIOLINE U.K.) 
Ammonium sulphate                     160mM 
Tris-HCl (pH 8.8)                      670mM 
Tween-20                           0.1% 
 
8. SOLUTIONS USED FOR THE ESTABLISHMENT OF BACTERIAL 
COMPETENT CELLS 
CAP buffer: 
60 mM CaCl2                                2.21 g 
15% glycerol                       37.5ml 
10mM PIPES                      0.76 g 
Make up to 250ml with sterile millipore H2O. pH to 7.0. Keep in fridge. 
 
9. BACTERIAL MEDIA 
 
Luria-bertani (LB) media 
Bacto tryptone                        5g 
Yeasy extract                     2.5g 
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NaCl                        5g 
ddH2O to final volume of 500ml 
Autoclave at 121 for 20min  and appropriate antibiotic (ampicillin, 25mg/ml; Kan 
5mg/ml) to media when a temperature of >55°C is reached.  
 
LB agar plates 
Bacto tryptone                        5g 
Yeasy extract                                                  2.5g 
NaCl                        5g 
Agar                        8g 
ddH2O to final volume of 500ml 
Autoclave at 121°C for 20min and appropriate antibiotic (ampicillin, 25mg/ml; Kan 
5mg/ml) to media when a temperature of >55°C is reached, prior to pouring plates. 
 
10. YEAST MEDIA 
 
YPDA media 
Difco peptone                      10g 
Yeast extract                      10g 
Glucose                      10g 
L-adenine hemisulphate (0.2% stock)          7.5ml 
Autoclave at for 121°C 15min 
 
YPDA agar 
Difco peptone                                                  10g 
Yeast extract                        5g 
Glucose                      10g 
Bacto agar                      10g 
L-adenine hemisulphate (0.2% stock)          7.5ml 
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Autoclave at 121°C for 15min and allow to cool to approximately 55°C prior to 
pouring plates. 
 
SD-Trp media 
Glucose                      12g 
Yeast nitrogen base without amino acids         4g 
SD-Trp amino acid supplement                       0.4g 
0.2% adenine hemisulphate                     9ml 
ddH2O to a final volume of 600ml 
Autoclave at 121°C for 15min. 
 
SD-Trp plates 
Glucose                      12g 
Yeast nitrogen base without amino acids         4g 
SD-Trp amino acid supplement                       0.4g 
Bacto agar                      12g 
0.2% adenine hemisulphate                      9ml 
ddH2O to a final volume of 600ml 
Autoclave at 121°C for 15min and allow to cool to approximately 55°C prior to 
pouring plates. 
 
SD-Leu media 
Glucose                      12g 
Yeast nitrogen base without amino acids         4g 
SD-Leu amino acid supplement                     0.4g 
0.2% adenine hemisulphate                      9ml 
ddH2O to a final volume of 600ml 
Autoclave at 121°C for 15min. 
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SD-Leu plates 
Glucose                      12g 
Yeast nitrogen base without amino acids         4g 
SD-Leu amino acid supplement                     0.4g 
Bacto agar                      12g 
0.2% adenine hemisulphate                      9ml 
ddH2O to a final volume of 600ml 
Autoclave at 121°C for 15min and allow to cool to approximately 55°C prior to 
pouring plates. 
 
SD-Leu-Trp media 
Glucose                      12g 
Yeast nitrogen base without amino acids         4g 
SD-Leu-Trp amino acid supplement                   0.4g 
0.2% adenine hemisulphate                      9ml 
ddH2O to a final volume of 600ml 
Autoclave at 121°C for 15min. 
 
SD-Leu-Trp plates 
Glucose                      12g 
Yeast nitrogen base without amino acids         4g 
SD-Leu-Trp amino acid supplement                   0.4g 
Bacto agar                      12g 
0.2% adenine hemisulphate                      9ml 
ddH2O to a final volume of 600ml 
Autoclave at 121°C for 15min and allow to cool to approximately 55°C prior to 
pouring plates. 
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TDO media 
Glucose                      12g 
Yeast nitrogen base without amino acids         4g 
SD-Leu-Trp-His amino acid supplement              0.4g 
0.2% adenine hemisulphate                      9ml 
ddH2O to a final volume of 600ml 
Autoclave at 121°C for 15min. 
 
TDO plates 
Glucose                      12g 
Yeast nitrogen base without amino acids         4g 
SD-Leu-Trp-His amino acid supplement              0.4g 
Bacto agar                     12g 
0.2% adenine hemisulphate                            9ml 
ddH2O to a final volume of 600ml 
Autoclave at 121°C for 15min and allow to cool to approximately 55°C prior to 
pouring plates. 
 
QDO media 
Glucose                      12g 
Yeast nitrogen base without amino acids         4g 
SD-Leu-Trp-His-Ade amino acid supplement         0.4g 
0.2% adenine hemisulphate                      9ml 
ddH2O to a final volume of 600ml 
Autoclave at 121°C for 15min. 
 
QDO PLATES 
Glucose                      12g 
Yeast nitrogen base without amino acids         4g 
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SD-Leu-Trp-His-Ade amino acid supplement          0.4g 
Bacto agar                      12g 
0.2% adenine hemisulphate                      9ml 
ddH2O to a final volume of 600ml 
Autoclave at 121°C for 15min and allow to cool to approximately 55°C prior to 
pouring plates. 
 
11. EUKARYOTIC CELL CULTURE MEDIA 
 
Complete growth media 
DMEM                    90ml 
Hams F12                    90ml 
Foetal calf serum                    20ml 
 
Serum-free media 
DMEM                  100ml 
Hams F12                  100ml 
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APPENDIX II 
 
CALCULATING YEAST MATING EFFICIENCIES 
 
Count number of colonies on all plates with 30-300 colonies after 4 days 
 
#colony forming units (cfu)/ml=  cfu x 1000μl/ml 
  
  
 volume plated (μl) x dilution factor 
 
1. Number of cfu/ml on SD-L plates = viability of prey partner 
2. Number of cfu/ml on SD-W plates = viability of bait partner 
3. Number of cfu/ml on SD-L-W plates = viability of diploids 
4. Lowest Number of cfu/ml of SD-L or SD-W plates indicate limiting partner 
 
5. Mating efficiency= #cfu/ml of diploids x 100 
  
 #cfu/ml of limiting partner 
 
Library titre 
Count number of colonies on all plates with 30-300 colonies after 4 days 
 
#cfu/ml=   #colonies 
  plating volume(ml) x dilution factor 
 
# colonies clones screened= # cfu/ml x final resuspension volume 
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APPENDIX III 
 
LIST OF SUPPLIERS 
 
AciI  New England Biolabs 
Acrylamide  Merck 
Adenie hemisulphate  Bio101 
Agar  Merck 
Agarose  Whitehead Scientific 
AgNO3          Merck 
Ammonium persulphate        Merck 
Ampicillin          Roche 
Aptotinin          Roche 
Autoradiography film        Kodak 
BamHI                Promega 
BanII                 Promega 
β-galactose               Southern Cross 
BseRI                 New England Biolabs 
BsrI                 New England Biolabs 
Bis-acrylamide         Merck 
Boric acid          Merck 
Bromophenol blue         Merck 
Calf intestinal alkaline phosphatase           Promega 
Chloroform/octanol         Sigma 
dATP               Boerhinger Mannheim 
dCTP               Boerhinger Mannheim 
DdeI                                    Promega 
dGTP               Boerhinger Mannheim 
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DMEM        Highveld biological 
dNTP mix               TaKaRa 
DTT                  Roche 
dTTP             Boerhinger Mannheim 
EcoRI                                  Promega 
EcoRV                                 Promega 
EarI                                  Promega 
EDTA             Boerhinger Mannheim 
Ethanol            Boerhinger Mannheim 
Ex TaqTM polymerase                                TaKaRa 
Ex TaqTM polymerase Mg2+-containing reaction buffer                            TaKaRa 
FACS Lysing Solution              Beckton Dickenson 
Foetal calf serum                 Delta Bioproducts 
Formamide                                    Merck 
Formaldeyde                                    Merck 
Gelbond                                    Merck 
GFX® DNA purification kit          Amersham Pharmacia 
Glucose                                      Kimix 
Glycerol                       FMC Promega 
Great EScAPeTM chemiluminescence detection kit               BD Biosciences 
HA monoclonal antibody                                 Roche 
HaeIII                                Promega 
Ham’s H12               Highveld biological 
Herring sperm DNA                              Promega 
Hsp92II                               Promega 
Isopropanol                                   Merck 
K-acetate                                   Sigma 
Kanamycin                                  Roche 
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KCl                                   Merck 
Lambda DNA                             Promega 
LiAc                                   Sigma 
MatchmakerTM Mammalian Assay Kit 2               BD Biosciences 
MatchmakerTM Two-hybrid system 3                BD Biosciences 
Mineral oil                    BDH Chemicals 
MnlI                             Fermentas 
MgCl2                                       Bioline 
Myc monoclonal antibody                                     Roche 
NaAc                                        Merck 
NaCl                          BDH Chemicals 
Na2HPO4.7H2O  Merck 
Na2HPO4.H2O  Merck 
NaOH            Sigma 
NdeI                 Promega 
NlaIII                 New England Biolabs 
NruI                                    Promega 
Oligonucleotide primers Department of Molecular and Cell Biology, University of 
Cape Town (UCT), Cape Town, South Africa. 
pGBKT7              BD Biosciences 
PBS           Sigma 
PEG4000          Merck 
Penicillin/streptomycin        Highveld biological 
Peptone            Difco 
pG5SEAP               BD Biosciences 
pGBKT7               BD Biosciences 
pM                BD Biosciences 
PMSF           Roche 
Phenol          Merck 
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Phenol/choloform         Sigma 
Phenol/choroform/isoamyl        Sigma 
Proteinase K          Sigma 
pVP16              BD Biosciences 
QDO               BD Biosciences 
Qiagen Kit            Stratagene 
RNAse wipes                Ambion 
SDS                    Sigma 
SD-Leu               BD Biosciences 
SD-Trp               BD Biosciences 
SD-Leu-Trp                        BD Biosciences 
T4 Ligase                Promega 
Taq polymerase                   Bioline 
TDO                BD Biosciences 
TEMED                    Sigma 
TNT® Quick Coupled transcription/translation system                  BD Biosciences 
Tris           Merck 
Tris-OH Merck 
Tris-HCl Merck 
Trypsin Highveld biological 
Tryptone Fluka 
Urea BDH Chemicals 
Whatman 3M paper Whatman international 
Wizard® Purefection plasmid purification kit BD Bioscences 
X-α-galactsoe Southern Cross 
Yeast extract Difco 
Yeast nitrogen base (without amino acids) BD Biosciences 
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APPENDIX IV 
BACTERIAL STRAIN PHENOTYPE 
 
E.coli strain DH5α 
Φ 80d lacZΔM15 recA1, endA1, Gry A96 thi-1, hsdR17 supE44, relA1, deoR 
Δ(lacZYA argF)u169 
 
YEAST STRAIN PHENOTYPEs 
 
Yeast strain AH109 
MATa, trp1-901, leu2-3, ura3-5, his3-200, gal4Δ, gal80Δ, LYS2::GAL1uas-GAL1TATA-
HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZ (James et al., 
1996) 
 
Yeast strain Y187 
MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, gal4Δ, met-, gal80Δ, 
URA3::GAL1UAS-GAL1TATA-lacZ (Harper et al., 1993) 
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APPENDIX V 
Reference sequence with regions used to design primers to amplify the region encoding the 
COOH-terminal domain of Cx45. Region highlighted in turquoise, forward primer sequence 
atgcttcatttagggtttgggaccattcgagactcactaaacagtaaaaggagggaacttgaggatccgggtgcttataattatcctt
tcacttggaatacaccatctgctccccctggctataacattgctgtcaaaccagatcaaatccagtacaccgaactgtccaatgcta
agatcgcctacaagcaaaacaaggccaacacagcccaggaacagcagtatggcagccatgaggagaacctcccagctga
cctggaggctctgcagcgggagatcaggatggctcaggaacgcttggatctggcagttcaggcctacagtcaccaaaacaacc
ctcatggtccccgggagaagaaggccaaagtggggtccaaagctgggtccaacaaaagcactgccagtagcaaatcaggg
gatgggaagaactctgtctggatttaa 
 
Alignment of the sequenced Cx45-pGBKT7 bait construct (CO2_CN4_PGKK_06a) and its 
reverse complimentary sequence, against the reference sequence (Cx45 COOK-term) 
obtained from the Genbank database (www.ncbi.gov.org). Sequence highlighted in red 
represents the unaligned region of the vector sequence; green, regions of homology only 
between the Cx45-pGBKT7 bait construct and the reference sequence; black , regions of 
homology between the Cx45-pGBKT7 bait construct, the reverse complimentary sequence 
of the construct as well and the reference sequence. Dotted regions; no homology detected. 
 
pGBKT7 GAL4 DNA-binding domain of the pGBKT7 vector  
gja7%20cyto%20tail[ ........................................       
C02_CN4_PGBK_F_06.a caagtcaagcagttgttgtatcgccagnaatttgtaatac      
Reverse_Complement_ ........................................       
Consensus            
 
Cx45 COOH-term ref  ........................................      
C02_CN4_PGBK_F_06.a gactcactataacgcgagccgccatcatggtaggagcaga      
Reverse_Complement_ ........................................      
Consensus            
 
Cx45 COOH-term ref  .............................ATGCTTCATTT      
C02_CN4_PGBK_F_06.a agctgatctcagaggaggacctgcatatgATGCTTCATTT     
Reverse_Complement_ ........................................       
Consensus            
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Cx45 COOH-term ref  AGGGTTTGGGACCATTCGAGACTCACTAAACAGTAAAAGG      
C02_CN4_PGBK_F_06.a AGGGTTTGGGACCATTCGAGACTCACTAAACAGTAAAAGG     
Reverse_Complement_ Consensus            
 
Cx45 COOH-term ref  AGGGAACTTGAGGATCCGGGTGCTTATAATTATCCTTTCA      
C02_CN4_PGBK_F_06.a AGGGAACTTGAGGATCCGGGTGCTTATAATTATCCTTTCA     
Reverse_Complement_Consensus            
 
Cx45 COOH-term ref  CTTGGAATACACCATCTGCTCCCCCTGGCTATAACATTGC     
C02_CN4_PGBK_F_06.a CTTGGAATACACCATCTGCTCCCCCTGGCTATAACATTGC     
Reverse_Complement_Consensus    
         
Cx45 COOH-term ref  TGTCAAACCAGATCAAATCCAGTACACCGAACTGTCCAAT     
C02_CN4_PGBK_F_06.a TGTCAAACCAGATCAAATCCAGTACACCGAACTGTCCAAT     
Reverse_Complement_ ............TCAAATCCAGTACACCGAACTGTCCAAT      
Consensus                       tcaaatccagtacaccgaactgtccaat 
 
Cx45 COOH-term ref  GCTAAGATCGCCTACAAGCAAAACAAGGCCAAC.ACAGCC     
C02_CN4_PGBK_F_06.a GCTAAGATCGCCTACAAGCAAAACAAGGCCAACnACAGCC     
Reverse_Complement_ GCTAAGATCGCCTACAAGCAAAACAAGGCCAAC.ACAGCC      
Consensus           gctaagatcgcctacaagcaaaacaaggccaac acagcc 
 
Cx45 COOH-term ref  CAGG.AACAGCAGTATGGCAGCCATG.AGGAGAACCTCCC     
C02_CN4_PGBK_F_06.a CAGGnAACAGCAGTATGGCAGCCATGnAGGAGAACCTCCC     
Reverse_Complement_ CAGG.AACAGCAGTATGGCAGCCATG.AGGAGAACCTCCC     
Consensus           cagg aacagcagtatggcagccatg aggagaacctccc 
 
Cx45 COOH-term ref  AGCTGACCTGGAGGCTCTGCAGCGGGAG..ATCAGG.ATG     
C02_CN4_PGBK_F_06.a AGCTGACCTGGAGGCTCTGCAGCGGGAagnATCAGGnATG     
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Reverse_Complement_ AGCTGACCTGGAGGCTCTGCAGCGGGAG..ATCAGG.ATG     
Consensus           agctgacctggaggctctgcagcggga   atcagg atg 
 
Cx45 COOH-term ref  GCTCAGG.AACGCTTGG..ATCTGGCAG..TTCAGGCCTA     
C02_CN4_PGBK_F_06.a GCTCAGGnAACGCTTtGgnATCTGGCcagtTTCAGGCCTA     
Reverse_Complement_ GCTCAGG.AACGCTTGG..ATCTGGCAG..TTCAGGCCTA     
Consensus           gctcagg aacgctt g  atctggc    ttcaggccta 
 
Cx45 COOH-term ref  CAGTCACC..AAAACAACCCTCATGG.TCCCCGGGAGAAG     
C02_CN4_PGBK_F_06.a CAGntcaCcaAAAACAACCCTCATGGnTCCCCGGGAGAAa     
Reverse_Complement_ CAGTCACC..AAAACAACCCTCATGG.TCCCCGGGAGAAG     
Consensus           cag    c  aaaacaaccctcatgg tccccgggagaa 
 
Cx45 COOH-term ref  AAGGCCAAAGTGGGGTCCAAAGCTGGGTCCAACAAAAGCA     
C02_CN4_PGBK_F_06.a gAaa........GGGcCCAAAGnTGGGggntcCnAAAGCn     
Reverse_Complement_ AAGGCCAAAGTGGGGTCCAAAGCTGGGTCCAACAAAAGCA     
Consensus            a          ggg ccaaag tggg     c aaagc 
 
Cx45 COOH-term ref  CTGCCAGTAGCAAATCAGGGGATGGGAAGAACTCTGTCTG     
C02_CN4_PGBK_F_06.a tgGggntcc...............................     
Reverse_Complement_ CTGCCAGTAGCAAATCAGGGGATGGGAAGAcCTCcGTCTG     
Consensus             g 
 
Cx45 COOH-term ref  GATTTAA.................................     
C02_CN4_PGBK_F_06.a ........................................     
Reverse_Complement_ GATTTAAgaattcccggggatccgtcgacctgcagcggcc     
Consensus            
 
Cx45 COOH-term ref  ........................................     
C02_CN4_PGBK_F_06.a ........................................     
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Reverse_Complement_ gcataactagcataaccccttggggcctctaaacgggtct     
Consensus            
 
Cx45 COOH-term ref  ........................................     
C02_CN4_PGBK_F_06.a ........................................     
Reverse_Complement_ tgaggggttttttgcgcgcttgcagccaagctaattccgg     
Consensus            
 
Cx45 COOH-term ref  ........................................     
C02_CN4_PGBK_F_06.a ........................................     
Reverse_Complement_ gcgaatttcttatgatttatgatttttattattaaataag     
Consensus            
 
Cx45 COOH-term ref  ................                             
C02_CN4_PGBK_F_06.a ................                             
Reverse_Complement_ ttaaaaaaaaaaaaa     
Consensus        
 
Electropherogram sequences of preys clones in pVP16. Regions highlighted in pink, 
unaligned regions of the pVP16 vector; highlighted in turquoise, conserved regions of the 
GAL4-activation domain of the vector sequence; highlighted in red, restriction enzyme sites; 
regions in black, the prey specific regions of the construct. 
 
 
 
 
NADH dehydrogenase subunit 4 
 
CTGGACATGTTGGGGGACGGGGATTCCCCGGGGCCGGGATTTACCCCCCACGACTCCGCCCCCTACGGCGCTCTG
GATATGGCCGACTTCGAGTTTGAGCAGATGTTTACCGATGCCCTTGGAATTGACGAGGGGAATTCGCCCACGGGC
TTACATCCTCATTACTATTCTGCCTAGCAAACTCAAACTACGAACGCACTCACAGTCGCATCATAATCCTCTCTC
AAGGACTTCAAACTCTACTCCCACTAATAGCTTTTTGATGACTTCTAGCAAGCCTCGCTAACCTCGCCTTACCCC
CCACTATTAACCTACTGGGAGAACTCTCTGTGCTAGTAACCACGTTCTCCTGATCAAATATCACTCTCCTACTTA
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CAGGACTCAACATACTAGTCACAGCCCTATACTCCCTCTACATATTTACCACAACACAATGGGGCTCACTCACCC
ACCACATTAACAACATAAAACCCTCATTCACACGAGAAAACACCCTCATGTTCATACACCTATCCCCCATTCTCC
TCCTATCCCTCAACCCCGACATCATTACCGGGTTTTCCTCTTAAACATGTCGGCCGCCTCGGCCTCTAAGGGTGG
GCATCATACGGGATCCATCGAGCTCGAGCTGCARATGAATCGTAGATACTGAAAAACCCCGCAAGTTCACTTCAA
CTGTGCATCGTGCACCATCTCAATTTCTTTCATTTATACATCGTTTTGCCTTCTTTTATGTAACTATACTCCTCT
AAGTTTCAATCTTGGCCATGTAACCTCTGATCTATAGAATTTTTTAAATGACTAGAATTATGCCATCTTTTTTTG
GACCTAAATTCTCATGAAAATATATACGAGGGCTATCAGAGCTTGACTCCTCGCAGAGGTTTGTCAGTCTCATCA
GTGTCGGCTGTCTACTGCCGAATACGAAAGATGAACGTCATCGTTGTARAWCGTGTGACTTCGTAGCGATCTAGA
TTAGATTTWTATAGTTAAAAATGTTACAGTAGKACCTAGTACGAATCTATCTGAACGCTCGTG 
 
Thioredoxin 2 
 
TGGGGGACGGGGATTCCCCGGGGCCGGGATTTACCCCCCACGACTCCGCCCCCTACGGCGCTCTGGATATGGCCG
ACTTCGAGTTTGAGCAGATGTTTACCGATGCCCTTGGAATTGACGAGGGGAATTCGGGGGGAGGAAGTGACGACA
GGCGTGCCCTTGACAGGCAGGGAGGGCTAGGCTGTGCATCCCTCCGCTCGCATTGCAGGGAGATGGCTCAGCGAC
TTCTTCTGAGGAGGTTCCTGGCCTCTGTCATCTCCAGGAAGCCCTCTCAGGGTCAGTGGCCACCCCTCACTTCCA
GAGCCCTGCAGACCCCACAATGCAGTCCTGGTGGCCTGACTGTAACACCCAACCCAGCCCGGACAATATACACCA
CGAGGATCTCCTTGACAACCTTTAATATCCAGGATGGACCTGACTTTCAAGACCGAGTGGTCAACAGTGAGACAC
CAGTGGTTGTGGATTTCCACGCACAGTGGTGTGGACCCTGCAAGATCCTGGGGCCGAGGTTAGAGAAGATGGTGG
CCAAGCAGCACGGGAAGGTGGTGATGGCCAAGGTGGATATTGATGACCACACAGACCCCGCCATTGAGTATGAGG
TGTCAGCGGTGCCCACTGTGCTGGCCATGAAGAATGGGGACGTGGTGGACAAGTTTGTGGGCATCAAGGATGAGG
ATCAGTTGGAGGCCTTCCTGAAGAAGCTGATTGGCTGACAAGCAGGGATGAGTCCTGGTTCCCTTGCCCGCGTGG
GACCCCAATAGAACTCAGCCCTTCCATGCCAGCCCTTCCTGCTGCCTCCCTCCTGTCTGGCTCCTGGGGCCCATG
CTTAGAGCCCAGGCTCCAGCCCTGAGTGCTTCCGAGCTGGCGGACTGCCCAGGGGCCATCAGGATGGTGGTGCTG
CTGCTGATCCGGGGACCGCTGTCTTCCCTCCCATACGCCTTTCATCCCTCCTTCTAGGGCCTATGGCAGTTCTCC
CAGGATGTGTGGCGAGAGCCTGGGCCAGCCCACAGCGTCCTAGTCAGCAGCCACACCTTGGTCCTCATCTCTGTC
CTCATCTGAACCTCGTGCTGGCTCGTCTGCACTAMCATTCTCTTCAGCTGCTGTTTGCAAGAATAGTAGAATATA
CCTGTCGGCCGCCYGG 
 
Homo sapiens CD63-antigen 
 
AAAAGAAGCGTAAAGTCGCCCCCCCGACCGATGTCAGCCTGGGGGACGAGCTCCACTTAGACGGCGAGGACGTGG
CGATGGCGCATGCCGACGCGCTAGACGATTTCGATCTGGACATGTTGGGGGACGGGGATTCCCCGGGGCCGGGAT
TTACCCCCCACGACTCCGCCCCCTACGGCGCTCTGGATATGGCCGACTTCGAGTTTGAGCAGATGTTTACCGATG
CCCTTGGAATTGACGAGGGGAATTCGGGGAGAGAGCCCCGGAGCCGCGGCGGGAGAGGAACGCGCAGCCAGCCTT
GGGAAGCCCAGGCCCGGCAGCCATGGCGGTGGAAGGAGGAATGAAATGTGTGAAGTTCTTGCTCTACGTCCTCCT
GCTGGCCTTTTGCGCCTGTGCAGTGGGACTGATTGCCGTGGGTGTCGGGGCACAGCTTGTCCTGAGTCAGACCAT
AATCCAGGGGGCTACCCCTGGCTCTCTGTTGCCAGTGGTCATCATCGCAGTGGGTGTCTTCCTCTTCCTGGTGGC
TTTTGTGGGCTGCTGCGGGGCCTGCAAGGAGAACTATTGTCTTATGATCACGTTTGCCATCTTTTCTGTCTCTTA
TCATGTTGGTGGGAGGTGGCCGCAGCCATTGCTGGCTATGTGTTTAGAAGATAAGGTGATGTCAGAGTTTAATAA
AMACTTCCGGGCAGCARRATKGGARGAATTACCCCGAAAAAACACCCACACCTGCCTTCCGAATTCCTGGACAGG
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GATGCAAGCCAGATTTTACGTGCTGTGGGACTKGCTAACTACACAGATTTGGGAGAAAATTCCTTCAAKGTCGGG
AGGACGAGTTTCCGATTCTTGCCTGCCAATTAATT 
 
Myomegalin 
 
AGGACGTGGCGATGGCGCATGCCGACGCGCTAGACGATTTCGATCTGGACATGTTGGGGGACGGGGATTCCCCGG
GGCCGGGATTTACCCCCCACGACTCCGCCCCCTACGGCGCTCTGGATATGGCCGACTTCGAGTTTGAGCAGATGT
TTACCGATGCCCTTGGAATTGACGAGGGGGATCCGGGGACACATMCCMARAGACACTGAGAGAGACAGACAGACA
GTAAACAGAGGAGCACTAACCACAAACGGTTTACAAATGACCTCTGWGCTCATTCACCTGTCTGTTCCCCACCTT
GCCTTTTATARCAACTATAGCAACAGCCATGARAGTCATTGTGGAAAGAAATAAAATAAAATTAAAAAYTCCTGG
AAGCTTGTAAAGAATGTGAGCAAAGGGGARGAAGTTGYRAAWAAAATGAWCWA 
 
SCF apoptosis response protein 1 
 
TAAAGTCGCCCCCCCGACCGATGTCAGCCTGGGGGACGAGCTCCACTTAGACGGCGAGGACGTGGCGATGGCGCA
TGCCGACGCGCTAGACGATTTCGATCTGGACATGTTGGGGGACGGGGATTCCCCGGGGCCGGGATTTACCCCCCA
CGACTCCGCCCCCTACGGCGCTCTGGATATGGCCGACTTCGAGTTTGAGCAGATGTTTACCGATGCCCTTGGAAT
TGACGAGGGGAATTCCGGGGAGGGAAGGGGAAAGAGGTCACCAAGGGMAGAGGTGTCCAGGCCGGAGCCAGGGGC
CCCACTGTTGGGATGCTGGCTGCAGTGGGGCGCCCCAAGCCCAGGTCCCCTCTGTCTTCTCTTTCGACTTTGCAG
CTGTACTTGTTTTGCTCCTCTACCCGCAGGAGCTGACATGGACCCAAATCCTCGGGCCGCCCTGGAGCGCCAGCA
GCTCCGCCTTCGGGAGCGGCAAAAATTCTTCGAGGACATTTTACAGCCAGAGACAGAGTTTGTCTTTCCTCTGTC
CCATCTGCATCTCGAGTCGCAGAGACCCCCCATAGGTAGTATCTCATCCATGGAAGTGAATGTGGACACACTGGA
GCAAGTAGAACTTATTGACCTTGGGGACCCGGATGCAGCAGATGTGTTCTTGCCTTGCGAAGATCCTCCACCAAC
CCCCCAGTCGTCTGGGGTGGACAACCATTTGGAGGAGCTGAGCCTGCCGGTGCCTACATCAGACAGGACCACATC
TAGGACCTCCTCCTCCWCCTCCTCCRACTCCTCCACCAACCTGCATAGCCCAAATCCAAGTGATGATGGAGCAGA
TACGCCCTTGGCACAGTCGGATGAAGAGGAGGAAAGGGGTGATGGAGGGGCAGAGCCTGGAGCCTGCAGCTAGCA
GTGGGCCCCTGCCTACAGACTGACCACGCTGGCTATTCTCCACATGAGACCACAGGCCCAGCCAGAGCCTGTCGG
GAGAAGACCAGACTCTTTACTTGCAGTAGGCACCAGAGGTGGGAAGGATGGTGGGATTGTGTACCTTTCTAAGAA
TTAACCCTCTCCTGCTTTACTGCTAATTTTTTCCTGCTGCAACCTCCCAMCAGTTTTGGCTTACTCTGARATATG
ATTGCAATGAGAGAGARAGATGAGGTTGGACAAGATGCCACTGCTTTTCTAGCMCTCTTCCTCCCTAAACAATCC
GTAGTCTTTCTAATACAGTCTCTCAGAMCAGKGTCTCTGAATGATGTGAACTCATTACTCATCAAGTAAGAGTAG
SW 
 
Obscurin 
 
CCCTAAAAAGAAGCGTAAAGTCGCCCCCCCGACCGATGTCAGCCTGGGGGACGAGCTCCACTTAGACGGCGAGGA
CGTGGCGATGGCGCATGCCGACGCGCTAGACGATTTCGATCTGGACATGTTGGGGGACGGGGATTCCCCGGGGCC
GGGATTTACCCCCCACGACTCCGCCCCCTACGGCGCTCTGGATATGGCCGACTTCGAGTTTGAGCAGATGTTTAC
CGATGCCCTTGGAATTGACGAGGGGAATTCGGGGCAGCTGGCCCTCATCAGTGGTGGACTCTGTTCCCTCCTGCT
Stellenbosch University  https://scholar.sun.ac.za
 159 
 
CCCGGCTGGACAGGTAGCCTTGGGCACTGAAGTAGGATGAGGACTCCGTGGCATCTGCTGCAGTGTCATAGTCTG
TGCTTGTCAAGTCCACACGGAGCTCAGCCTTGGTGGAGGAGACACCCATGCTGTTCTCGGCCAGGCAGCGGTAGA
CGCCCATGTCTGCTGGCACCACGGCTGTGATGATGAGCTGATGGCCACCCTGTTGGTCTTCATTAATCATGTAGT
GATCATCCTCCTCCAAAAAACCTTGTCGGCCGCCTCGGCCTCTANAGGGTGGGCATCGATACGGGATCCATCGAG
CTCGAGCTGCANATGAATCGTAAATACTGAAAAACCCCGCAAGTTCACTTCAACTGTGCATCGTGCACCATCTCA
ATTTCTTTCATTTATACATCGTTTTGCCTTCTTTTATGTAACTATACTCCTCTAAGTTTCAATCTTGGCCATGTA
ACCTCTGATCTATANAATTTTTTAAATGACTANAATTAATGCCCATCTTTTTTTTTGGACCTAAATTCTTCATGA
AAATATATTACGAGGGCTTATNCAAAACTTTGGACNTCTTCCCCNNAAGTTTGGTCAAGTCCCCANTCANGGTTG
TCGGCTTGTCTACNTNGCCNAAAA 
 
Cytochrome C oxidase subunit 1 
 
GCCTCTGAGCTATTCCAGAAGTAGTGAAGAGGCTTTTTTGGAGGAGATCTAAGCTAGCGCCGCCACCATGGGCCC
TAAAAAGAAGCGTAAAGTCGCCCCCCCGACCGATGTCAGCCTGGGGGACGAGCTCCACTTAGACGGCGAGGACGT
GGCGATGGCGCATGCCGACGCGCTAGACGATTTCGATCTGGACATGTTGGGGGACGGGGATTCCCCGGGGCCGGG
ATTTACCCCCCACGACTCCGCCCCCTACGGCGCTCTGGATATGGCCGACTTCGAGTTTGAGCAGATGTTTACCGA
TGCCCTTGGAATTGACGAGGGGAATTCGGGGACCCCATTCTATACCAACACCTATTCTGATTTTTCGGTCACCCT
GAAGTTTATATTCTTATCCTACCAGGCTTCGGAATAATCTCCCATATTGTAACTTACTACTCCGGAAAAAAAGAA
CCATTTGGATACATAGGTATGGTCTGAGCTATGATATCAATTGGCTTCCTAGGGTTTATCGTGTGAGCACACCAT
ATATTTACAGTAGGAATAGACGTAGACACACGAGCATATTTCACCTCCGCTACCATAATCATCGCTATCCCCACC
GGCGTCAAAGTATTTAGCTGACTCGCCACACTCCACGGAAGCAATATGAAATGATCTGCTGCAGTGCTCTGGGCC
CTAGGATTCATCTTTCTTTTCACCGTAGGTGGCCTGACTGGCATTGTATTAGCAAACTCATCACTAGACATCGTA
CTACACGACACGTACTACGTTGTAGCTCACTTCCACTATGTCCTATCAATAGGAGCTGTATTTGCCATCATAGGA
GGCTTCATTCACTGATTTCCCCTATTCTCAGACTACACCCTAGACCAAACCTACGCCAAAATCCATTTCACTATC
ATATTCATCGGCGTAAATCTAACTTTCTTCCCACAACACTTTCTCGGCCTATCCGGAATGCCCCGACGTTACTCG
GACTACCCCGATGCATACACCACATGAAACATCCTATCATCTGTAGGCTCATTCATTTCTCTAACAGCAGTAATA
TTAATAATTTTCATGATTTGAGAAGCCTTCGCTTCGAAGCGAAAGTCCTAATAGTAGAAGAACCCTCCATAAACC
TGGAGTGACTATATGGATGCCCCCCCACCCTACCACACATTCGAGACCCGTATACATAAAATCTAGACAAAAAAA
GAGATCGACCCCCAAGCTGGTTCAGCACCATGCTCATGACTTTCAAAAAAACAGAAAAAACTGTTCGCGCCTCGC
YCTAAGTGCATCGAWCCGGATCCATCGRGCYTCGAGACTSA 
 
Electropherogram sequence of Cx45-bait fragment cloned in pM. Regions 
highlighted in pink, unaligned region of the pM vector; highlighted in turquoise, 
conserved regions of the GAL4-DNA binding domain of the vector sequence; 
highlighted in red, restriction enzyme site; region in black, the Cx45-bait specific 
region of the construct. 
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Cx45-pM bait construct for M2H 
 
TGTTAACAGGATTATTTGTACAAGATAATGTGAATAAAGATGCCGTCACAGATAGATTGGCTTCAGTGGAGACTG
ATATGCCTCTAACATTGAGACAGCATAGAATAAGTGCGACATCATCATCGGAAGAGAGTAGTAACAAAGGTCAAA
GACAGTTGACTGTATCGCCGGAATTCATGCTTCATTTAGGGTTTGGGACCATTCGAGACTCACTAAACAGTAAAA
GGAGGGAACTTGAGGATCCGGGTGCTTATAATTATCCTTTCACTTGGAATACACCATCTGCTCCCCCTGGCTATA
ACATTGCTGTCAAACCAGATCAAATCCAGTACACCGAACTGTCCAATGCTAAGATCGCCTACAAGCAAAACAAGG
CCAACACAGCCCAGGnAACAGCAGTATGGCAGCCATGAGGAGAACCTCCCAGCTGACCTGGAGGCTCTGCAGCGG
GAAGATCAGGATGGCTCAGGAACGCTTTGGATCTGGCCAGTTTCAGGCCTACAGTCCCCAAAAACAACCCTCATG
GTCCCCGGGAGAAAAAGGCCAAAGTGGGGTCCAAAGCTGGGTCCAACAAAAGCACTGCCAGTAGCAAATCAGGGG
ATGGGAAGAACTCTGTCTGG 
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